Section 72

EurekaMag PDF full texts Chapter 71,392


Yadava, O.P.; Winkler, B. 2018: Can we improve the results of venous grafts in CABG?. Indian Journal of Thoracic and Cardiovascular Surgery 34(4): 531
Cass, G.K.S.; Goyder, K.; Strachan, B.; Bahl, R. 2020: Can we improve women's experience of operative vaginal birth?. European Journal of Obstetrics Gynecology and Reproductive Biology 252: 424-430
Tournier, A.; Clouqueur, E.; Drumez, E.; Petit, C.él.; Guckert, M.; Houfflin-Debarge, V.ér.; Subtil, D.; Garabedian, C. 2020: Can we induce labor by mechanical methods following preterm premature rupture of membranes?. Journal of Gynecology Obstetrics and Human Reproduction 49(8): 101745
Farrier, J.N.; Farrier, S.; Haworth, S.; Beech, A.N. 2020: Can we justify the continued use of botulinum toxin a in the management of myofascial pain?. British Journal of Oral and Maxillofacial Surgery 58(9): 1133-1138
Folger, T. 2012: Can we keep getting smarter?. Scientific American 307(3): 44-47
Montravers, P.; Gouel-Cheron, A. 2021: Can we learn from others? The Swedish intensive care unit database for COVID-19 cases. European Journal of Anaesthesiology 38(4): 331-332
Khatoon, B.; Hill, K.B.; Walmsley, A.D. 2013: Can we learn, teach and practise dentistry anywhere, anytime?. British Dental Journal 215(7): 345-347
Bonsack, C. 1948: Can we leave decayed dentin under a filling?. Schweizerische Monatsschrift für Zahnheilkunde 58(6): 586-601
Marchand, R. 1949: Can we lower our maternal mortality rate?. Laval Medical 14(6): 758-764
Levine, A.M. 2001: Can we make a difference?. Journal of the American Academy of Orthopaedic Surgeons 9(5): 279
Temte, J.L.; Yusuf-Safavi, Y.; Shult, P.A. 2000: Can we make it better?. Family Medicine 32(9): 596-597
Nyssen, R. 1948: Can we measure intelligence?. Bruxelles Medical 28(47): 2455
Nyssen, R. 1948: Can we measure intelligence?. Le Scalpel 101(48): 1147
Sormani, M.Pia.; Bruzzi, P. 2015: Can we measure long-term treatment effects in multiple sclerosis?. Nature Reviews. Neurology 11(3): 176-182
Chen, Q. 2021: Can we migrate COVID-19 spreading risk?. Frontiers of Environmental Science and Engineering 15(3): 35
Płusa, T.; Badowska-Kozakiewicz, A. 2021: Can we minimize carbon footprint by using "greener" inhalers and improve clinical outcome at the same time in asthma therapy?. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 49(292): 252-254
Reilly, J.J. 2011: Can we modulate physical activity in children?. International Journal of Obesity 35(10): 1266-1269
Wilkin, T.J. 2011: Can we modulate physical activity in children? No. International Journal of Obesity 35(10): 1270-1276
Nocentini, U. 2020: Can we offer more for cognitive impairment in patients with chronic hepatitis C?. Arquivos de Neuro-Psiquiatria 78(6): 319-320
Agewall, S. 2020: Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?. European Heart Journal. Cardiovascular PharmacoTherapy 6(4): 201-202
Castelvecchi, D. 2016: Can we open the black box of AI?. Nature 538(7623): 20-23
Tuech, J.-J.; Schwarz, L. 2020: Can we operate our patients without fear during the period of COVID-19 infection?. Eclinicalmedicine 23: 100382
Gago, T.ân.; Caldeira, P.; Cunha, A.C.; Campelo, P.; Guerreiro, H.ác. 2021: Can we optimize CEA as a response marker in rectal cancer?. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(6): 423-428
Ankay Yilbas, A.; Basaran, B. 2020: Can we palpate cricothyroid membrane in children accurately?. Paediatric Anaesthesia 30(5): 629
Ahmed, N. 2020: Can we perform like "super-cripples" during this challenging pandemic? Opportunities for disabled people working in academia. Alter 14(3): 247-248
Macías, E.; Elosua González, A.; Juanmartiñena, J.é F.; Borda Martín, A.; Elizalde, I.; Fernández-Urién, I. 2022: Can we predict an incomplete capsule endoscopy? Results of a multivariate analysis using a logistic regression model. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 114(6): 329-334
Tei, S.; Becker, C.; Kawada, R.; Fujino, J.; Jankowski, K.F.; Sugihara, G.; Murai, T.; Takahashi, H. 2014: Can we predict burnout severity from empathy-related brain activity?. Translational Psychiatry 4: E393
Kim, J.; Lee, W.G.; Park, S.; Park, K.M. 2020: Can we predict drug response by functional connectivity in patients with juvenile myoclonic epilepsy?. Clinical Neurology and Neurosurgery 198: 106119
Saleh, S.N.; Makam, A.N.; Halm, E.A.; Nguyen, O.K. 2020: Can we predict early 7-day readmissions using a standard 30-day hospital readmission risk prediction model?. Bmc Medical Informatics and Decision Making 20(1): 227
Ito, M.; Seo, E.; Ogawa, R.; Sanuki, M.; Maeno, T.; Maeno, T. 2015: Can we predict future depression in residents before the start of clinical training?. Medical Education 49(2): 215-223
Röttjers, L.; Faust, K. 2019: Can we predict keystones?. Nature Reviews. Microbiology 17(3): 193
Szczypiński, F.T.; Bennett, S.; Jelfs, K.E. 2020: Can we predict materials that can be synthesised?. Chemical Science 12(3): 830-840
Hotchen, A.J.; Dudareva, M.; Corrigan, R.A.; Ferguson, J.Y.; McNally, M.A. 2020: Can we predict outcome after treatment of long bone osteomyelitis?. Bone and Joint Journal 2020: 1-10
Hotchen, A.J.; Dudareva, M.; Corrigan, R.A.; Ferguson, J.Y.; McNally, M.A. 2020: Can we predict outcome after treatment of long bone osteomyelitis?. Bone and Joint Journal 102-B(11): 1587-1596
Siao, F.-Y.; Chiu, C.-W.; Chiu, C.-C.; Chang, Y.-J.; Chen, Y.-C.; Chen, Y.-L.; Hsieh, Y.-K.; Chou, C.-C.; Yen, H.-H. 2020: Can we predict patient outcome before extracorporeal membrane oxygenation for refractory cardiac arrest?. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine 28(1): 58
Michalak, K.W.; Sobczak-Budlewska, K.; Moll, J.J.; Szymczyk, K.; Moll, J.A.; Niwald, M.; Dryżek, Pł.; Moll, M. 2019: Can we predict potentially dangerous coronary patterns in patients with transposition of the great arteries after an arterial switch operation?. Cardiology in the Young 29(11): 1350-1355
Fortelny, N.; Overall, C.M.; Pavlidis, P.; Freue, G.V.Cohen. 2017: Can we predict protein from mRNA levels?. Nature 547(7664): E19-E20
Veronig, A.M. 2020: Can we predict solar flares?. Science 369(6503): 504-505
Wheeler, M.; Grigg, L.; Zentner, D. 2014: Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?. Congenital Heart Disease 9(4): 326-332
Kara, M.; Kose, S.; Cayirci, C.E.; Koksal, A. 2019: Can we predict the compensatory hyperhidrosis following a thoracic sympathectomy?. Indian Journal of Thoracic and Cardiovascular Surgery 35(2): 190-195
Forsyth, J.R.; Tsai, M-Chang.; Sheppard, J.M.; Whitting, J.W.; Riddiford-Harland, D.L.; Steele, J.R. 2021: Can we predict the landing performance of simulated aerials in surfing?. Journal of Sports Sciences 2021: 1-10
Kapoor, D.; Perwaiz, A.; Singh, A.; Chaudhary, A. 2021: Can we predict the need of nutritional support following pancreatoduodenectomy?. AnnalsofHepato-Biliary-PancreaticSurgery 25(Suppl.1):S389
Pecha, S. 2021: Can we predict the risk for atrial fibrillation recurrence after concomitant surgical atrial fibrillation ablation and should this influence our treatment strategy?. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 59(6): 1225-1226
Vardar, Y.M.; Akturk, O.M. 2020: Can we predict the risk of conversion in elective laparoscopic cholecystectomy?. Annali Italiani di Chirurgia 91: 181-186
Katzenschlager, S.; Zimmer, A.J.; Gottschalk, C.; Grafeneder, J.; Seitel, A.; Maier-Hein, L.; Benedetti, A.; Larmann, J.; Weigand, M.A.; McGrath, S.; Denkinger, C.M. 2020: Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?. Medrxiv: the Preprint Server for Health Sciences 2020
Katzenschlager, S.; Zimmer, A.J.; Gottschalk, C.; Grafeneder, J.ür.; Schmitz, S.; Kraker, S.; Ganslmeier, M.; Muth, A.; Seitel, A.; Maier-Hein, L.; Benedetti, A.; Larmann, J.; Weigand, M.A.; McGrath, S.; Denkinger, C.M. 2021: Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?. Plos one 16(7): E0255154
Golestani, A.; Gras, R. 2014: Can we predict the unpredictable?. Scientific Reports 4: 6834
Yanovski, S.Z. 2006: Can we predict treatment response to antiobesity medication?. Nature Clinical Practice. Endocrinology and Metabolism 2(6): 314-315
Wang, A.Z.; Ehrman, R.; Bucca, A.; Croft, A.; Glober, N.; Holt, D.; Lardaro, T.; Musey, P.; Peterson, K.; Schaffer, J.; Trigonis, R.; Hunter, B.R. 2021: Can we predict which COVID-19 patients will need transfer to intensive care within 24 hours of floor admission?. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 28(5): 511-518
Murgatroyd, H.; Cox, A.; Ellingford, A.; Ellis, J.D.; Macewen, C.J.; Leese, G.P. 2008: Can we predict which patients are at risk of having an ungradeable digital image for screening for diabetic retinopathy?. Eye 22(3): 344-348
Şahan, E.; Ünal, S.M.; Kırpınar, İs. 2021: Can we predict who will be more anxious and depressed in the COVID-19 ward?. Journal of Psychosomatic Research 140: 110302
Freedland, S.J. 2005: Can we preoperatively identify men who are at high risk for aggressive prostate cancer?. Nature Clinical Practice. Urology 2(12): 584-585
Suyama, Y.; Okada, M. 2019: Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?. Annals of the Rheumatic Diseases 78(2): E17
Tamburello, L.; Chiarore, A.; Fabbrizzi, E.; Colletti, A.; Franzitta, G.; Grech, D.; Rindi, F.; Rizzo, L.; Savinelli, B.; Fraschetti, S. 2022: Can we preserve and restore overlooked macroalgal forests?. Science of the Total Environment 806(Part 4): 150855
Chen, F.; He, J.; Liu, Y.; Zheng, S. 2021: Can we pursue a "herd immunity" policy?. Infection Control and Hospital Epidemiology 42(12): 1539-1540
Lee, J.-K. 2021: Can we reach a 70% level of herd immunity to return to normality?. Osong Public Health and Research Perspectives 12(2): 51-53
Franssen, R.F.W.; Strous, M.T.A.; Vogelaar, F.J.; Janssen-Heijnen, M.L.G. 2021: Can we really conclude that treatment delays are associated with poorer outcome in patients with colorectal cancer awaiting elective surgery?. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 23(8): 2197-2198
Simhi, N.; Yovel, G. 2020: Can we recognize people based on their body-alone? the roles of body motion and whole person context. Vision Research 176: 91-99
Hellig, F. 2021: Can we reduce bleeding risk after interventional procedures?. Cardiovascular Journal of Africa 32(1): 3-4
Mathieu, C. 2004: Can we reduce hypoglycaemia with insulin detemir?. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 28 Suppl. 2: S35-S40
Aydin, M.; Dirik, Y.; Demir, C.; Tolunay, H.E.; Demir, H. 2021: Can we reduce oxidative stress with liver transplantation?. Journal of Medical Biochemistry 40(4): 351-357
Foster, S. 2021: Can we reduce the risk of burnout?. British Journal of Nursing 30(12): 763
Abdoolakhan, S.; Ong, K.T. 2021: Can we relax surveillance on more mobile older inpatients with high fall risk?. Australasian Journal on Ageing 40(2): 225-226
Farhadi, N. 2021: Can we rely on COVID-19 data? An assessment of data from over 200 countries worldwide. Science Progress 104(2): 368504211021232
Twiss, J.; Meads, D.M.; Preston, E.P.; Crawford, S.R.; McKenna, S.P. 2012: Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?. Journal of Investigative Dermatology 132(1): 76-84
Escat, M. 1949: Can we remove all or part of a clinically cancerous larynx without having obtained histological confirmation of the diagnosis?. Toulouse Medical 50(5): 278
Park, J.H.; Filho, A.R.; Pires, A.P.M.; Telles, G.J.é P.; Esteves, F.P.; Caffaro, R.A.; Parrillo, E.F. 2022: Can we replace computed tomography angiography by contrast-enhanced ultrasound in the surveillance of patients submitted to aortoiliac aneurysm repair?. Vascular 30(4): 803-808
Hill, B.L.; Moroney, M.R.; Post, M.D.; Sawyer, B.; Sheeder, J.; Wolsky, R.J.; Lefkowits, C. 2021: Can we safely forgo hysterectomy in non-fertility-sparing surgery for borderline ovarian tumors?. Gynecologic Oncology Reports 36: 100730
Iconaru, L.; Baleanu, F.; Taujan, G.; Duttmann, R.; Spinato, L.; Karmali, R.; Bergmann, P.; Hambye, A.-S. 2020: Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? - experience of the Brugmann hospital in Brussels. Thyroid Research 13: 15
Beukema, J.C.; Kawaguchi, Y.; Sijtsema, N.M.; Zhai, T-Tian.; Langendijk, J.A.; van Dijk, L.V.; van Luijk, P.; Teshima, T.; Muijs, C.T. 2020: Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 149: 222-227
Beukema, J.C.; Kawaguchi, Y.; Sijtsema, N.M.; Zhai, T.-T.; Langendijk, J.A.; van Dijk, L.V.; van Luijk, P.; Teshima, T.; Muijs, C.T. 2020: Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 149: 222-227
Kahn, M. 2014: Can we safely target the WNT pathway?. Nature Reviews. Drug Discovery 13(7): 513-532
Ness, E.; Skotte, J.R.; Christensen, T.B.; Andresen, J.F. 2020: Can we save more lives?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 140(8)
Khamsi, R. 2005: Can we score the millennium goals?. Nature 437(7057): 304
Malhotra, A.; Rachet, B.; Bonaventure, A.; Pereira, S.P.; Woods, L.M. 2021: Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data. Plos one 16(6): E0251876
Ling, G.N. 2014: Can we see living structure in a cell?. Physiological Chemistry and Physics and Medical NMR 43: 1-53; Discussion: 53-73
Nitta, K. 2007: Can we simplify the measurement of cardiovascular calcification in hemodialysis patients?. Nature Clinical Practice. Nephrology 3(5): 250-251
Schröder, S. 2007: Can we simplify the measurement of cardiovascular calcification in patients on hemodialysis?. Nature Clinical Practice. Cardiovascular Medicine 4(5): 248-249
Ratel, Sébastien.; Martin, V.; Tonson, A.; Cozzone, P.J.; Bendahan, D. 2012: Can we simply infer mitochondrial function from PCr resynthesis after exercise in skeletal muscle?. Pediatric Research 72(2): 221
Miceli, A.; Di Bacco, L.; Donatelli, F.; Glauber, M. 2021: Can we solve two problems with a TAVR?. International Journal of Cardiology 322: 95-96
McIsaac, D.I.; Boet, S. 2020: Can we sooth the subconscious during general anaesthesia?. Bmj 371: M4547
Landau, E. 1947: Can we speak of a vegetative innervation of the nerve cell?. Medecine et Hygiene 5(89): 7
Ottaviani, G. 1947: Can we speak of pituitary lymphocrine?. Bulletin d'Histologie Appliquee et de Technique Microscopique 24(7): 146-148
Bonati, E.; Bettoni, S.; Loderer, T.; Del Rio, P. 2021: Can we still consider thyroid hyperfunction a protective condition for the onset of thyroid cancer?. Gland Surgery 10(4): 1359-1367
Bonhomme 1948: Can we still cure cervical cancer at its very beginning?. Journal des Praticiens; Revue Generale de Clinique et de Therapeutique 62(41): 501-504
Folliasson, A.; Grepinet, H. 1949: Can we stop a thrombophlebitis at its initial stage?. Paris Medical 39(17): 181-184
Pushpam, D.; Kumar, L. 2019: Can we stop imatinib?. National Medical Journal of India 32(5): 296-297
Dickenson, A.H.; Kehlet, H. 2014: Can we stop pain before it starts?. Pain 155(2): 208-209
Taneichi, H.; Inami, S.; Moridaira, H.; Takeuchi, D.; Sorimachi, T.; Ueda, H.; Aoki, H.; Iimura, T. 2020: Can we stop the long fusion at L5 for selected adult spinal deformity patients with less severe disability and less complex deformity?. Clinical Neurology and Neurosurgery 194: 105917
Vila, J.; Strempler-Rubio, E.; Alvarado, A.él. 2021: Can we study episodic-like memory in preschoolers from an animal foraging model?. Journal of Experimental Psychology. Animal Learning and Cognition 47(3): 357-363
Elawady, H.; Mahmoud, M.A.; Samir, M. 2022: Can we successfully predict the outcome for extracorporeal shock wave lithotripsy (ESWL) for medium size renal stones? a single-center experience. Urologia 89(2): 235-239
Wurmser, L. 1947: Can we support or justify homeopathy by experimentation?. L' Homeopathie Francaise 23(3-4): 143-157
Papazian, H. 1948: Can we take care of our own teeth?. L' Information Dentaire 30(38): 1041
Taillé, C. 2020: Can we talk about asthma in the midst of a COVID-19 epidemic?. Revue des Maladies Respiratoires Actualites 12(1): S1-S2
Wolcott, M.D.; Quinonez, R.B.; Ramaswamy, V.; Murdoch-Kinch, C.A. 2020: Can we talk about trust? Exploring the relevance of "Entrustable Professional Activities" in dental education. Journal of Dental Education 84(9): 945-948
Henrickson, S.E. 2021: Can we teach a tired cell new tricks?. Science Immunology 6(64): Eabm 5115
Wilson, N.R. 2020: Can we teach psychiatry in medical school in a better way?. New Zealand Medical Journal 133(1517): 133-134
Fernandez, A.V.; Zahavi, D. 2021: Can we train basic empathy? a phenomenological proposal. Nurse Education Today 98: 104720
Hsu, C.-W.; Chiu, Y.-C.; Hu, H.-Y.; Fan, Y.-H.; Hong, S.-C.; Cheng, W.-M. 2020: Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? a population-based cohort study. Bmc Urology 20(1): 91
Lip, G.Y. 1997: Can we treat hypertensive menopausal women with hormone replacement therapy?. Journal of Human Hypertension 11(7): 397-399
Milling, S. 2021: Can we treat inflammation by managing misbehaving monocytes?. Immunology 163(1): 1-2
Al-Farsi, N.; Al Habsi, A. 2021: Can we treat retinopathy of prematurity under topical anesthesia?. Oman Journal of Ophthalmology 14(2): 67-68
van Tilburg, M.A.L. 2017: Can we treat visceral hypersensitivity in functional abdominal pain?. LANCET. Gastroenterology and Hepatology 2(10): 694-695
Naymagon, L. 2021: Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms. Pathology Research and Practice 218: 153321
Minha, S.'a.; Marcus, G. 2021: Can we Truly Predict Futility for TAVR Based on Pre-Procedural Indices?. Cardiovascular Revascularization Medicine: Including Molecular Interventions 23: 77-78
Darrigol, O. 2021: Can we trust Einstein's accounts of the genesis of special relativity?. Studies in History and Philosophy of Science 89: 138-154
Hernández, A.; Lakhani, K.; Núñez, J.H.; Mimendia, I.ña.; Pons, A.; Barro, V.íc. 2021: Can we trust combined anteversion and Lewinnek safe zone to avoid hip prosthesis dislocation?. Journal of Clinical Orthopaedics and Trauma 21: 101562
Skovlund, E. 2020: Can we trust subgroup analyses?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 140(7)
Mroz, D.; Wang, R.; Englert, U.; Dronskowski, R. 2020: Can we trust the experiment? Anisotropic displacement parameters in 1-(halomethyl)-3-nitrobenzene (halogen = Cl or Br). Acta Crystallographica. Section C Structural Chemistry 76(Part 6): 591-597
Schäfer, K.-H.; Christmann, A.; Gries, M. 2020: Can we trust the gut? the role of the intestine in neurodegeneration. Journal of Physiology 598(19): 4141-4142
Roessler, M.; Schmitt, J.; Schoffer, O. 2021: Can we trust the standardized mortality ratio? a formal analysis and evaluation based on axiomatic requirements. Plos one 16(9): E0257003
Hoskin, E.R.; Keenan, A.Veitz. 2016: Can we trust visual methods alone for detecting caries in teeth?. Evidence-Based Dentistry 17(2): 41-42
Valentina, G.; Amelia, F.; Carmine, S. 2020: Can we turn off the "Covid-biting-tail" inflammation?. Translational Medicine @ Unisa 23: 39-41
Djekic, I.; Ilic, J.; Guiné, R.P.F.; Tomasevic, I. 2020: Can we understand food oral processing using Kano model? Case study with confectionery products. Journal of Texture Studies 51(6): 861-869
Luhmann, H.J.; Fukuda, A. 2020: Can we understand human brain development from experimental studies in rodents?. Pediatrics International: Official Journal of the Japan Pediatric Society 62(10): 1139-1144
Traill, L.W.; Plard, F.; Gaillard, J.-M.; Coulson, T. 2021: Can we use a functional trait to construct a generalized model for ungulate populations?. Ecology 102(4): E03289
Deligözoğlu, D.; Kasap-Demir, B.; Alparslan, C.; Erbak, H.; Çatlı, G.ön.ül.; Mutlubaş, F.; Alaygut, D.; Soyaltın, E.; Arslansoyu-Çamlar, S.çi.; Yavaşcan, Ön. 2020: Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?. Journal of Pediatric Endocrinology and Metabolism: Jpem 33(12): 1551-1561
Baykan, A.R.; Baydar, I.; Şebin, E.; Ozdemir, Y.; Cerrah, S.; Albayrak, B.; Senyurt, M. 2021: Can we use endocan level to determine severity of pancreatitis?. Acta Gastro-Enterologica Belgica 84(2): 321-325
Amengual, J.E. 2020: Can we use epigenetics to prime chemoresistant lymphomas?. Hematology. American Society of Hematology. Education Program 1: 85-94
Gautret, P.; Lagier, J-Christophe.; Honoré, Séphane.; Hoang, V.Thuan.; Colson, P.; Raoult, D. 2021: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. International Journal of Antimicrobial Agents 57(1): 106243
Chen, J.; Liu, D.; Yin, L.; Zhang, L.; Lu, H. 2021: Can we use hydroxychloroquine to treat COVID-19 now?. International Journal of Antimicrobial Agents 57(1): 106173
Paulson, R.J. 2021: Can we use in vitro fertilization with preimplantation genetic testing to avoid molar pregnancies?. F&s Reports 2(2): 137
Merder, E.; Arıman, A.; Dinçer, S.; Altunrende, F. 2022: Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?. Urologia 89(2): 203-209
Díaz Lobato, S.; Carratalá Perales, J.é M.; Alonso Íñigo, J.é M. 2020: Can we use noninvasive respiratory therapies in COVID-19 pandemic?. Medicina Clinica 155(4): 183
Díaz Lobato, S.; Carratalá Perales, J.é M.; Alonso Íñigo, J.é M. 2020: Can we use noninvasive respiratory therapies in COVID-19 pandemic]?. Medicina Clinica 155(4): 183
Moridaira, H.; Inami, S.; Takeuchi, D.; Ueda, H.; Aoki, H.; Imura, T.; Taneichi, H. 2020: Can we use shorter constructs while maintaining satisfactory sagittal plane alignment for adult spinal deformity?. Journal of Neurosurgery. Spine 34(4): 589-596
Fairs, A.; Strijkers, K. 2021: Can we use the internet to study speech production? Yes we can! Evidence contrasting online versus laboratory naming latencies and errors. Plos one 16(10): E0258908
Boivin, A.; Delaunay, A. 1946: Can we, in terms of O antigen bacteria, distinguish absolutely haptens and complete antigens. Annales de l'Institut Pasteur 72: 139-143
Jones, L.; Tan, L.; Carey-Jones, S.; Riddell, N.; Davies, R.; Brownsdon, A.; Kelson, M.; Williams-Thomas, R.; Busse, M.; Davies, M.M.; Morgan, M.P.G. 2021: Can wearable technology be used to approximate cardiopulmonary exercise testing metrics?. Perioperative Medicine 10(1): 9
Střížová, Z.; Bartůňková, J.ři.; Smrž, D. 2020: Can wearing face masks in public affect transmission route and viral load in COVID-19?. Central European Journal of Public Health 28(2): 161-162
Breinl, K.; Di Baldassarre, G.; Girons Lopez, M.; Hagenlocher, M.; Vico, G.; Rutgersson, A. 2017: Can weather generation capture precipitation patterns across different climates, spatial scales and under data scarcity?. Scientific Reports 7(1): 5449
Rowland, S.T.; Chillrud, L.G.; Boehme, A.K.; Wilson, A.; Rush, J.; Just, A.C.; Kioumourtzoglou, M.-A. 2022: Can weather help explain 'why now?': the potential role of hourly temperature as a stroke trigger. Environmental Research 207: 112229
Allison, M. 2009: Can web 2.0 reboot clinical trials?. Nature Biotechnology 27(10): 895-902
Wen, C.P.; Wai, J.P.M.; Chen, C.H.; Gao, W. 2021: Can weight loss be accelerated if we exercise smarter with wearable devices by subscribing to Personal Activity Intelligence (PAI)?. Lancet Regional Health. Europe 5: 100133
Juniper, F.; Jameson, B.D.; Juniper, S.K.; Smith, C.R.; Bell, L.S. 2021: Can whale-fall studies inform human forensics?. Science and Justice: Journal of the Forensic Science Society 61(5): 459-466
Gazal, S.; Gosset, S.; Verdura, E.; Bergametti, Fçoise.; Guey, Séphanie.; Babron, M-Claude.; Tournier-Lasserve, E. 2016: Can whole-exome sequencing data be used for linkage analysis?. European Journal of Human Genetics: Ejhg 24(4): 581-586
Gies, E. 2016: Can wind and solar fuel Africa's future?. Nature 539(7627): 20-22
Dunker, Ø; Lie, M.U.; Nilsen, K.B. 2021: Can within-subject comparisons of thermal thresholds be used for diagnostic purposes?. Clinical Neurophysiology Practice 6: 63-71
Michalíková, Ažbeta.; Beck, Tézia.; Gáper, Ján.; Pristaš, P.; Gáperová, S. 2021: Can wood-decaying urban macrofungi be identified by using fuzzy interference system? An example in Central European Ganoderma species. Scientific Reports 11(1): 13222
Sánchez-Caballero, C.A.; Borges-Souza, J.M.; Abelson, A. 2021: Can wrecks serve as exploitable surrogate habitats for degraded natural reefs?. Marine Environmental Research 169: 105399
Günzler, C.; Kriston, L.; Stodden, V.; Leiber, C.; Berner, M.M. 2007: Can written information material help to increase treatment motivation in patients with erectile dysfunction? A survey of 1188 men. International Journal of Impotence Research 19(3): 330-335
G Mez, M.B.; Castro, P.A.; Mignone, C.; Bertero, H.D. 2011: Can yield potential be increased by manipulation of reproductive partitioning in quinoa (Chenopodium quinoa)? Evidence from gibberellic acid synthesis inhibition using Paclobutrazol. Functional Plant Biology: Fpb 38(5): 420-430
Mondal, S.; Mishra, J.S.; Poonia, S.P.; Kumar, R.; Dubey, R.; Kumar, S.; Verma, M.; Rao, K.K.; Ahmed, A.; Dwivedi, S.; Bhatt, B.P.; Malik, R.K.; Kumar, V.; McDonald, A. 2021: Can yield, soil C and aggregation be improved under long-term conservation agriculture in the eastern Indo-Gangetic plain of India?. European Journal of Soil Science 72(4): 1742-1761
Williams, K. 2008: Can your company survive a disaster?. Hawaii Dental Journal 39(6): 10
Roshni, S.Babu.; Sebastian, M.Thomas.; Surendran, K.Peethambharan. 2017: Can zinc aluminate-titania composite be an alternative for alumina as microelectronic substrate?. Scientific Reports 7: 40839
Güçlü, Z.A.ı; Çalışkan, S.çi.; Efe, Z.; Doğan, S. 2021: Can zirconia crowns be the first restorative choice after endodontic treatment of primary teeth?. International Journal of Clinical Practice 75(12): E14888
Riiser, A.; Stensrud, T.; Stang, J.; Andersen, L.B. 2020: Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs. British Journal of Sports Medicine 54(22): 1351-1359
Dirksen, K.M.; Judd, L. 2020: Can't Hit Pause? On the Constitutive Elements of Responsible Ventilator Management & the Apnea Test. American Journal of Bioethics: Ajob 20(6): 35-37
Sundin, A.; Balkan, W.; Hare, J.M. 2021: Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy. Journal of the American Heart Association 10(13): E021867
Ishøi, L.; Nielsen, M.F.; Hölmich, P.; Thorborg, K. 2020: Can't see the Right Forest Plot for the Wrong Trees!. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 36(11): 2787-2789
Schuster, J.E. 2021: Can't Touch This: a Novel Method of Contactless Respiratory Surveillance During a Novel time. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 73(11): E4419-E4420
Rawlings, S.A.; Scott, B.; Layman, L.; Naranatt, P.; Heltsley, R.; Ignacio, C.; Porrachia, M.; Gianella, S.; Smith, D.; Chaillon, A. 2021: Can't Work from Home: Pooled Nucleic Acid Testing of Laboratory Workers During the COVID-19 Pandemic. Open Forum Infectious Diseases 8(7): Ofab 129
Van den Hoek Ostende, M.M.; Neuser, M.P.; Teckentrup, V.; Svaldi, J.; Kroemer, N.B. 2021: Can't decide how much to EAT? Effort variability for reward is associated with cognitive restraint. Appetite 159: 105067
Hontela, S. 1994: Can't get away from Latin. Cmaj: Canadian Medical Association Journal 150(6): 824
Sotak, B.N.; Gleeson, J.G. 2012: Can't get there from here: cilia and hydrocephalus. Nature Medicine 18(12): 1742-1743
Wadman, M. 2006: Can't hide your lying eyes. Nature Medicine 12(5): 494
Peasley, M.C.; Hochstein, B.; Britton, B.P.; Srivastava, R.V.; Stewart, G.T. 2020: Can't leave it at home? the effects of personal stress on burnout and salesperson performance. Journal of Business Research 117: 58-70
Jacobs, H. 2010: Can't pay, must pay. Embo Reports 11(12): 897
Gulland, A. 1997: Can't pay, won't pay. Nursing Times 93(39): 17
Doyle, R. 2001: Can't read, can't count. Scientific American 285(4): 24
Vankov, D.; Schroeter, R.; Twisk, D. 2021: Can't simply roll it out: Evaluating a real-world virtual reality intervention to reduce driving under the influence. Plos one 16(4): E0250273
Sullman, M.J.M.; Przepiorka, A.M.; Błachnio, A.P.; Hill, T. 2021: Can't text, I'm driving - Factors influencing intentions to text while driving in the UK. Accident; Analysis and Prevention 153: 106027
Adam, R.; Bond, C.M.; Burton, C.D.; de Bruin, M.; Murchie, P. 2021: Can-Pain-a digital intervention to optimise cancer pain control in the community: development and feasibility testing. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 29(2): 759-769
Sankaran, S.; Dikshit, J.B.; Prakash Sv, C.; Mallikarjuna, S.E.; Somashekhar, S.P.; Patil, S.; Kumar, R.; Prasad, K.; Shet, D.; Bakre, M.M. 2021: CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario. Indian Journal of Surgical Oncology 12(Suppl 1): 21-29
McCusker, J.; Jones, J.M.; Li, M.; Faria, R.; Yaffe, M.J.; Lambert, S.D.; Ciampi, A.; Belzile, E.; de Raad, M. 2021: CanDirect: Effectiveness of a Telephone-Supported Depression Self-Care Intervention for Cancer Survivors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 39(10): 1150-1161
Zhang, W.; Zeng, B.; Lin, H.; Guan, W.; Mo, J.; Wu, S.; Wei, Y.; Zhang, Q.; Yu, D.; Li, W.; Chan, G.Chi-Fung. 2021: CanImmunother: a manually curated database for identification of cancer immunotherapies associating with biomarkers, targets, and clinical effects. Oncoimmunology 10(1): 1944553
Carver, T.; Hartley, S.; Lee, A.; Cunningham, A.P.; Archer, S.; Babb de Villiers, C.; Roberts, J.; Ruston, R.; Walter, F.M.; Tischkowitz, M.; Easton, D.F.; Antoniou, A.C. 2021: CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 30(3): 469-473
Soerjomataram, I.; Ervik, M.; Fox, C.; Hawkins, S.; Yeung, K.; Napolitano, G.; Tittenbrun, Z.; Bray, F.; Gavin, A. 2021: CanStaging+: an electronic staging tool for population-based cancer registries. LANCET. Oncology 22(8): 1069
Martin, J.C. 1984: Canada Health Act--the debate continues. Hospital Trustee 8(2): 4-5
Scott, P.F. 1984: Canada Health Act: a plan of attack. Canadian Medical Association Journal 130(1): 12
Butler, D.; Spurgeon, D. 1997: Canada and France fall out over the risks of asbestos. Nature 385(6615): 379
Jones, N. 2009: Canada assumes weighty mantle. Nature 460(7259): 1070
Spurgeon, D. 2003: Canada boosts spending on science. Nature 421(6926): 880
Jones, N. 2017: Canada budget falls flat with scientists. Nature 543(7647): 598-599
Owens, B. 2019: Canada budget overlooks basic research. Nature 567(7749): 443-444
Spurgeon, D. 1992: Canada commits money for human genome research. Nature 357(6378): 428
Jones, N. 2015: Canada creates science-minister post. Nature 527(7577): 146
Spurgeon, D. 1993: Canada decides, at last, to increase spending on AIDS. Nature 362(6417): 199
Dove, A. 2000: Canada expands networked research--up to a limit. Nature Medicine 6(3): 240
Houston, A.R.; Murthy, S. 2021: Canada is no global health leader on COVID-19 vaccine equity. Lancet 397(10287): 1803
Walker, T.R. 2021: Canada is right to classify single-use plastics as toxic. Nature 594(7864): 496
England, J. 2010: Canada needs a polar policy. Nature 463(7278): 159
Gallagher, R.; Passmore, M.J. 2020: Canada needs equitable, earlier access to palliative care. Cmaj: Canadian Medical Association Journal 192(20): E559
Scarabel, F.; Pellis, L.; Bragazzi, N.L.; Wu, J. 2020: Canada needs to rapidly escalate public health interventions for its COVID-19 mitigation strategies. Infectious Disease Modelling 5: 316-322
Spurgeon, D. 2000: Canada plans reduction in greenhouse-gas emissions. Nature 407(6806): 824
Dickson, D. 2001: Canada plans to give unified voice to science. Nature 412(6847): 573
Spurgeon, D. 2004: Canada pledges cash for more victims of blood-bank debacle. Nature 432(7017): 540
Spurgeon, D. 2001: Canada pours funds into health research. Nature 409(6820): 549
Brumfiel, G. 2003: Canada prepares to pull the plug on fusion project. Nature 425(6961): 887
Spurgeon, D. 1998: Canada putting its faith in consolidation in health sector. Nature 393(6686): 613
Check, E. 2004: Canada rings the changes for study of northern birds. Nature 430(7003): 957
Gilchrist, C.W. 1947: Canada sees new horizons for health education. American Journal of Public Health and the Nation's Health 37(11): 1415-1420
Dalton, R. 2001: Canada stakes claim on fusion energy project. Nature 411(6834): 122
Check, E. 2002: Canada stops Harvard's oncomouse in its tracks. Nature 420(6916): 593
Spurgeon, D. 1995: Canada to set up genome research centre in Toronto. Nature 373(6512): 274
Frantz, S. 2001: Canada tops cancer research impact list. Nature Medicine 7(12): 1261
Spurgeon, D. 2000: Canada unifies medical research community. Nature 405(6788): 722
Hoyle, B. 2000: Canada ushers in new era in health research. Nature Medicine 6(1): 8
Spurgeon, D. 1997: Canada wins biotech boost of cancer vaccine project. Nature 388(6639): 214
Spurgeon, D. 2001: Canada's BSE fears 'groundless'. Nature 409(6823): 968
MacPherson, N.; Montague, T.; Aylen, J.; Martin, L.; Gogovor, A.éd.é; Baxter, S.; Nemis-White, J. 2021: Canada's Evolving Medicare: End-of-Life Care. Journal of Palliative Care 36(3): 157-161
Spurgeon, D. 1996: Canada's HIV blood inquiry turns poisonous. Nature 384(6610): 602
Mitchell, C.A. 1953: Canada's Oldest Veterinary Practice. Canadian Journal of Comparative Medicine and Veterinary Science 17(6): 255-259
Mitchell, C.A. 1954: Canada's Oldest Veterinary Practice. Canadian Journal of Comparative Medicine and Veterinary Science 18(10): 357-358
Mitchell, C.A. 1955: Canada's Oldest Veterinary Practice. Canadian Journal of Comparative Medicine and Veterinary Science 19(3): 76-77
Mitchell, C.A. 1966: Canada's Oldest Veterinary Practice. Canadian Journal of Comparative Medicine and Veterinary Science 30(10): 287-289
Vogel, L. 2020: Canada's PPE crisis isn't over yet, say doctors. Cmaj: Canadian Medical Association Journal 192(20): E563
Krausz, R.M.; Wong, J.S.H.; Westenberg, J.N.; Choi, F.; Schütz, C.G.; Jang, K.L. 2021: Canada's Response to the Dual Public Health Crises: a Cautionary Tale. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 66(4): 349-353
Spurgeon, D. 1998: Canada's blood agency up and running. Nature 395(6702): 534
Duong, D. 2021: Canada's health system is at a breaking point, say medical leaders. Cmaj: Canadian Medical Association Journal 193(42): E1638
Kamran, R. 2021: Canada's history of failing to provide medical care for Indigenous children. Paediatrics and Child Health 26(5): 279-282
Webster, P. 2021: Canada's municipalities push for health-based climate action. Lancet 397(10268): 14-15
Macilwain, C. 2000: Canada's plans for neutrons stall. Nature 405(6783): 107-108
Armstrong, M.J. 2021: Canada's provinces and territories should disclose cannabis data to support research. Cmaj: Canadian Medical Association Journal 193(10): E341-E342
Hillier, S.A.; Chaccour, E.; Al-Shammaa, H.; Vorstermans, J. 2020: Canada's response to COVID-19 for Indigenous Peoples: a way forward?. Canadian Journal of Public Health 111(6): 1000-1001
Jones, N. 2015: Canada's top scientist faces tough challenge. Nature 528(7583): 445
Megyesi, J.F. 2020: Canada, Neurosurgery, and 5-Aminolevulinic Acid (5-ALA): the Long and Winding Road. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 47(6): 734-735
Reynolds, J.D.; Côté, I.M.; Favaro, B. 2012: Canada: A bleak day for the environment. Nature 487(7406): 171
Marchildon, G.P.; Allin, S.; Merkur, S. 2020: Canada: Health System Review. Health Systems in Transition 22(3): 1-194
Chen, J. 2002: Canada: Northern poles of excellence. Nature 415(6874): 831-832
Hoag, H. 2011: Canada: Quebec's research ambitions. Nature 471(7336): 125-126
Spurgeon, D. 1994: Canadian AIDS suit raises hopes for HIV-blood victims. Nature 368(6469): 281
Auer, A.M.; Andersson, R. 2001: Canadian Aboriginal communities and medical service patterns for the management of injured patients: a basis for surveillance. Public Health 115(1): 44-50
Spolaor, A.; Vallelonga, P.; Turetta, C.; Maffezzoli, Nò.; Cozzi, G.; Gabrieli, J.; Barbante, C.; Goto-Azuma, K.; Saiz-Lopez, A.; Cuevas, C.A.; Dahl-Jensen, D. 2016: Canadian Arctic sea ice reconstructed from bromine in the Greenland NEEM ice core. Scientific Reports 6: 33925
Fraser, K.; Brady, J. 2021: Canadian Dietitians' Understandings of, Attitudes Toward, and Engagement in Social Justice and Advocacy. Canadian Journal of Dietetic Practice and Research: a Publication of Dietitians of Canada 82(1): 2-10
King, L.; Yuan, J.Hao.; Li, H.; Do, V. 2021: Canadian Federation of Medical Students' response to " The alarming situation of medical student mental health". Canadian Medical Education Journal 12(3): 182-183
Walker, J.D.; O'Connell, M.E.; Pitawanakwat, K.; Blind, M.; Warry, W.; Lemieux, A.; Patterson, C.; Allaby, C.; Valvasori, M.; Zhao, Y.; Jacklin, K. 2021: Canadian Indigenous Cognitive Assessment (CICA): Inter-rater reliability and criterion validity in Anishinaabe communities on Manitoulin Island, Canada. Alzheimer's and Dementia 13(1): E12213
Dalton, J.B. 1996: Canadian MDs gone south dispute view of US medicine. Cmaj: Canadian Medical Association Journal 154(7): 1003-1004
Munro, M.G. 1992: Canadian Medicare: view from Utopia. Cmaj: Canadian Medical Association Journal 146(5): 674; Author Reply 674 676
Tanenbaum, H.L. 1992: Canadian Medicare: view from Utopia. Cmaj: Canadian Medical Association Journal 146(5): 674; Author Reply 674 676
Rasaiah, B. 1992: Canadian Medicare: view from Utopia. Cmaj: Canadian Medical Association Journal 147(2): 149-150
Aboujaoudé, A.; Bier, N.; Lussier, M.; Ménard, C.; Couture, M.él.; Demers, L.; Auger, C.; Pigot, H.él.èn.; Caouette, M.; Lussier-Desrochers, D.; Belchior, P. 2021: Canadian Occupational Therapists' use of Technology with Older Adults: a Nationwide Survey. Otjr: Occupation Participation and Health 41(2): 67-79
Stinchcombe, A.; Hopper, S.; Mullen, N.; Bédard, M. 2021: Canadian Older Adults' Perceptions of Transitioning from Driver to Non-Driver. Occupational Therapy in Health Care 2021: 1-21
Bennett, J.; Erker, C.; Lafay-Cousin, L.; Ramaswamy, V.; Hukin, J.; Vanan, M.I.; Cheng, S.; Coltin, H.; Fonseca, A.; Johnston, D.; Lo, A.; Zelcer, S.; Alvi, S.; Bowes, L.; Brossard, J.ée.; Charlebois, J.; Eisenstat, D.; Felton, K.; Fleming, A.; Jabado, N.; Larouche, V.ér.; Legault, G.èv.; Mpofu, C.; Perreault, S.éb.; Silva, M.; Sinha, R.; Strother, D.; Tsang, D.S.; Wilson, B.; Crooks, B.; Bartels, U. 2020: Canadian Pediatric Neuro-Oncology Standards of Practice. Frontiers in Oncology 10: 593192
Foley, R.; Kaedbey, R.; Song, K.; Venner, C.P.; White, D.; Doucette, S.; Christofides, A.; Reece, D.E. 2020: Canadian Perspective on Managing Multiple Myeloma during the COVID-19 Pandemic: Lessons Learned and Future Considerations. Current Oncology 27(5): 270-274
Eisen, A.; Taylor, D. 2021: Canadian Pioneers of Amyotrophic Lateral Sclerosis: a Brief History. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 48(5): 708-714
Yeung, C.; Shih, J.G.; Knox, A.D.C.; Zhygan, N.; Courtemanche, D.J.; Fish, J.S.; Brown, M.H.; Anastakis, D. 2020: Canadian Plastic Surgery Resident Operative Experience in Hand Surgery. Journal of Hand Surgery 45(9): 820-829
Keyes, M.; Leiter, M.; Ingledew, P.A.; Loewen, S.; Tyldesley, S.K.; Dosani, M.; Brundage, M.D. 2021: Canadian Radiation Oncology 2020, Work Engagement and Burnout Survey. International Journal of Radiation Oncology Biology Physics 111(3s): E194-E195
Lang, C.M.; McNicholas, D.; Wilson, M.P.; Hartery, A.; Probyn, L.J.; Ward, R. 2020: Canadian Radiology Medical Student Interest Groups: What They Are and How We Can Help Them Improve. Canadian Association of Radiologists Journal 71(2): 154-160
Haddad, H.; Bergeron, S.; Ignaszewski, A.; Searles, G.; Rochdi, D.; Dhage, P.; Bastien, N. 2020: Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction: Insight from the PARASAIL Study. Cjc Open 2(5): 344-353
Brown, R.E.; Vienneau, T.; Aronson, R. 2021: Canadian Real-World Outcomes of Omnipod Initiation in people with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry. Diabetic Medicine: a Journal of the British Diabetic Association 38(6): E14420
Giulivi, A. 1997: Canadian Red Cross seeks to reform itself. Nature 385(6617): 574
Hrabok, M.; Watterson, R.; DeVetten, G.; Wagner, A. 2020: Canadian Refugee Women Are at Increased Risk of Postpartum Depression: how can we Help?. Journal of Obstetrics and Gynaecology Canada: Jogc 42(11): 1391-1393
Hodgson, Z.ë G.; Latka, P. 2020: Canadian Registered Midwives' Experiences with Nipple Stimulation: An Exploratory Survey in British Columbia and Ontario. Journal of Obstetrics and Gynaecology Canada: Jogc 42(7): 861-867
Erdmann, R.; Morrin, L.; Harvey, R.; Joya, L.; Clifford, A.; Soroka, S. 2020: Canadian Senior Renal Leaders Community of Practice: Vulnerable Populations with Chronic Kidney Disease-Evidence to Inform Policy. Canadian Journal of Kidney Health and Disease 7: 2054358120930977
Smith, E.E.; Mountain, A.; Hill, M.D.; Wein, T.H.; Blacquiere, D.; Casaubon, L.K.; Linkewich, E.; Foley, N.; Gubitz, G.; Simard, A.; Lindsay, M.P. 2020: Canadian Stroke Best Practice Guidance During the COVID-19 Pandemic. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 47(4): 474-478
Williamson, L.E.; Lawson, K.L. 2021: Canadian Support for IVF Access and use. Journal of Obstetrics and Gynaecology Canada: Jogc 43(2): 175-181
Meisenheimer, E.S.; Rogers, T.S.; Saguil, A. 2021: Canadian Syncope Risk Score: a Validated Risk Stratification Tool. American Family Physician 103(6): 375-376
Powell, D.G.; McCallum, A.L. 2020: Canadian Transport Medicine: Waypoints and Destinations. Cjem 22(S2): S1-S3
Dol, J.; Hughes, B.; Tomblin Murphy, G.; Aston, M.; McMillan, D.; Campbell-Yeo, M. 2022: Canadian Women's Experience of Postnatal Care: a Mixed Method Study. Canadian Journal of Nursing Research 54(4): 497-507
Elias, P.H.; Montemurro, G.; Sulz, L.; Torrance, B.; Storey, K.E. 2020: Canadian after-school care providers' perceived role promoting healthy lifestyles: a focused ethnography. Bmc Public Health 20(1): 1279
Nadis, S. 2001: Canadian astronomers mount lobby effort. Nature 409(6817): 123
Shoesmith, C.; Abrahao, A.; Benstead, T.; Chum, M.; Dupre, N.; Izenberg, A.; Johnston, W.; Kalra, S.; Leddin, D.; O'Connell, C.; Schellenberg, K.; Tandon, A.; Zinman, L. 2020: Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. Cmaj: Canadian Medical Association Journal 192(46): E1453-E1468
Spurgeon, D. 2000: Canadian biomedical collaboration keeps on growing. Nature 403(6768): 350
Spurgeon, D. 2001: Canadian budget cranks up investment in research. Nature 414(6866): 832
Munro, M. 2015: Canadian budget pushes applied research. Nature 520(7549): 595-596
Rowe, S.; Rose, G.A. 2018: Canadian cod comeback derailed. Nature 556(7702): 436
Dalton, R. 2002: Canadian collaboration aims to protect tribes. Nature 417(6887): 371
Gyorkos, T.W.; Carabin, H.él.èn.; Phillip, M.; Benedict, L.; Davis, A.; Hatcher Roberts, J.; Wasan, K.M.; Ndao, M.; Krentel, A. 2021: Canadian contributions to research on neglected tropical diseases. Plos Neglected Tropical Diseases 15(7): E0009476
Dyer, O. 2020: Canadian court says wife cannot block husband's medically assisted death. Bmj 370: M3581
Dickson, D. 2001: Canadian doctors unhappy at prescribing 'medicine'. Nature Medicine 7(9): 983
Spurgeon, D. 1993: Canadian drug companies fund universities. Nature 363(6429): 484
Jones, N. 2016: Canadian earthquake detector has deep-sea edge over US rival. Nature 534(7608): 446-447
Bombay, K.; Murphy, M.S.Q.; Denize, K.M.; Sharif, A.; Sikora, L.; Murray, R.; Cobey, K.D.; Corsi, D.J. 2021: Canadian educational resources about cannabis use and fertility, pregnancy and breast feeding: a scoping review protocol. Bmj Open 11(2): E045006
Mulla, A.; Bigham, B.L.; Frolic, A.; Christian, M.D. 2020: Canadian emergency medicine and critical care physician perspectives on pandemic triage in COVID-19. Journal of Emergency Management 18(7): 31-35
Ajib, K.; Tjong, M.C.; Tan, G.H.; Nason, G.J.; Berjaoui, M.B.; Erlich, A.; Maganti, M.; Sridhar, S.S.; Fleshner, N.E.; Zlotta, A.R.; Catton, C.; Berlin, A.; Chung, P.; Kulkarni, G.S. 2020: Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer. Canadian Urological Association Journal 14(12): 404-410
Adrien, A.; Hankins, C.; Remis, R. 1988: Canadian experiences with AIDS and HIV infection. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 105(5-6): 464-474
Fox, J.L. 2001: Canadian farmer found guilty of Monsanto canola patent infringement. Nature Biotechnology 19(5): 396-397
Hoyle, B. 1999: Canadian farmers seek compensation for "genetic pollution". Nature Biotechnology 17(8): 747
Naylor, C.D.; Boozary, A.; Adams, O. 2020: Canadian federal-provincial/territorial funding of universal health care: fraught history, uncertain future. Cmaj: Canadian Medical Association Journal 192(45): E1408-E1412
Bonetta 1999: Canadian fight over thalassemia drug worsens. Nature Medicine 5(11): 1223
Chomyn, A.; Chan, E.S.; Yeung, J.; Vander Leek, T.K.; Williams, B.A.; Soller, L.; Abrams, E.M.; Mak, R.; Wong, T. 2021: Canadian food ladders for dietary advancement in children with IgE-mediated allergy to milk and/or egg. Allergy Asthma and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology 17(1): 83
Pala, C. 2011: Canadian forest deal at risk. Nature 471(7340): 560
Prentice, J. 2008: Canadian government is committed to science. Nature 452(7186): 409
Check, E. 2007: Canadian government pushed to protect land. Nature 447(7142): 241
Baltzan, M.; Baltzan, M. 1993: Canadian heart health care--product and cost. Canadian Journal of Cardiology 9(10): 863-864
Thiam, I. 1997: Canadian immunization cuts will cause child deaths. Canadian Journal of Public Health 88(4): 229
Spurgeon, D. 1997: Canadian inquiry calls for 'safety first' blood agency. Nature 390(6659): 432
Knight, J. 2002: Canadian lab loses Amgen backing. Nature 417(6884): 4
Hudson, A.; Mclaughlin, R.; Miller, S.; Holland, J.; Blake, K. 2020: Canadian medical schools' preclerkship paediatric clinical skills curricula: how can we improve?. Paediatrics and Child Health 25(8): 505-510
Glavas, P. 2002: Canadian medical students voice their concerns. Cmaj: Canadian Medical Association Journal 167(3): 234; Author Reply 235-6
Bastedo, C.; Bellaire, J.; Malhotra, J.; Mrkobrada, M.; Touw, A. 2002: Canadian medical students voice their concerns. Cmaj: Canadian Medical Association Journal 167(3): 235; Author Reply 235-6
Spurgeon, D. 2001: Canadian minister keeps researchers guessing. Nature 409(6819): 444
Sullivan, P. 1987: Canadian obstetric care system among finest in world, major CMA study finds. Cmaj: Canadian Medical Association Journal 136(6): 643; 646-649
Schiermeier, Q. 2011: Canadian ozone network faces axe. Nature 477(7364): 257-258
Fouché, J.; Christiansen, C.T.; Lafrenière, M.J.; Grogan, P.; Lamoureux, S.F. 2020: Canadian permafrost stores large pools of ammonium and optically distinct dissolved organic matter. Nature Communications 11(1): 4500
Foley, R.; Kaedbey, R.; Song, K.; Venner, C.P.; White, D.; Doucette, S.; Christofides, A.; Reece, D.E. 2020: Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations. Current Oncology 27(5): 270-274
Macpherson-Smith, M. 1993: Canadian physicians and euthanasia. Cmaj: Canadian Medical Association Journal 149(7): 926
Huapaya, L.V. 1993: Canadian physicians and euthanasia. Cmaj: Canadian Medical Association Journal 149(7): 926; 928
Duong, D. 2021: Canadian physicians frustrated with vaccine rollout. Cmaj: Canadian Medical Association Journal 193(13): E458-E459
Vandewater, S.; Douglas, H.E. 1994: Canadian physicians in wartime. Cmaj: Canadian Medical Association Journal 150(12): 1944; Author Reply 1945
Spurgeon, D. 2004: Canadian prime minister makes science a priority. Nature 427(6970): 91
Hoag, H. 2009: Canadian research infrastructure receives support, but will it last?. Nature Medicine 15(2): 121
Hoag, H. 2011: Canadian research shift makes waves. Nature 472(7343): 269
Malla, A.; Iyer, S.; Shah, J.; Joober, R.; Boksa, P.; Lal, S.; Fuhrer, R.; Andersson, N.; Abdel-Baki, A.; Hutt-MacLeod, D.; Beaton, A.; Reaume-Zimmer, P.; Chisholm-Nelson, J.; Rousseau, Cécile.; Chandrasena, R.; Bourque, J.; Aubin, D.; Levasseur, M.Anne.; Winkelmann, I.; Etter, M.; Kelland, J.; Tait, C.; Torrie, J.; Vallianatos, H. 2019: Canadian response to need for transformation of youth mental health services: ACCESS Open Minds (Esprits ouverts). Early Intervention in Psychiatry 13(3): 697-706
Spurgeon, D.; Smith, M. 1993: Canadian science gets Nobel gift. Nature 366(6457): 712
Hoag, H.; Goodyear, G. 2009: Canadian science minister under fire. Nature 458(7237): 393
Spurgeon, D. 2000: Canadian science told to look north. Nature 407(6803): 433
Owens, B. 2018: Canadian science wins billions in new budget. Nature 555(7695): 153
Owens, B. 2018: Canadian science wins billions in new budget. Nature 555(7695): 153
Tanentzap, A.J. 2012: Canadian science: Reallocate funds to boost performance. Nature 490(7421): 487
Spurgeon, D. 1993: Canadian study fuels move to limit rise in drug prices. Nature 362(6423): 780
Levine, M.A.; Luke, P.P.; Sener, A. 2020: Canadian survey on the rates of use of intraoperative diuretics and justification for their use during renal allograft reperfusion. Canadian Journal of Surgery. Journal Canadien de Chirurgie 63(5): E483-E488
Diaz, F.; Abbasi, S.J.; Fuller, D.; Diab, E. 2021: Canadian transit agencies response to COVID-19: Understanding strategies, information accessibility and the use of social media. Transportation Research Interdisciplinary Perspectives 12: 100465
Subbaraman, N. 2020: Canadian universities mourn researchers who died in Iran plane crash. Nature 577(7790): 301-302
Gaspar, D.L. 1995: Canadian vs. U.S. health care: which system is 'best'?. American Family Physician 52(2): 374
Spurgeon, D. 1998: Canadian whistleblower row prompts broader code of conduct. Nature 396(6713): 715
Reardon, S. 2015: Canadians baulk at reforms to health-research agency. Nature 520(7547): 272-273
Zhao, Y.; Li, Y.; Liu, Q.; Tang, Q.; Zhang, Z.; Zhang, J.; Huang, C.; Huang, H.; Zhang, G.; Zhou, J.; Yan, J.; Xia, Y.; Zhang, Z.; He, J. 2021: Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway. Drug Design Development and Therapy 15: 2117-2128
Nishinarita, R.; Niwano, S.; Niwano, H.; Nakamura, H.; Saito, D.; Sato, T.; Matsuura, G.; Arakawa, Y.; Kobayashi, S.; Shirakawa, Y.; Horiguchi, A.; Ishizue, N.; Igarashi, T.; Yoshizawa, T.; Oikawa, J.; Hara, Y.; Katsumura, T.; Kishihara, J.; Satoh, A.; Fukaya, H.; Sakagami, H.; Ako, J. 2021: Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model. Journal of the American Heart Association 10(2): E017483
Lin, F.; Song, C.; Zeng, Y.; Li, Y.; Li, H.; Liu, B.; Dai, M.; Pan, P. 2020: Canagliflozin alleviates LPS-induced acute lung injury by modulating alveolar macrophage polarization. International Immunopharmacology 88: 106969
Ashry, N.A.; Abdelaziz, R.R.; Suddek, G.M.; Saleh, M.A. 2021: Canagliflozin ameliorates aortic and hepatic dysfunction in dietary-induced hypercholesterolemia in the rabbit. Life Sciences 280: 119731
Yoshino, K.; Hosooka, T.; Shinohara, M.; Aoki, C.; Hosokawa, Y.; Imamori, M.; Ogawa, W. 2021: Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2. Biochemical and Biophysical Research Communications 557: 62-68
Wei, D.; Liao, L.; Wang, H.; Zhang, W.; Wang, T.; Xu, Z. 2020: Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro. Life Sciences 247: 117414
Hasan, R.; Lasker, S.; Hasan, A.; Zerin, F.; Zamila, M.; Parvez, F.; Rahman, M.Mizanur.; Khan, F.; Subhan, N.; Alam, M.Ashraful. 2020: Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK-Akt-eNOS pathway in the isoprenaline-induced oxidative stress model. Scientific Reports 10(1): 14659
Isreb, M.; Al-Makki, A.; Buatois, E. 2019: Canagliflozin and Renal Outcomes in Diabetic Nephropathy. New England Journal of Medicine 381(11): 1088
Lima, J.G.; Santos, M.C.; Simas, B.C. 2019: Canagliflozin and Renal Outcomes in Diabetic Nephropathy. New England Journal of Medicine 381(11): 1088-1089
Post, A.; Eisenga, M.F.; Bakker, S.J.L. 2019: Canagliflozin and Renal Outcomes in Diabetic Nephropathy. New England Journal of Medicine 381(11): 1089
Hasan, R.; Lasker, S.; Hasan, A.; Zerin, F.; Zamila, M.; Chowdhury, F.Islam.; Nayan, S.Islam.; Rahman, M.Mizanur.; Khan, F.; Subhan, N.; Alam, M.Ashraful. 2020: Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways. Scientific Reports 10(1): 14459
Sun, P.; Wang, Y.; Ding, Y.; Luo, J.; Zhong, J.; Xu, N.; Zhang, Y.; Xie, W. 2021: Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway. Iscience 24(6): 102521
Zhou, S.; Zhang, Y.; Wang, T.; Huang, S.; Gong, S.; Wang, J.; Yu, P. 2021: Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function. Diabetes and Metabolism 47(5): 101274
Kruger, D.; Valentine, V. 2020: Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: a Narrative Review. Diabetes Therapy: Research Treatment and Education of Diabetes and Related Disorders 11(6): 1237-1250
Hung, M-Hsin.; Chen, Y-Li.; Chen, L-Ju.; Chu, P-Yi.; Hsieh, F-Shu.; Tsai, M-Hsien.; Shih, C-Ting.; Chao, T-I.; Huang, C-Yuan.; Chen, K-Feng. 2019: Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation. Cell Death and Disease 10(6): 420
Mancini, S.J.; Boyd, D.; Katwan, O.J.; Strembitska, A.; Almabrouk, T.A.; Kennedy, S.; Palmer, T.M.; Salt, I.P. 2018: Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Scientific Reports 8(1): 5276
Secker, P.F.; Beneke, S.; Schlichenmaier, N.; Delp, J.; Gutbier, S.; Leist, M.; Dietrich, D.R. 2018: Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect. Cell Death and Disease 9(2): 226
Angé, M.; De Poortere, J.; Ginion, A.; Battault, S.; Dechamps, Mélanie.; Muccioli, G.G.; Roumain, M.; Morelle, J.; Druart, Sébastien.; Mathivet, T.; Bertrand, L.; Castanares-Zapatero, D.; Horman, S.; Beauloye, C. 2021: Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK. Scientific Reports 11(1): 13700
Morsy, M.A.; Khalaf, H.M.; Rifaai, R.A.; Bayoumi, A.M.A.; Khalifa, E.M.M.A.; Ibrahim, Y.F. 2021: Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomedicine and PharmacoTherapy 141: 111902
Shiba, K.; Tsuchiya, K.; Komiya, C.; Miyachi, Y.; Mori, K.; Shimazu, N.; Yamaguchi, S.; Ogasawara, N.; Katoh, M.; Itoh, M.; Suganami, T.; Ogawa, Y. 2018: Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. Scientific Reports 8(1): 2362
Ciudin, A.; Sánchez, M.; Hernandez, I.; Cordero, E.; Fidilio, E.; Comas, M.; Gonzalez, C.; Lopez, N.; Vilallonga, R.; Giralt, M.; Ferrer, R.; Hernández, C.; Simó, R. 2021: Canagliflozin: a new Therapeutic Option in Patients that Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: a Pilot Study. Obesity Facts 14(3): 291-297
Krisai, P.; Blum, S.; Schnabel, R.B.; Sticherling, C.; Kühne, M.; von Felten, S.; Ammann, P.; Pruvot, E.; Albert, C.M.; Conen, D. 2020: Canakinumab After Electrical Cardioversion in Patients with Persistent Atrial Fibrillation: a Pilot Randomized Trial. CIRCULATION. Arrhythmia and Electrophysiology 13(7): E008197
Generali, D.; Bosio, G.; Malberti, F.; Cuzzoli, A.; Testa, S.; Romanini, L.; Fioravanti, A.; Morandini, A.; Pianta, L.; Giannotti, G.; Viola, E.M.; Giorgi-Pierfranceschi, M.; Foramitti, M.; Tira, R.A.; Zangrandi, I.; Chiodelli, G.; Machiavelli, A.; Cappelletti, M.R.; Giossi, A.; De Giuli, V.; Costanzi, C.; Campana, C.; Bernocchi, O.; Sirico, M.; Zoncada, A.; Molteni, A.; Venturini, S.; Giudici, F.; Scaltriti, M.; Pan, A. 2021: Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 104: 433-440
Derlin, T.; Bengel, F.M. 2018: Canakinumab for Atherosclerotic Disease. New England Journal of Medicine 378(2): 196-197
Hjuler, K.F.; Egeberg, A. 2018: Canakinumab for Atherosclerotic Disease. New England Journal of Medicine 378(2): 197
Rothman, A.M.; Morton, A.C.; Crossman, D.C. 2018: Canakinumab for Atherosclerotic Disease. New England Journal of Medicine 378(2): 197-198
O'Neill, L.A.; Cooper, M.A. 2018: Canakinumab for Atherosclerotic Disease. New England Journal of Medicine 378(2): 198-199
Nerlekar, N.; Harper, R.W. 2018: Canakinumab for Atherosclerotic Disease. New England Journal of Medicine 378(2): 199
Kedor, C.; Listing, J.; Zernicke, J.; Weiß, A.; Behrens, F.; Blank, N.; Henes, J.Christoph.; Kekow, J.; Rubbert-Roth, A.; Schulze-Koops, H.; Seipelt, E.; Specker, C.; Feist, E. 2020: Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Annals of the Rheumatic Diseases 79(8): 1090-1097
Kedor, C.; Listing, J.; Zernicke, J.; Weiß, A.; Behrens, F.; Blank, N.; Henes, J.C.; Kekow, J.; Rubbert-Roth, A.; Schulze-Koops, H.; Seipelt, E.; Specker, C.; Feist, E. 2020: Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Annals of the Rheumatic Diseases 79(8): 1090-1097
Ucciferri, C.; Auricchio, A.; Di Nicola, M.; Potere, N.; Abbate, A.; Cipollone, F.; Vecchiet, J.; Falasca, K. 2020: Canakinumab in a subgroup of patients with COVID-19. Lancet. Rheumatology 2(8): E457-Ee458
Çakan, M.; Karadağ, Şe.G.ül.; Ayaz, N.A. 2020: Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases. Turkish Journal of Pediatrics 62(2): 167-174
Sheng, C.C.; Sahoo, D.; Dugar, S.; Prada, R.Aguillon.; Wang, T.Kai.Ming.; Abou Hassan, O.K.; Brennan, D.; Culver, D.A.; Rajendram, P.; Duggal, A.; Lincoff, A.Michael.; Nissen, S.E.; Menon, V.; Cremer, P.C. 2020: Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clinical cardiology 43(10): 1055-1063
Hage, W.; Zogheib, C.; Bukiet, F.éd.ér.; Sfeir, G.; Khalil, I.; Gergi, R.; Naaman, A. 2020: Canal Transportation and Centring Ability of Reciproc and Reciproc Blue with or Without use of Glide Path Instruments: a CBCT Study. European Endodontic Journal 5(2): 118-122
Chen, Y.; Tian, L. 2021: Canal surface evaporation along the China's South-to-North Water Diversion quantified by water isotopes. Science of the Total Environment 779: 146388
Mahdiani, S.; Lasminingrum, L.; Purwanto, B.; Handayani, R. 2021: Canal wall down in tuberculosis matoiditis: 4 case series. International Journal of Surgery Case Reports 83: 106029
Parvizi, F.; Rippin, J.W.; Edmondson, H.D. 1996: Canalicular adenoma of the palatal mucosa. British Dental Journal 181(1): 27-28
Pettas, E.; Theofilou, V.-I.; Georgaki, M.; Daskalopoulos, A.; Kalyvas, D.; Lazaris, A.C.; Younis, R.H.; Nikitakis, N.G. 2021: Canalicular adenoma with unicystic morphology. a rare entity. Journal of Clinical and Experimental Dentistry 13(1): E88-E94
Saini, P.; Bothra, N.; Ali, M.Javed. 2021: Canalicular fistula in a setting of chronic infective canaliculitis. Orbit 2021: 1
Hussain, I.; Bonshek, R.E.; Loudon, K.; Armstrong, M.; Tullo, A.B. 1993: Canalicular infection caused by Actinomyces. Eye 7: 542-544
Men, C.J.; Ko, A.C.; Ediriwickrema, L.S.; Liu, C.Y.; Kikkawa, D.O.; Korn, B.S. 2020: Canalicular laceration repair using a self-retaining, bicanalicular, hydrophilic nasolacrimal stent. Orbit 2020: 1-4
Raj, A.; Thakur, S.; Arya, K.S.; Kesarwani, P.; Sinha, U. 2020: Canalicular lacerations in a tertiary eye hospital: our experience with monocanalicular stents. Romanian Journal of Ophthalmology 64(2): 146-152
Shelley, A.M.; Rushton, V.E.; Horner, K. 1999: Canalis sinuosus mimicking a periapical inflammatory lesion. British Dental Journal 186(8): 378-379
Gibson, G.; Lacek, K.A. 2020: Canalization and Robustness in Human Genetics and Disease. Annual Review of Genetics 54: 189-211
Jojić, V.; Čabrilo, B.; Bjelić-Čabrilo, O.; Jovanović, V.M.; Budinski, I.; Vujošević, M.; Blagojević, J. 2021: Canalization and developmental stability of the yellow-necked mouse (Apodemus flavicollis) mandible and cranium related to age and nematode parasitism. Frontiers in Zoology 18(1): 55
Ohimain, E.I.; Eteh, D. 2021: Canalization induced topographic, hydrologic, and land use changes in Olero Creek, Benin River owing to petroleum exploration activities. Environmental Monitoring and Assessment 193(8): 528
Waddington, C.H. 1959: Canalization of development and genetic assimilation of acquired characters. Nature 183(4676): 1654-1655
Hornstein, E.; Shomron, N. 2006: Canalization of development by microRNAs. Nature Genetics 38 Suppl: S20-S24
Tricot, R.; Chiche, P.; Acar, J. 1957: Canalized thrombosis of the left auricle. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 33(35): 2221-2227
Gallardo, M.J.; Sarkisian, S.R.; Vold, S.D.; Singh, I.P.; Flowers, B.E.; Campbell, A.; Dhamdhere, K.; Samuelson, T.W. 2021: Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: Interim Results from the GEMINi Study. Clinical Ophthalmology 15: 481-489
Sun, P.; Liu, H.-W.; Zhou, P.-P.; Meng, Y. 2020: Canaloplasty for the treatment of primary open-angle glaucoma: a protocol of systematic review and meta-analysis. Medicine 99(22): E20408
Seuthe, A-Maria.; Szurman, P.; Januschowski, K. 2020: Canaloplasty with Suprachoroidal Drainage in Patients with Pseudoexfoliation Glaucoma - Four Years Results. Current Eye Research 2020: 1-7
Elksne, E.; Mercieca, K.; Prokosch-Willing, V. 2022: Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. European Journal of Ophthalmology 32(1): 712-716
Sayyid, Z.N.; Vaisbuch, Y.; Sajjadi, A.; Sajjadi, H. 2021: Canalplasty for Exostosis Removal Comparing Microscopic Versus Endoscopic Ear Surgery Techniques. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 42(10): E1661-E1668
Thomas, O.L. 1955: Canals within pancreas cells. Nature 176(4490): 978-979
Kimrey, J.; Vo, T.; Bertram, R. 2020: Canard analysis reveals why a large Ca2+ window current promotes early afterdepolarizations in cardiac myocytes. Plos Computational Biology 16(11): E1008341
Köksal Ersöz, E.; Wendling, F. 2021: Canard solutions in neural mass models: consequences on critical regimes. Journal of Mathematical Neuroscience 11(1): 11
Alejandro, J. 2021: Canaries in the Coal Mine. Professional Case Management 26(1): 34-35
McDerby, N.; Bail, K.; Kosari, S.; Shield, A.; Peterson, G.; Dawda, P.; Naunton, M. 2020: Canaries in the coalmine: Stakeholder perspectives of medication management reviews for residents with dementia. Research in Social and Administrative Pharmacy: Rsap 16(9): 1220-1227
Dalli, J.; Khan, M.F.; Nolan, K.; Cahill, R.A. 2021: Canaries in the mine. British Journal of Surgery 108(2): E69-E70
Bray, N. 2020: Canaries record song history. Nature Reviews. Neuroscience 21(9): 450-451
Leiden, J.M. 2008: Canaries, coal mines and the drug supply. Nature Biotechnology 26(6): 624-626
Sokoudjou, J.Baptiste.; Tagousop, C.Ngoufack.; Khan, A.; Fodouop, Séon.Pierre.Chegaing.; Atsafack, S.Secco.; Kodjio, N.; Atolani, O.; Gatsing, D. 2020: Canarimoic acid: new tirucallane triterpene with antisalmonellal activity from the stem bark of Canarium schweinfurthii Engl. Natural Product Research 2020: 1-7
Punjani, N.; Lamb, D.J. 2020: Canary in the Coal Mine? Male Infertility as a Marker of Overall Health. Annual Review of Genetics 54: 465-486
Stone, W.; Louw, T.M.; Booysen, M.J.; Wolfaardt, G.M. 2021: Canary in the coliform mine: Exploring the industrial application limits of a microbial respiration alarm system. Plos one 16(3): E0247910
Odin, L.; Favrot, M.; Poujol, D.; Michot, J.P.; Moingeon, P.; Tartaglia, J.; Puisieux, I. 2001: Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53. Cancer Gene Therapy 8(2): 87-98
Lotun, A.; Gessler, D.J.; Gao, G. 2021: Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair. Frontiers in Cellular Neuroscience 15: 661928
Gowda, V.K.; Bharathi, N.K.; Bettaiah, J.; Bhat, M.; Shivappa, S.K. 2021: Canavan Disease: Clinical and Laboratory Profile from Southern Part of India. Annals of Indian Academy of Neurology 24(3): 347-350
Watterson, T.L.; Stone, J.A.; Brown, R.; Xiong, K.Z.; Schiefelbein, A.; Ramly, E.; Kleinschmidt, P.; Semanik, M.; Craddock, L.; Pitts, S.; Woodroof, T.; Chui, M.A. 2021: CancelRx: a health IT tool to reduce medication discrepancies in the outpatient setting. Journal of the American Medical Informatics Association: Jamia 28(7): 1526-1533
Schmidt, R.; Leventhal, D.K.; Mallet, N.; Chen, F.; Berke, J.D. 2013: Canceling actions involves a race between basal ganglia pathways. Nature Neuroscience 16(8): 1118-1124
Sakai, T.; Jinno, T.; Hoshino, C.; Okawa, A. 2019: Cancellation Criteria of Acute Rehabilitation: Rehabilitation Risk Management. Progress in Rehabilitation Medicine 4: 20190013
Reichhardt, T. 2005: Cancellation e-mail shakes recipients of outer-planet grants. Nature 433(7025): 447
Di Domenico, G.; Ruocco, G.; Colosi, C.; DelRe, E.; Antonacci, G. 2018: Cancellation of Bessel beam side lobes for high-contrast light sheet microscopy. Scientific Reports 8(1): 17178
Karki, O.B.; Hazra, N.K.; Timilsina, B. 2020: Cancellation of Elective General Surgical Operations on the day of Surgery. Journal of Nepal Health Research Council 18(2): 201-204
Koh, W.X.; Phelan, R.; Hopman, W.M.; Engen, D. 2021: Cancellation of elective surgery: rates, reasons and effect on patient satisfaction. Canadian Journal of Surgery. Journal Canadien de Chirurgie 64(2): E155-E161
Okeke, C.J.; Obi, A.O.; Tijani, K.H.; Eni, U.E.; Okorie, C.O. 2020: Cancellation of elective surgical cases in a nigerian teaching hospital: Frequency and reasons. Nigerian Journal of Clinical Practice 23(7): 965-969
Wu, R.L. 2005: Cancellation of operations on the day of intended surgery at a major Australian referral hospital. Medical Journal of Australia 183(10): 551; Discussion 551
Wang, B. 2015: Cancellation of the zeroth order by a low-contrast grating. Scientific Reports 5: 16501
Ferreira, J.; Boto, P. 2021: Cancellations of Elective Surgeries on the day of the Operation in a Portuguese Hospital: one year Overview. Acta Medica Portuguesa 34(2): 103-110
Thomson, P.J. 1991: Cancelled operations. A current problem in oral and maxillofacial surgery. British Dental Journal 171(8): 244-245
Cressey, D. 2012: Cancelled project spurs debate over geoengineering patents. Nature 485(7399): 429
Eng, C.; Plass, C. 2020: Cancer (Epi)Genomics Comes of Age. Human Molecular Genetics 29(R2): R127
von Loga, K.; Gerlinger, M. 2017: Cancer (r)evolution. Nature Ecology and Evolution 1(8): 1051-1052
Bosevski, M.; Trajkovska, E.L.; Krstevski, G.; Aliu, F.; Salkoski, S.; Matkova, D.; Trajkovski, A.; Bojovski, I.; Mitevska, I.; Stavrik, S.; Candelera, R.O.; Pavkovic, M. 2021: Cancer - Associated Thrombosis - a Study of Cases. Prilozi 42(2): 89-97
Ruggeri, B. 2021: Cancer 2021: new therapeutic approaches for the treatment of cancer - building on advances in cancer biology and the molecular genetics of cancer. Current Opinion in Pharmacology 60: 341-345
Yabuuchi, T.; Miura, K.; Shimizu, S.; Kaneko, N.; Ishizuka, K.; Kanda, S.; Chikamoto, H.; Akioka, Y.; Fujieda, M.; Hattori, M. 2021: Cancer After Pediatric Kidney Transplantation: a Long-term Single-center Experience in Japan. Transplantation Direct 7(4): E687
Ostwal, V.; Ramaswamy, A.; Bhargava, P.; Hatkhambkar, T.; Swami, R.; Rastogi, S.; Mandavkar, S.; Ghosh, J.; Bajpai, J.; Gulia, S.; Srinivas, S.; Rath, S.; Gupta, S. 2021: Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. Bmj Open 11(6): E047376
Goodwin, P.J.; Dowling, R.J.O.; Ennis, M.; Chen, B.E.; Parulekar, W.R.; Shepherd, L.E.; Gelmon, K.A.; Whelan, T.J.; Ligibel, J.A.; Hershman, D.L.; Mayer, I.A.; Hobday, T.J.; Rastogi, P.; Rabaglio-Poretti, M.; Lemieux, J.; Thompson, A.M.; Rea, D.W.; Stambolic, V. 2021: Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: a Breast Cancer Randomized Trial of Metformin vs Placebo. Jnci Cancer Spectrum 5(5)
Grewal, S.; Behniwal, N.; Kaur, J.; Mann, R.; Rao, R. 2021: Cancer Arising in a Duodenal Duplication Cyst: a Rare Genetic Anomaly. Cureus 13(4): E14782
VON Hoerschelmann, E.; Neumann, C.C.M.; Felsenstein, M.; Gogolok, J.; Reutzel-Selke, A.; Sauer, I.M.; Pratschke, J.; Bahra, M.; Schmuck, R.B. 2021: Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and their Role in Cell Migration. Anticancer Research 41(9): 4229-4238
Chen, L.-B.; Zhu, S.-P.; Liu, T.-P.; Zhao, H.; Chen, P.-F.; Duan, Y.-J.; Hu, R. 2021: Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO/Kyn/AhR Dependent Signaling Pathway. Frontiers in Oncology 11: 628821
Stahl, S.T.; Neagoe, I.; Smagula, S.F.; Posluszny, D.; Bovbjerg, D.H. 2020: Cancer Bereavement and Depression Symptoms in Older Spouses: The Possible Modifying Role of the Circadian Rest-Activity Rhythm. Clinical Gerontologist 2020: 1-7
Lam, S.T.T.; Lim, C.J. 2021: Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57. Progress in Molecular and Subcellular Biology 59: 181-196
Piña-Sánchez, P.; Chávez-González, A.; Ruiz-Tachiquín, M.; Vadillo, E.; Monroy-García, A.; Montesinos, J.J.é; Grajales, R.ío.; Gutiérrez de la Barrera, M.; Mayani, H. 2021: Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges from a Biomedical Perspective. Cancer Control: Journal of the Moffitt Cancer Center 28: 10732748211038735
Zhang, H.; Ba, S.; Lee, J.Y.; Xie, J.; Loh, T.-P.; Li, T. 2020: Cancer Biomarker-Triggered Disintegrable DNA Nanogels for Intelligent Drug Delivery. Nano Letters 20(11): 8399-8407
Yamada, T.; Ashida, Y.; Tatebayashi, D.; Abe, M.; Himori, K. 2020: Cancer Cachexia Induces Preferential Skeletal Muscle Myosin Loss when Combined with Denervation. Frontiers in Physiology 11: 445
Fujii, H.; Makiyama, A.; Iihara, H.; Okumura, N.; Yamamoto, S.; Imai, T.; Arakawa, S.; Kobayashi, R.; Tanaka, Y.; Yoshida, K.; Suzuki, A. 2020: Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients with Advanced Gastric Cancer. Anticancer Research 40(12): 7067-7075
Ni, J.; Zhang, L. 2020: Cancer Cachexia: Definition, Staging, and Emerging Treatments. Cancer Management and Research 12: 5597-5605
Febbraro, M.; Conlon, M.; Caswell, J.; Laferriere, N. 2020: Cancer Care Access in Northwestern Ontario-A Population-Based Study Using Administrative Data. Current Oncology 27(4): 408-419
Amundsen, D.B.; Choi, Y.; Nekhlyudov, L. 2021: Cancer Care Continuum Research and Educational Innovation: Are Academic Internists Keeping up with Population Trends?. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 2021
Shankar, A.; Saini, D.; Richa; Goyal, N.; Roy, S.; Angural, H.; Kaushal, V.; Bharati, S.J.; Upadhyaya, R.; Durga, T. 2021: Cancer Care Delivery Challenges in India during the COVID-19 Era: Are we Prepared for the Postpandemic Shock?. Asia-Pacific Journal of Oncology Nursing 8(1): 1-4
Falcone, R.; Grani, G.; Ramundo, V.; Melcarne, R.; Giacomelli, L.; Filetti, S.; Durante, C. 2020: Cancer Care During COVID-19 Era: the Quality of Life of Patients with Thyroid Malignancies. Frontiers in Oncology 10: 1128
Jafari, A.; Rezaei-Tavirani, M.; Karami, S.; Yazdani, M.; Zali, H.; Jafari, Z. 2020: Cancer Care Management During the COVID-19 Pandemic. Risk Management and Healthcare Policy 13: 1711-1721
Dusetzina, S.B. 2021: Cancer Care Under the Biden Administration. JAMA 325(6): 527-528
Olazagasti, C.; Duma, N. 2020: Cancer Care for All? Tales of Caring for Undocumented Patients with Cancer. Oncologist 25(7): 552-554
Mula-Hussain, L.; Al-Ghazi, M. 2020: Cancer Care in Times of War: Radiation Oncology in Iraq. International Journal of Radiation Oncology Biology Physics 108(3): 523-529
Yadav, S.K.; Luwaga, R.K.; Hambardzumyan, V.; Yadav, N.; Jaiswal, S.K. 2021: Cancer Care in the Era of COVID-19: Changing Rules of Engagement of Social Media Applications to Support Cancer Patients in LMICs. Indian Journal of Surgical Oncology 12(1): 117-118
Ades, S.; Herrera, D.A.; Lahey, T.; Thomas, A.A.; Jasra, S.; Barry, M.; Sprague, J.; Dittus, K.; Plante, T.B.; Kelly, J.; Kaufman, P.A.; Khan, F.; Hammond, C.J.; Gernander, K.; Parsons, P.; Holmes, C. 2022: Cancer Care in the Wake of a Cyberattack: how to Prepare and what to Expect. Jco Oncology Practice 18(1): 23-34
Vuattoux, D.; Colomer-Lahiguera, S.; Fernandez, P.-A.; Jequier Gygax, M.; Choucair, M.-L.; Beck-Popovic, M.; Diezi, M.; Manificat, S.; Latifyan, S.; Ramelet, A.-S.; Eicher, M.; Chabane, N.; Renella, R. 2020: Cancer Care of Children, Adolescents and Adults with Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams. Frontiers in Oncology 10: 595734
Geerdes, E.E.; Sideras, K.; Aziz, M.H.; van Eijck, C.H.; Bruno, M.J.; Sprengers, D.; Boor, P.P.C.; Kwekkeboom, J. 2021: Cancer Cell B7-H3 Expression Is more Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer than in Pancreatic Cancer. Frontiers in Oncology 11: 615691
Gomez, K.E.; Wu, F.; Keysar, S.B.; Morton, J.J.; Miller, B.; Chimed, T.-S.; Le, P.N.; Nieto, C.; Chowdhury, F.N.; Tyagi, A.; Lyons, T.R.; Young, C.D.; Zhou, H.; Somerset, H.L.; Wang, X.-J.; Jimeno, A. 2020: Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells. Cancer Research 80(19): 4185-4198
Mallin, M.M.; Pienta, K.J.; Amend, S.R. 2022: Cancer cell foraging to explain bone-specific metastatic progression. Bone 158: 115788
Roth, S.M.; Berens, E.B.; Sharif, G.M.; Glasgow, E.; Wellstein, A. 2021: Cancer Cell Invasion and Metastasis in Zebrafish Models (Danio rerio). Methods in Molecular Biology 2294: 3-16
Parigoris, E.; Lee, S.; Mertz, D.; Turner, M.; Liu, A.Y.; Sentosa, J.; Djomehri, S.; Chang, H.C.; Luker, K.; Luker, G.; Kleer, C.G.; Takayama, S. 2021: Cancer Cell Invasion of Mammary Organoids with Basal-in Phenotype. Advanced Healthcare Materials 10(4): E2000810
Bormio Nunes, J.H.; Hager, S.; Mathuber, M.; Pósa, V.; Roller, A.; Enyedy, Év.A.; Stefanelli, A.; Berger, W.; Keppler, B.K.; Heffeter, P.; Kowol, C.R. 2020: Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. Journal of Medicinal Chemistry 63(22): 13719-13732
Jia, M.; Zheng, D.; Wang, X.; Zhang, Y.; Chen, S.; Cai, X.; Mo, L.; Hu, Z.; Li, H.; Zhou, Z.; Li, J. 2020: Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity. International Journal of Medical Sciences 17(11): 1652-1664
Li, L.; Zhao, J.; Zhang, Q.; Tao, Y.; Shen, C.; Li, R.; Ma, Z.; Li, J.; Wang, Z. 2021: Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway. Frontiers in Oncology 11: 756205
Sun, M.; Duan, Y.; Ma, Y.; Zhang, Q. 2020: Cancer Cell-Erythrocyte Hybrid Membrane Coated Gold Nanocages for Near Infrared Light-Activated Photothermal/Radio/Chemotherapy of Breast Cancer. International Journal of Nanomedicine 15: 6749-6760
Feng, S.; Ren, Y.; Li, H.; Tang, Y.; Yan, J.; Shen, Z.; Zhang, H.; Chen, F. 2021: Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy. International Journal of Nanomedicine 16: 2123-2136
Ding, L.; Lin, X.; Lin, Z.; Wu, Y.; Liu, X.; Liu, J.; Wu, M.; Zhang, X.; Zeng, Y. 2020: Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy. Acs Applied Materials and Interfaces 12(33): 36906-36916
Matsunaga, W.; Hamada, K.; Tagawa, M.; Morinaga, T.; Gotoh, A. 2021: Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector. Anticancer Research 41(8): 3731-3740
Adrian, G.; Konradsson, E.; Beyer, S.; Wittrup, A.; Butterworth, K.T.; McMahon, S.J.; Ghita, M.; Petersson, K.; Ceberg, C. 2021: Cancer Cells can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic in Vitro-Conditions. Frontiers in Oncology 11: 686142
Vyskočil, J.; Mayorga-Martinez, C.C.; Jablonská, E.; Novotný, F.; Ruml, T.áš; Pumera, M. 2020: Cancer Cells Microsurgery via Asymmetric Bent Surface Au/Ag/Ni Microrobotic Scalpels Through a Transversal Rotating Magnetic Field. Acs Nano 14(7): 8247-8256
Printz, C. 2021: Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients with Cancer, Survivors. Cancer 127(8): 1170-1171
Xiong, Y.; Ye, M.; Wu, C. 2021: Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble. Computational and Mathematical Methods in Medicine 2021: 5556992
Alessandrino, F.; Smith, D.A.; Spierling, A.; Kikano, E.; Somarouthu, B.; Tirumani, S.H.; Ramaiya, N.H. 2021: Cancer Clinical Trials: what Every Radiologist Wants to know but Is Afraid to Ask. AJR. American Journal of Roentgenology 216(4): 1099-1111
Shah, S.C.; Kayamba, V.; Peek, R.M.; Heimburger, D. 2019: Cancer Control in Low- and Middle-Income Countries: Is it time to Consider Screening?. Journal of Global Oncology 5: 1-8
Yang, T.-H.; Chiang, Y.-H.; Shiue, S.-C.; Lin, P.-H.; Yang, Y.-C.; Tu, K.-C.; Tseng, Y.-Y.; Tseng, J.T.; Wu, W.-S. 2021: Cancer DEIso: An integrative analysis platform for investigating differentially expressed gene-level and isoform-level human cancer markers. Computational and Structural Biotechnology Journal 19: 5149-5159
Yu, P.; Kibbe, W. 2021: Cancer Data Science and Computational Medicine. Jco Clinical Cancer Informatics 5: 487-489
Moqadam, S.M.; Grewal, P.K.; Haeri, Z.; Ingledew, P.A.; Kohli, K.; Golnaraghi, F. 2018: Cancer Detection Based on Electrical Impedance Spectroscopy: a Clinical Study. Journal of Electrical Bioimpedance 9(1): 17-23
Jacewicz, M.; Rud, E.; Galtung, K.F.; Noor, D.; Baco, E. 2021: Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia. Anticancer Research 41(9): 4395-4400
Sakellariou, D.; Rotarou, E.S. 2020: Cancer Disparities for people with Disabilities: Bridging the Gap. Journal of the National Comprehensive Cancer Network: Jnccn 18(8): 1144-1146
Chang, Y.; Park, H.; Yang, H-Jin.; Lee, S.; Lee, K-Yum.; Kim, T.Soon.; Jung, J.; Shin, J-Min. 2018: Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature. Scientific Reports 8(1): 8857
Goh, B.-C.; Lim, J.F.-Y. 2020: Cancer Drugs in Asian Populations: Availability, Accessibility, and Affordability. Cancer Journal 26(4): 323-329
Alpuim Costa, D.; Nobre, J.é G.; de Almeida, S.B.; Ferreira, M.H.; Gonçalves, I.ês.; Braga, S.; Pais, D. 2020: Cancer During Pregnancy: how to Handle the Bioethical Dilemmas?-A Scoping Review with Paradigmatic Cases-Based Analysis. Frontiers in Oncology 10: 598508
Jin, K.; Zhou, F.; Zhang, L. 2021: Cancer Environment Immunotherapy: targeting TGF-β finds its way towards tissue healing and vasculature remodeling. Signal Transduction and Targeted Therapy 6(1): 41
Cao, J.; Yan, Q. 2020: Cancer Epigenetics, Tumor Immunity, and Immunotherapy. Trends in Cancer 6(7): 580-592
Wapner, J. 2016: Cancer Gene Tests Provide Few Answers. Scientific American 315(3): 24-25
Hinoi, T. 2021: Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants. Journal of the Anus Rectum and Colon 5(3): 213-228
Sng, C.C.T.; Wong, Y.N.S.; Wu, A.; Ottaviani, D.; Chopra, N.; Galazi, M.; Benafif, S.; Soosaipillai, G.; Roylance, R.; Lee, A.J.X.; Shaw, H. 2020: Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: a UK Tertiary Hospital Experience. Frontiers in Oncology 10: 595804
Khawaja, S.N.; Qadri, H.A.; Yusuf, M.A. 2021: Cancer Hospital Stockpiles: Strategizing for an Efficient and Sufficient Inventory List of Essential Items. Jco Global Oncology 7: 1490-1499
Boettcher, A.N.; Hammoud, D.A.; Weinberg, J.B.; Agarwal, P.; Mendiratta-Lala, M.; Luker, G.D. 2020: Cancer Imaging and Patient Care during the COVID-19 Pandemic. RADIOLOGY. Imaging Cancer 2(6): E200058
Wang, S.; Xie, K.; Liu, T. 2021: Cancer Immunotherapies: from Efficacy to Resistance Mechanisms - not only Checkpoint Matters. Frontiers in Immunology 12: 690112
Gotti, M.; Defrancesco, I.; D'Angelo, M.; Basso, S.; Crotto, L.; Marinelli, A.; Maccalli, C.; Iaconianni, V. 2020: Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers. Frontiers in Immunology 11: 565236
Abdel-Magid, A.F. 2020: Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta. Acs Medicinal Chemistry Letters 11(6): 1083-1085
Hassani Najafabadi, A.; Zhang, J.; Aikins, M.E.; Najaf Abadi, Z.I.; Liao, F.; Qin, Y.; Okeke, E.B.; Scheetz, L.M.; Nam, J.; Xu, Y.; Adams, D.; Lester, P.; Hetrick, T.; Schwendeman, A.; Wicha, M.S.; Chang, A.E.; Li, Q.; Moon, J.J. 2020: Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs. Nano Letters 20(10): 7783-7792
Digklia, A.; Duran, R.; Homicsko, K.; Kandalaft, L.E.; Hocquelet, A.; Orcurto, A.; Coukos, G.; Denys, A. 2019: Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches. Cardiovascular and Interventional Radiology 42(9): 1221-1229
Mulder, W.J.M.; Gnjatic, S. 2017: Cancer Immunotherapy: From local to global. Nature Nanotechnology 12(9): 840-841
Villanueva, M.Teresa. 2018: Cancer Immunotherapy: The right shape. Nature Reviews. Drug Discovery 17(1): 18
Weir, H.K.; Thompson, T.D.; Stewart, S.L.; White, M.C. 2021: Cancer Incidence Projections in the United States Between 2015 and 2050. Preventing Chronic Disease 18: E59
Kaucher, S.; Kajüter, H.; Becher, H.; Winkler, V. 2018: Cancer Incidence and Mortality Among Ethnic German Migrants From the Former Soviet Union. Frontiers in Oncology 8: 378
Krieger, N.; Feldman, J.M.; Kim, R.; Waterman, P.D. 2018: Cancer Incidence and Multilevel Measures of Residential Economic and Racial Segregation for Cancer Registries. Jnci Cancer Spectrum 2(1): Pky009
Hulvat, M.C. 2020: Cancer Incidence and Trends. Surgical Clinics of North America 100(3): 469-481
Weir, H.K.; Sherman, R.; Yu, M.; Gershman, S.; Hofer, B.M.; Wu, M.; Green, D. 2020: Cancer Incidence in Older Adults in the United States: Characteristics, Specificity, and Completeness of the Data. Journal of Registry Management 47(3): 150-160
Kerlavage, A.R.; Kirchhoff, A.C.; Guidry Auvil, J.M.; Sharpless, N.E.; Davis, K.L.; Reilly, K.; Reaman, G.; Penberthy, L.; Deapen, D.; Hwang, A.; Durbin, E.B.; Gallotto, S.L.; Aplenc, R.; Volchenboum, S.L.; Heath, A.P.; Aronow, B.J.; Zhang, J.; Vaske, O.; Alonzo, T.A.; Nathan, P.C.; Poynter, J.N.; Armstrong, G.; Hahn, E.E.; Wernli, K.J.; Greene, C.; DiGiovanna, J.; Resnick, A.C.; Shalley, E.R.; Nadaf, S.; Kibbe, W.A. 2021: Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. Jco Clinical Cancer Informatics 5: 881-896
Warner, J.L.; Patt, D. 2020: Cancer Informatics in 2019: Deep Learning Takes Center Stage. Yearbook of Medical Informatics 29(1): 243-246
Furgurson, K.F.; Sandberg, J.C.; Hsu, F-Chi.; Mora, D.C.; Quandt, S.A.; Arcury, T.A. 2019: Cancer Knowledge Among Mexican Immigrant Farmworkers in North Carolina. Journal of Immigrant and Minority Health 21(3): 515-521
Vancura, A.; Lanzós, A.és.; Bosch-Guiteras, N.úr.; Esteban, M.òn.T.; Gutierrez, A.H.; Haefliger, S.; Johnson, R. 2021: Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs. Nar Cancer 3(2): Zcab 013
Carlevaro-Fita, J.; Lanzós, Aés.; Feuerbach, L.; Hong, C.; Mas-Ponte, D.; Pedersen, J.Skou.; Johnson, R.; Abascal, F.; Amin, S.B.; Bader, G.D.; Barenboim, J.; Beroukhim, R.; Bertl, J.; Boroevich, K.A.; Brunak, Søren.; Campbell, P.J.; Carlevaro-Fita, J.; Chakravarty, D.; Chan, C.Wing.Yiu.; Chen, K.; Choi, J.Kyoon.; Deu-Pons, J.; Dhingra, P.; Diamanti, K.; Feuerbach, L.; Fink, J.Lynn.; Fonseca, N.A.; Frigola, J.; Gambacorti-Passerini, C.; Garsed, D.W.; Gerstein, M.; Getz, G.; Gonzalez-Perez, A.; Guo, Q.; Gut, I.G.; Haan, D.; Hamilton, M.P.; Haradhvala, N.J.; Harmanci, A.O.; Helmy, M.;, 2020: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Communications Biology 3(1): 56
Brewer, H.R.; Hirst, Y.; Sundar, S.; Chadeau-Hyam, M.; Flanagan, J.M. 2020: Cancer Loyalty Card Study (CLOCS): protocol for an observational case-control study focusing on the patient interval in ovarian cancer diagnosis. Bmj Open 10(9): E037459
Alkhudair, N.; Alshamrani, M.; Samarkandi, H.; Almodaheem, H.; Alabdulkarim, H.; Alsaqaaby, M.; Alnajjar, F.; Alhashem, H.; Bakkar, M.; Bazarbashi, S.; Alnahedh, M.; Alfraih, F.; Alawagi, M.; Al-Jedai, A. 2021: Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP). Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 29(2): 115-120
Lee, G.; Han, S.-B.; Lee, J.-H.; Kim, H.-W.; Kim, D.-H. 2019: Cancer Mechanobiology: Microenvironmental Sensing and Metastasis. Acs Biomaterials Science and Engineering 5(8): 3735-3752
Dart, A. 2017: Cancer Models: Modeling clear cell renal cell carcinoma. Nature Reviews. Cancer 17(7): 397
Liu, Y.; Wang, W.; Liu, J.; Yin, P.; Qi, J.; You, J.; Wang, L.; Zhou, M. 2020: Cancer Mortality - China, 2018. China Cdc Weekly 2(5): 64-69
ReFaey, K.; Tripathi, S.; Grewal, S.S.; Bhargav, A.G.; Quinones, D.J.; Chaichana, K.L.; Antwi, S.O.; Cooper, L.T.; Meyer, F.B.; Dronca, R.S.; Diasio, R.B.; Quinones-Hinojosa, A. 2021: Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications. Mayo Clinic Proceedings. Innovations Quality and Outcomes 5(3): 645-653
Williamson, M.R.; Ahmed, R.M. 2021: Cancer Mortality and Research Outcomes in a Rural State. Wmj: Official Publication of the State Medical Society of Wisconsin 120(2): 120-126
Tini, G.; Bertero, E.; Signori, A.; Sormani, M.P.; Maack, C.; De Boer, R.A.; Canepa, M.; Ameri, P. 2020: Cancer Mortality in Trials of Heart Failure with Reduced Ejection Fraction: a Systematic Review and Meta-Analysis. Journal of the American Heart Association 9(18): E016309
Guo, P.; Huang, J.; Moses, M.A. 2020: Cancer Nanomedicines in an Evolving Oncology Landscape. Trends in Pharmacological Sciences 41(10): 730-742
Rosa, W.E.; Hinds, P.S.; Burnett, C. 2021: Cancer Nurses, Relational Care, and Science to Achieve Social Justice in Oncology. Cancer Nursing 44(3): 178-179
Yates, P.; Charalambous, A.; Fennimore, L.; So, W.K.W.; Suh, E.E.; Woodford, E.; Young, A. 2020: Cancer Nursing's Potential to Reduce the Growing Burden of Cancer Across the World. Oncology Nursing Forum 47(6): 625-627
Chisale, M.R.O.; Sinyiza, F.; Kaseka, P.; Wu, J.S.T.; Chimbatata, C.; Mbakaya, B.C.; Kamudumuli, P.S.; Kayira, A.B. 2020: Cancer obscures extrapulmonary tuberculosis (EPTB) at a tertiary hospital in Northern Malawi. Epidemiology and Infection 149: E3
De Cholnoky, T. 1945: Cancer of the Face; Clinical and Statistical Study of 1,062 Cases. Anales de Cirugia 4: 1004-1018 Transl
Parisi, J.M. 1945: Cancer of the Stomach; the Value of Some Statistics. Revista Medico-Quirurgica de Patologia Femenina 24: 369-375
El Jaddaoui, I.; Allali, I.; Sehli, S.; Ouldim, K.; Hamdi, S.; Al Idrissi, N.; Nejjari, C.; Amzazi, S.ïd.; Bakri, Y.; Ghazal, H. 2020: Cancer Omics in Africa: Present and Prospects. Frontiers in Oncology 10: 606428
Silvestri, G.A.; Jemal, A.; Yabroff, K.R.; Fedewa, S.; Sineshaw, H. 2021: Cancer Outcomes Among Medicare Beneficiaries and their Younger Uninsured Counterparts. Health Affairs 40(5): 754-762
Fritsche, L.G.; Patil, S.; Beesley, L.J.; VandeHaar, P.; Salvatore, M.; Ma, Y.; Peng, R.B.; Taliun, D.; Zhou, X.; Mukherjee, B. 2020: Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and their Evaluation in two Independent Biobanks. American Journal of Human Genetics 107(5): 815-836
Dupoiron, D. 2021: Cancer Pain Management-A European Perspective. Cancer Treatment and Research 182: 39-55
Varrassi, G.; De Conno, F.; Orsi, L.; Puntillo, F.; Sotgiu, G.; Zeppetella, J.; Zucco, F. 2020: Cancer Pain Management: An Italian Delphi Survey from the Rational use of Analgesics (RUA) Group. Journal of Pain Research 13: 979-986
Fishman, S.M.; Copenhaver, D.; Mongoven, J.M.; Lorenzen, K.; Schlingmann, E.; Young, H.M. 2020: Cancer Pain Treatment and Management: An Interprofessional Learning Module for Prelicensure Health Professional Students. Mededportal: the Journal of Teaching and Learning Resources 16: 10953
Khatooni, M. 2021: Cancer Pain: An Evolutionary Concept Analysis. Professional Case Management 26(6): 275-285
Harky, A.; Chiu, C.M.; Yau, T.H.L.; Lai, S.H.D. 2020: Cancer Patient Care during COVID-19. Cancer Cell 37(6): 749-750
Bartley, N.; Napier, C.E.; Butt, Z.; Schlub, T.E.; Best, M.C.; Biesecker, B.B.; Ballinger, M.L.; Butow, P. 2021: Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results. Frontiers in Psychology 12: 647502
Busheri, L.; Nare, S.; Banale, R.; Bapat, A.; Nagarkar, M.; Vetale, D.; Joseph, R.; Suryawanshi, S.; Alhat, R.; Thomas, G.; Navgire, R.; Ansari, D.; Unde, R.; Shaikh, S.; Gangurde, N.; Dixit, S.; Varghese, B.; Deshmukh, C.; Kelkar, D.A.; Kulkarni, M.; Koppiker, C.B. 2021: Cancer Patient Management during COVID-19 Pandemic: An Audit of a Single-Surgeon Unit in a COVID-Hotspot. South Asian Journal of Cancer 10(1): 39-41
Franklin, E.F.; Nichols, H.M.; House, L.; Buzaglo, J.; Thiboldeaux, K. 2020: Cancer Patient Perspectives on Sharing of Medical Records and Mobile Device Data for Research Purposes. Journal of Patient Experience 7(6): 1115-1121
Chazal, R.A.; Valentine, C.M. 2021: Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients. JACC. Cardiovascular Interventions 14(16): 1848
Yoon, H.-J.; Chung, Y.S.; Lee, Y.J.; Yu, S.E.; Baek, S.; Kim, H.-S.; Kim, S.W.; Lee, J.-Y.; Kim, S.; Sung, H.-J. 2021: Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor. Advanced Science 8(22): E2102640
Curigliano, G. 2020: Cancer Patients and Risk of Mortality for COVID-19. Cancer Cell 38(2): 161-163
Blaschke, K.; Hermes-Moll, K.; Lappe, V.; Ihle, P.; Baumann, W.; Schubert, I. 2020: Cancer Patients and the Last year of Life: Palliative Care, Hospitalization and Place of Death. Gesundheitswesen 82(8-09): 702-709
Haddad, F.G.; Kourie, H.R.; Gebara, N.; Matta, C.; Eid, R.; El Karak, F.; Nasr, F.; Chahine, G.; Ghosn, M.; Kattan, J. 2021: Cancer Patients in the Era of Coronavirus: what to Fear Most?. Journal of Patient Safety 17(1): E35-E38
Brown, J.H.; Torres, H.P.; Maddi, R.D.; Williams, J.L.; Dibaj, S.S.; Liu, D.; Bruera, E. 2020: Cancer Patients' Perceived Difficulties Filling Opioid Prescriptions After Receiving Outpatient Supportive Care. Journal of Pain and Symptom Management 60(5): 915-922
Kongshaug, N.; Skolbekken, J.-A.; Faxvaag, A.; Hofsli, E. 2021: Cancer Patients' Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study. Jmir Formative Research 5(1): E20636
Epstein, R.S.; Basu Roy, U.K.; Aapro, M.; Salimi, T.; Moran, D.; Krenitsky, J.; Leone-Perkins, M.L.; Girman, C.; Schlusser, C.; Crawford, J. 2021: Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and its Impact on Daily Life. Patient Preference and Adherence 15: 453-465
Ohnesorge, J.; Weigand, M.A. 2020: Cancer Patients: Relevant Aspects for Anesthesiology. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 55(6): 394-404
Jitnarin, N.; Poston, W.S.C.; Jahnke, S.A.; Haddock, C.K.; Kelley, H.N. 2020: Cancer Perceptions Among Smokeless Tobacco Users: a Qualitative Study of US Firefighters. Safety and Health at Work 11(3): 284-290
Ceglie, G.; Del Baldo, G.; Agolini, E.; Rinelli, M.; Cacchione, A.; Del Bufalo, F.; Vinci, M.; Carta, R.; Boccuto, L.; Miele, E.; Mastronuzzi, A.; Locatelli, F.; Carai, A. 2020: Cancer Predisposition Syndromes Associated with Pediatric High-Grade Gliomas. Frontiers in Pediatrics 8: 561487
Carta, R.; Del Baldo, G.; Miele, E.; Po, A.; Besharat, Z.M.; Nazio, F.; Colafati, G.S.; Piccirilli, E.; Agolini, E.; Rinelli, M.; Lodi, M.; Cacchione, A.; Carai, A.; Boccuto, L.; Ferretti, E.; Locatelli, F.; Mastronuzzi, A. 2020: Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era. Frontiers in Oncology 10: 566822
Mitchell, S.G.; Pencheva, B.; Westfall, E.; Porter, C.C. 2021: Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance. Clinics in Perinatology 48(1): 1-14
Takeuchi, M.; McDonald, J.S.; Takahashi, N.; Frank, I.; Thompson, R.H.; King, B.F.; Kawashima, A. 2021: Cancer Prevalence and Risk Stratification in Adults Presenting with Hematuria: a Population-Based Cohort Study. Mayo Clinic Proceedings. Innovations Quality and Outcomes 5(2): 308-319
Houghton, S.C.; Hankinson, S.E. 2021: Cancer Progress and Priorities: Breast Cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 30(5): 822-844
Lupo, P.J.; Spector, L.G. 2020: Cancer Progress and Priorities: Childhood Cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 29(6): 1081-1094
McDonald, R. 2020: Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis. Oncology 34(7): 249
Quesnel-Crooks, S.; Martin, D.N.; Hanisch, R.; Kohler, B.; Mery, L.; Edwards, B.K.; Andall-Brereton, G. 2020: Cancer Registration in the Caribbean. Journal of Registry Management 47(3): 161-169
Chowdhury, R.A.; Brennan, F.P.; Gardiner, M.D. 2020: Cancer Rehabilitation and Palliative Care-Exploring the Synergies. Journal of Pain and Symptom Management 60(6): 1239-1252
Bednarova, R.; Biancuzzi, H.; Rizzardo, A.; Dal Mas, F.; Massaro, M.; Cobianchi, L.; Barcellini, A.; Orlandi, E.; Miceli, L. 2022: Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 37(4): 1066-1068
Tay, M.R.J.; Wong, C.J. 2021: Cancer Rehabilitation-Improving Cancer Survivorship in Singapore. Asia-Pacific Journal of Oncology Nursing 8(4): 346-348
Horwich, A. 1993: Cancer Research Campaign review of radiobiology research. British Journal of Cancer 67(1): 198-201
Aboagye, E.O.; Luthra, S.K.; Brady, F.; Poole, K.; Anderson, H.; Jones, T.; Boobis, A.; Burtles, S.S.; Price, P. 2002: Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients. British Journal of Cancer 86(7): 1052-1056
Colbert, L.E.; Kouzy, R.; Abi Jaoude, J.; Ludmir, E.B.; Taniguchi, C.M. 2020: Cancer Research after COVID-19: Where do we go from Here?. Cancer Cell 37(5): 637-638
Bailey, C.; Black, J.R.M.; Swanton, C. 2020: Cancer Research: the Lessons to Learn from COVID-19. Cancer Discovery 10(9): 1263-1266
Tao, W.; Santoni, G.; von Euler-Chelpin, M.; Ljung, R.; Lynge, E.; Pukkala, E.; Ness-Jensen, E.; Romundstad, P.ål.; Tryggvadottir, L.; Lagergren, J. 2020: Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries. Obesity Surgery 30(10): 3761-3767
Shim, S.R.; Kitahara, C.M.; Cha, E.S.; Kim, S.-J.; Bang, Y.J.; Lee, W.J. 2021: Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: a Systematic Review and Meta-analysis. JAMA Network Open 4(9): E2125072
Yang, C.; Yang, J.; Liu, Y.; Geng, X. 2020: Cancer Risk Analysis Based on Improved Probabilistic Neural Network. Frontiers in Computational Neuroscience 14: 58
Harati, B.; Shahtaheri, S.J.; Yousefi, H.A.; Harati, A.; Askari, A.; Abdolmohamadi, N. 2020: Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran. Iranian Journal of Public Health 49(7): 1330-1338
Sharretts, J.; Galescu, O.; Gomatam, S.; Andraca-Carrera, E.; Hampp, C.; Yanoff, L. 2020: Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial. New England Journal of Medicine 383(11): 1000-1002
Alrawahi, A.H.; Alnaamani, A.; Al-Lawati, N.A. 2020: Cancer Risk Factors Among Omanis: a Review. Gulf Journal of Oncology 1(34): 70-77
Zeinomar, N.; Grant-Alfieri, A.; Burke, K.R.; de Hoz, M.; Tehranifar, P.; Walker, D.A.H.; Morton, T.; Shepard, P.; Herbstman, J.B.; Miller, R.L.; Perera, F.; Terry, M.B. 2022: Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 37(4): 1220-1227
Jatho, A.; Tran, B.T.; Cambia, J.M.; Nanyingi, M.; Mugisha, N.M. 2020: Cancer Risk Studies and Priority Areas for Cancer Risk Appraisal in Uganda. Annals of Global Health 86(1): 78
Lebwohl, B.; Green, P.H.R.; Emilsson, L.; Mårild, K.; Söderling, J.; Roelstraete, B.; Ludvigsson, J.F. 2022: Cancer Risk in 47,241 Individuals with Celiac Disease: a Nationwide Cohort Study. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 20(2): E111-E131
Yamamoto, A.; Mori, Y.; Suzuki, O.; Ishibashi, K.; Kamae, N.; Yoshida, H.; Hasegawa, K.; Fujiwara, K.; Eguchi, H.; Okazaki, Y.; Akagi, K.; Ishida, H. 2020: Cancer Risk in Lynch Syndrome-Associated Endometrial Cancer Patients and their Relatives. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 47(13): 2257-2259
El-Matary, W.; Bernstein, C.N. 2020: Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease. Frontiers in Pediatrics 8: 400
Kjærgaard, V.S.; Jensen, C.B.; Elmahdi, R.; Burisch, J.; Allin, K.H.; Jess, T. 2020: Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: a Population-Based Danish Cohort Study. Gastroenterology 159(4): 1609-1611
Cuomo, A.; Pirozzi, F.; Attanasio, U.; Franco, R.; Elia, F.; De Rosa, E.; Russo, M.; Ghigo, A.; Ameri, P.; Tocchetti, C.G.; Mercurio, V. 2020: Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications. Current Oncology Reports 23(1): 7
Huo, Z.; Li, C.; Xu, X.; Ge, F.; Wang, R.; Wen, Y.; Peng, H.; Wu, X.; Liang, H.; Peng, G.; Li, R.; Huang, D.; Chen, Y.; Zhong, R.; Cheng, B.; Xiong, S.; Lin, W.; He, J.; Liang, W. 2020: Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies. Oncoimmunology 9(1): 1848068
Bian, Y.; Li, W.; Kremer, D.M.; Sajjakulnukit, P.; Li, S.; Crespo, J.; Nwosu, Z.C.; Zhang, L.; Czerwonka, A.; Pawłowska, A.; Xia, H.; Li, J.; Liao, P.; Yu, J.; Vatan, L.; Szeliga, W.; Wei, S.; Grove, S.; Liu, J.Rebecca.; McLean, K.; Cieslik, M.; Chinnaiyan, A.M.; Zgodziński, W.; Wallner, G.; Wertel, I.; Okła, K.; Kryczek, I.; Lyssiotis, C.A.; Zou, W. 2020: Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585(7824): 277-282
Murphy, K.A.; Stone, E.M.; Presskreischer, R.; McGinty, E.E.; Daumit, G.L.; Pollack, C.E. 2021: Cancer Screening Among Adults with and Without Serious Mental Illness: a Mixed Methods Study. Medical Care 59(4): 327-333
Kotwal, A.A.; Walter, L.C. 2020: Cancer Screening Among Older Adults: a Geriatrician's Perspective on Breast, Cervical, Colon, Prostate, and Lung Cancer Screening. Current Oncology Reports 22(11): 108
Bryant, J.; Patterson, K.; Vaska, M.; Chiang, B.; Letendre, A.; Bill, L.; Yang, H.; Kopciuk, K. 2021: Cancer Screening Interventions in Indigenous Populations: a Rapid Review. Current Oncology 28(3): 1728-1743
Chan, T.K.-C.; Tan, L.W.L.; van Dam, R.M.; Seow, W.J. 2021: Cancer Screening Knowledge and Behavior in a Multi-Ethnic Asian Population: the Singapore Community Health Study. Frontiers in Oncology 11: 684917
Willems, B.; Cullati, S.ép.; Prez, V.D.; Jolidon, V.; Burton-Jeangros, C.; Bracke, P. 2020: Cancer Screening Participation and Gender Stratification in Europe. Journal of Health and Social Behavior 61(3): 377-395
Sabatino, S.A.; Thompson, T.D.; White, M.C.; Shapiro, J.A.; de Moor, J.; Doria-Rose, V.P.; Clarke, T.; Richardson, L.C. 2021: Cancer Screening Test Receipt - United States, 2018. MMWR. Morbidity and Mortality Weekly Report 70(2): 29-35
Giri, V.N.; Hyatt, C.; Leader, A. 2020: Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice. Journal of Urology 204(6): 1116-1118
Khargekar, N.C.; Khanna, D. 2020: Cancer Screening during COVID-19 Pandemic. Asia-Pacific Journal of Oncology Nursing 7(4): 308-309
Gaciong, Z.; Pruszczyk, P.; Religa, P. 2015: Cancer Screening in Unprovoked Venous Thromboembolism. New England Journal of Medicine 373(25): 2474-2475
Basu, P.; Alhomoud, S.; Taghavi, K.; Carvalho, A.L.; Lucas, E.; Baussano, I. 2021: Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a new Situation. Jco Global Oncology 7: 416-424
DeGregori, J.; Pharoah, P.; Sasieni, P.; Swanton, C. 2020: Cancer Screening, Surrogates of Survival, and the Soma. Cancer Cell 38(4): 433-437
Dhada, S.; Stewart, D.; Cheema, E.; Hadi, M.A.; Paudyal, V. 2021: Cancer Services During the COVID-19 Pandemic: Systematic Review of Patient's and Caregiver's Experiences. Cancer Management and Research 13: 5875-5887
Hosios, A.M.; Manning, B.D. 2021: Cancer Signaling Drives Cancer Metabolism: AKT and the Warburg Effect. Cancer Research 81(19): 4896-4898
Dzobo, K.; Sinkala, M. 2021: Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis. Omics: a Journal of Integrative Biology 25(5): 313-332
Dzobo, K.; Ganz, C.; Thomford, N.E.; Senthebane, D.A. 2021: Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. Omics: a Journal of Integrative Biology 25(2): 81-92
Bertlich, M.; Kitz, J.; Kruizenga, M.; Spiegel, J.L.; Canis, M.; Ihler, F.; Haubner, F.; Weiss, B.G.; Jakob, M. 2021: Cancer Stem Cell Markers in Squamous Cell Carcinomas of the Salivary Glands. Oncology 99(6): 402-412
Alvina, F.B.; Gouw, A.M.; Le, A. 2021: Cancer Stem Cell Metabolism. Advances in Experimental Medicine and Biology 1311: 161-172
Thankamony, A.P.; Saxena, K.; Murali, R.; Jolly, M.K.; Nair, R. 2020: Cancer Stem Cell Plasticity - a Deadly Deal. Frontiers in Molecular Biosciences 7: 79
Kilmister, E.J.; Patel, J.; van Schaijik, B.; Bockett, N.; Brasch, H.D.; Paterson, E.; Sim, D.; Davis, P.F.; Roth, I.M.; Itinteang, T.; Tan, S.T. 2020: Cancer Stem Cell Subpopulations Are Present Within Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology 10: 1091
Comertpay, B.; Gulfidan, G.; Arga, K.Y.; Gov, E. 2021: Cancer Stem Cell Transcriptome Profiling Reveals Seed Genes of Tumorigenesis: new Avenues for Cancer Precision Medicine. Omics: a Journal of Integrative Biology 25(6): 372-388
Cho, Y.; Kim, Y.K. 2020: Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance. Frontiers in Oncology 10: 764
Featherston, T.; Brasch, H.D.; Siljee, S.D.; van Schaijik, B.; Patel, J.; de Jongh, J.; Marsh, R.W.; Itinteang, T.; Tan, S.T. 2020: Cancer Stem Cells in Head and Neck Cutaneous Squamous Cell Carcinoma Express Cathepsins. Plastic and Reconstructive Surgery. Global Open 8(8): E3042
Veschi, V.; Verona, F.; Lo Iacono, M.; D'Accardo, C.; Porcelli, G.; Turdo, A.; Gaggianesi, M.; Forte, S.; Giuffrida, D.; Memeo, L.; Todaro, M. 2020: Cancer Stem Cells in Thyroid Tumors: from the Origin to Metastasis. Frontiers in Endocrinology 11: 566
Lee, D.-S.; Oh, K. 2021: Cancer Stem Cells in the Immune Microenvironment. Advances in Experimental Medicine and Biology 1187: 245-266
Walcher, L.; Kistenmacher, A.-K.; Suo, H.; Kitte, R.; Dluczek, S.; Strauß, A.; Blaudszun, A.é-R.é; Yevsa, T.; Fricke, S.; Kossatz-Boehlert, U. 2020: Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 11: 1280
Lei, M.M.L.; Lee, T.K.W. 2021: Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers. Frontiers in Cell and Developmental Biology 9: 692940
Masciale, V.; Grisendi, G.; Banchelli, F.; D'Amico, R.; Maiorana, A.; Sighinolfi, P.; Brugioni, L.; Stefani, A.; Morandi, U.; Dominici, M.; Aramini, B. 2020: Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. Frontiers in Oncology 10: 673
Shi, X.; Liu, Y.; Cheng, S.; Hu, H.; Zhang, J.; Wei, M.; Zhao, L.; Xin, S. 2021: Cancer Stemness Associated with Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma. Frontiers in Oncology 11: 651622
Chen, P.; Hsu, W.-H.; Han, J.; Xia, Y.; DePinho, R.A. 2021: Cancer Stemness Meets Immunity: from Mechanism to Therapy. Cell Reports 34(1): 108597
Ghatak, D.; Das Ghosh, D.; Roychoudhury, S. 2020: Cancer Stemness: p53 at the Wheel. Frontiers in Oncology 10: 604124
Eng, O.S.; Pawlik, T.M.; Ejaz, A. 2020: Cancer Surgery During COVID-19: how we Move Forward. Annals of Surgery 272(2): E94-E95
Tzeng, C.-W.D.; Teshome, M.; Katz, M.H.G.; Weinberg, J.S.; Lai, S.Y.; Antonoff, M.B.; Bird, J.E.; Shafer, A.; Davis, J.W.; Adelman, D.M.; Moon, B.; Reece, G.; Prabhu, S.S.; DeSnyder, S.M.; Skibber, J.M.; Mehran, R.; Schmeler, K.; Roland, C.L.; Tran Cao, H.S.; Aloia, T.A.; Caudle, A.S.; Swisher, S.G.; Vauthey, J.-N. 2020: Cancer Surgery Scheduling During and After the COVID-19 first Wave: the MD Anderson Cancer Center Experience. Annals of Surgery 272(2): E106-E111
Tischkowitz, M.; Colas, C.; Pouwels, S.; Hoogerbrugge, N.; Bisseling, T.; Bubien, V.; Caux, F.; Chabbert-Buffet, N.; Colas, C.; Da Mota Gomes, S.; Gotthardt, M.; Hoogerbrugge, N.; Kets, M.; Lachlan, K.L.; Links, T.P.; Longy, M.; Mann, R.; Pouwels, S.; Kool, L.Schultze.; Semple, R.K.; Stock, I.; Tischkowitz, M.; Vos, J.; Hoogerbrugge, N.; Ligtenberg, M.; Oostenbrink, R.; Sijmons, R.; Evans, G.; Woodward, E.; Tischkowitz, M.; Maher, E.; Ferner, R.E.; Aretz, S.; Spier, I.; Steinke-Lange, V.; Holinski-Feder, E.; Schröck, E.; Frebourg, T.; Houdayer, C 2020: Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. European Journal of Human Genetics: Ejhg 28(10): 1387-1393
Rossen, S.; Kayser, L.; Vibe-Petersen, J.; Christensen, J.F.; Ried-Larsen, M. 2020: Cancer Survivors' Receptiveness to Digital Technology-Supported Physical Rehabilitation and the Implications for Design: Qualitative Study. Journal of Medical Internet Research 22(8): E15335
Franco-Rocha, O.Y.; Carillo-Gonzalez, G.M.; Garcia, A.; Henneghan, A. 2022: Cancer Survivorship Care in Colombia: Review and Implications for Health Policy. Hispanic Health Care International: the Official Journal of the National Association of Hispanic Nurses 20(1): 66-74
Heathcote, L.C.; Zion, S.R.; Crum, A.J. 2020: Cancer Survivorship-Considering Mindsets. JAMA Oncology 6(9): 1468-1469
Islam Khan, M.Z.; Law, H.K.W. 2021: Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways. Frontiers in Molecular Biosciences 8: 627022
Sharma, U.; Barwal, T.S.; Acharya, V.; Tamang, S.; Vasquez, K.M.; Jain, A. 2020: Cancer Susceptibility Candidate 9 (CASC9): a Novel Targetable Long Noncoding RNA in Cancer Treatment. Translational Oncology 13(8): 100774
Cheng, H.; Fan, R.; Wei, W. 2020: Cancer Systems Biology in the Era of Single-Cell Multi-Omics. Proteomics 20(13): E1900106
Werner, H.M.J.; Mills, G.B.; Ram, P.T. 2014: Cancer Systems Biology: a peek into the future of patient care?. Nature Reviews. Clinical Oncology 11(3): 167-176
Becknell, B.; Caligiuri, M.A. 2003: Cancer T cell therapy expands. Nature Medicine 9(3): 257-258
Kamb, A.; Go, W.Y. 2020: Cancer T-cell therapy: building the foundation for a cure. F1000research 9: 1295
Kannan, A.; Philley, J.V.; Hertweck, K.L.; Ndetan, H.; Singh, K.P.; Sivakumar, S.; Wells, R.B.; Vadlamudi, R.K.; Dasgupta, S. 2019: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles. Scientific Reports 9(1): 11632
Kim, Y.-R.; Kim, K.-U.; Lee, J.-H.; Kim, D.-W.; Chung, J.-H.; Kim, Y.-D.; Shin, D.-H.; Lee, M.-K.; Shin, Y.-I.; Lee, S.-Y. 2021: Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer. Current Oncology 28(3): 1927-1937
Laufer-Perl, M.; Mor, L.; Milwidsky, A.; Derakhshesh, M.; Amrami, N.; Moshkovits, Y.; Arnold, J.; Topilsky, Y.; Arbel, Y.; Rozenbaum, Z. 2020: Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry. Israel Medical Association Journal: Imaj 9(22): 498-502
Laufer-Perl, M.; Mor, L.; Milwidsky, A.; Derakhshesh, M.; Amrami, N.; Moshkovits, Y.; Arnold, J.; Topilsky, Y.; Arbel, Y.; Rozenbaum, Z. 2020: Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: a Cardio-Oncology Registry. Israel Medical Association Journal: Imaj 22(9): 564-568
Kadowaki, H.; Akazawa, H.; Ishida, J.; Komuro, I. 2020: Cancer Therapeutics-Related Cardiac Dysfunction - Insights from Bench and Bedside of Onco-Cardiology. Circulation Journal: Official Journal of the Japanese Circulation Society 84(9): 1446-1453
Peleg Hasson, S.; Arnold, J.; Merdler, I.; Sivan, A.; Shamai, S.; Geva, R.; Merimsky, O.; Shachar, E.; Waissengrin, B.; Moshkovits, Y.; Arbel, Y.; Topilsky, Y.; Rozenbaum, Z.; Wolf, I.; Laufer-Perl, M. 2021: Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated with Immune Checkpoint Inhibitors: An Understudied Manifestation. Journal of ImmunoTherapy 44(5): 179-184
Yamato, M. 2020: Cancer Therapy with Cell Sheets. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 47(10): 1405-1406
Grover, S.P.; Hisada, Y.M.; Kasthuri, R.S.; Reeves, B.N.; Mackman, N. 2021: Cancer Therapy-Associated Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology 41(4): 1291-1305
Kamphuis, J.A.M.; Linschoten, M.; Cramer, M.J.; Gort, E.H.; van Rhenen, A.; Asselbergs, F.W.; Doevendans, P.A.; Teske, A.J. 2019: Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: what Is the Evidence?. JACC. Cardiooncology 1(2): 280-290
Spratt, D.E. 2020: Cancer Treatment Decision-Making During the COVID-19 Pandemic: Data over Opinion. International Journal of Radiation Oncology Biology Physics 108(2): 338-339
Lesley, G.C.; Tahmasebi, H.; Meti, N.; Wright, F.C.; Thawer, A.; Cheung, M.; Singh, S. 2021: Cancer Treatment During COVID-19: a Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual Care. Journal of Patient Experience 8: 23743735211039328
Patel, P. 2021: Cancer Treatment Related Pain. Cancer Treatment and Research 182: 27-37
Li, J.; Zhang, H.; Dai, Z. 2021: Cancer Treatment with the Ketogenic Diet: a Systematic Review and Meta-analysis of Animal Studies. Frontiers in Nutrition 8: 594408
De Las Heras, B.ña.; Saini, K.S.; Boyle, F.; Ades, F.; de Azambuja, E.; Bozovic-Spasojevic, I.; Romano, M.; Capelan, M.; Prasad, R.; Pattu, P.; Massard, C.; Portera, C.; Saini, M.L.; Singh, B.P.; Venkitaraman, R.; McNally, R.; Leone, M.; Grande, E.; Gupta, S. 2020: Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the first 6 Months. Oncology and Therapy 8(2): 171-182
Houshdar Tehrani, M.H.; Gholibeikian, M.; Bamoniri, A.; Mirjalili, B.B.F. 2020: Cancer Treatment by Caryophyllaceae-Type Cyclopeptides. Frontiers in Endocrinology 11: 600856
Diana, A.; Carlino, F.; Giunta, E.F.; Franzese, E.; Guerrera, L.P.; Di Lauro, V.; Ciardiello, F.; Daniele, B.; Orditura, M. 2021: Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy. Current Treatment Options in Oncology 22(5): 45
Fortunati, N.; Gatti, F.; Felicetti, F.; Brignardello, E. 2021: Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: the Paradigm of Cancer Survivor Bone Health Management. Frontiers of Hormone Research 54: 91-102
Hadji, P. 2015: Cancer Treatment-Induced Bone Loss in women with breast cancer. Bonekey Reports 4: 692
Nonaka, M.; Hosoda, H.; Uezono, Y. 2021: Cancer treatment-related cardiovascular disease: Current status and future research priorities. Biochemical Pharmacology 190: 114599
Aydin, C.; Kalkan, R. 2020: Cancer Treatment: An Epigenetic View. Global Medical Genetics 7(1): 3-7
Kitadani, J.; Ojima, T.; Iwamoto, H.; Tabata, H.; Nakamori, M.; Nakamura, M.; Hayata, K.; Katsuda, M.; Miyajima, M.; Yamaue, H. 2018: Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells. Scientific Reports 8(1): 4569
Paston, S.J.; Brentville, V.A.; Symonds, P.; Durrant, L.G. 2021: Cancer Vaccines, Adjuvants, and Delivery Systems. Frontiers in Immunology 12: 627932
Cuzzubbo, S.; Mangsbo, S.; Nagarajan, D.; Habra, K.; Pockley, A.G.; McArdle, S.E.B. 2020: Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11: 615240
Igarashi, Y.; Sasada, T. 2020: Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy. Journal of Immunology Research 2020: 5825401
Nelson, A.C.; Yohe, S.L. 2021: Cancer Whole-Genome Sequencing: the Quest for Comprehensive Genomic Profiling in Routine Oncology Care. Journal of Molecular Diagnostics: Jmd 23(7): 784-787
Junkins, C.C.; Kent, E.; Litzelman, K.; Bevans, M.; Cannady, R.S.; Rosenberg, A.R. 2020: Cancer across the ages: a narrative review of caregiver burden for patients of all ages. Journal of Psychosocial Oncology 38(6): 782-798
Goldacre, M.J.; Abisgold, J.D.; Seagroatt, V.; Yeates, D. 2005: Cancer after cholecystectomy: record-linkage cohort study. British Journal of Cancer 92(7): 1307-1309
Cohen, E.P. 2014: Cancer after kidney transplant. Kidney International 86(6): 1271
Williams, D. 2002: Cancer after nuclear fallout: lessons from the Chernobyl accident. Nature Reviews. Cancer 2(7): 543-549
Butler, D. 1994: Cancer agency denies mismanagement. Nature 372(6506): 493
Garber, K. 2016: Cancer anabolic metabolism inhibitors move into clinic. Nature Biotechnology 34(8): 794-795
Bosque-Prous, M.; Mendieta-Paredes, J.; Bartroli, M.; Brugal, M.Teresa.; Espelt, A. 2018: Cancer and Alcohol Consumption in People Aged 50 Years or More in Europe. Alcohol and Alcoholism 53(3): 317-324
Schwartz, L.; Peres, S.; Jolicoeur, M.; da Veiga Moreira, J. 2020: Cancer and Alzheimer's disease: intracellular pH scales the metabolic disorders. Biogerontology 21(6): 683-694
Moris, D.; Tsilimigras, D.I.; Schizas, D. 2020: Cancer and COVID-19. Lancet 396(10257): 1066
Malek, A.E.; Raad, I.I.; Jabbour, E. 2020: Cancer and COVID-19. Lancet 396(10257): 1066-1067
Nagar, H.; Formenti, S.C. 2020: Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy. Nature Reviews. Clinical Oncology 17(6): 332-334
Grossheim, L.; Ruff, P.; Ngoma, T.; Vanderpuye, V.; Mwango, G.; Ochieng, P.; Palmer, D.; Kouya, F.; Lasebikan, N.; Ntekim, A.; Ngoma, M.; Bih, N.; Malloum, A.; Elzawawy, A.; Kerr, D.; Ngwa, W. 2021: Cancer and COVID-19 Experiences at African Cancer Centers: the Silver Lining. Jco Global Oncology 7: 410-415
Bajwa, S.J.S.; Kurdi, M.; Stroumpoulis, K. 2020: Cancer and COVID-19: a war on multiple fronts. Indian Journal of Anaesthesia 64(Suppl 2): S103-S106
Kahn, A.M.; Andrews, R. 2020: Cancer and COVID-19: How Understanding Grief Helps the Pandemic Frontlines. Current Oncology 27(4): 440-441
Kwok, M.; Fritsch, E.F.; Wu, C.J. 2021: Cancer and COVID-19: On the Quest for Effective Vaccines. Cancer Discovery 2(1): 13-18
Kwok, M.; Fritsch, E.F.; Wu, C.J. 2021: Cancer and COVID-19: on the Quest for Effective Vaccines. Blood Cancer Discovery 2(1): 13-18
Millar, C.; Campbell, S.; Fisher, P.; Hutton, J.; Morgan, A.; Cherry, M.G. 2020: Cancer and COVID-19: Patients' and psychologists' reflections regarding psycho-oncology service changes. Psycho-Oncology 29(9): 1402-1403
Addeo, A.; Friedlaender, A. 2020: Cancer and COVID-19: Unmasking their ties. Cancer Treatment Reviews 88: 102041
Sinha, S.; Kundu, C.N. 2021: Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?. Medical Oncology 38(9): 101
Kong, Y.-C.; Sakti, V.-V.; Sullivan, R.; Bhoo-Pathy, N. 2020: Cancer and COVID-19: economic impact on households in Southeast Asia. Ecancermedicalscience 14: 1134
Kahn, A.M.; Andrews, R. 2020: Cancer and COVID-19: how understanding grief helps the pandemic frontlines. Current Oncology 27(4): E440-E441
Poortmans, P.M.; Guarneri, V.; Cardoso, M.-J.ão. 2020: Cancer and COVID-19: what do we really know?. Lancet 395(10241): 1884-1885
Bottinor, W.; Hundley, W.G. 2020: Cancer and Cardiovascular Disease: Finding the Signal Through the Noise. JACC. Cardiooncology 2(4): 578-580
Kawahara, L.T.; Costa, I.B.S.d.S.; Barros, C.íl.C.S.; Almeida, G.C.d.; Bittar, C.S.; Rizk, S.I.; Testa, L.; Moniz, C.M.V.; Pereira, J.; Oliveira, G.áu.M.M.d.; Diz, M.D.P.E.; Guimarães, P.O.; Pinto, I.M.; Kalil Filho, R.; Hajjar, L.A.ão.; Hoff, P.M. 2020: Cancer and Cardiovascular Diseases during the COVID-19 Pandemic. Arquivos Brasileiros de Cardiologia 115(3): 547-557
Powell, M.J.; Dufault, S.M.; Gunderson, E.P.; Benz, C.C. 2020: Cancer and Cardiovascular Risk in Women with Hypertensive Disorders of Pregnancy Carrying a Common IGF1R Variant. Mayo Clinic Proceedings 95(12): 2684-2696
Panageas, K.S.; DeAngelis, L.M. 2021: Cancer and Clot: a Deadly Dance. JACC. Cardiooncology 3(2): 219-220
Navi, B.B.; Kasner, S.E.; Elkind, M.S.V.; Cushman, M.; Bang, O.Y.; DeAngelis, L.M. 2021: Cancer and Embolic Stroke of Undetermined Source. Stroke 52(3): 1121-1130
Vigano, S.; Bobisse, S.; Coukos, G.; Perreau, M.; Harari, A. 2020: Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure. Frontiers in Immunology 11: 1350
Eastham, J.A.; Heller, G.; Halabi, S.; Monk, J.P.; Beltran, H.; Gleave, M.; Evans, C.P.; Clinton, S.K.; Szmulewitz, R.Z.; Coleman, J.; Hillman, D.W.; Watt, C.R.; George, S.; Sanda, M.G.; Hahn, O.M.; Taplin, M.-E.; Parsons, J.K.; Mohler, J.L.; Small, E.J.; Morris, M.J. 2020: Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy with or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 38(26): 3042-3050
Gadebusch Bondio, M.; Herrmann, I.F. 2021: Cancer and Life Beyond It: Patient Testimony as a Contribution to Subjective Evidence. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 218: 259-274
Alcindor, T. 2021: Cancer and Neurofibromatosis Type 1-Confirming What We Knew and Telling Us Something New. JAMA Network Open 4(3): E211061
Amankwaa, G.; Yin, X.; Akyeampong, S.; Zhang, L.; Huang, W.; Cao, Y.; Ni, X.; Gyimah, E. 2021: Cancer and non-cancer risks in humans exposed to trace elements in drinking water from a crater lake (Bosumtwi/Bosomtwe). Water Environment Research: a Research Publication of the Water Environment Federation 93(11): 2537-2548
Balligand, J.-L. 2019: Cancer and Peripartum Cardiomyopathy: a Diabolic Couple. JACC. Cardiooncology 1(2): 206-207
Sarezky, J.; Sachs, G.; Elinzano, H.; Stavros, K. 2021: Cancer and Peripheral Nerve Disease. Clinics in Geriatric Medicine 37(2): 289-300
Nalbant, B.; Karger, A.é; Zimmermann, T. 2021: Cancer and Relationship Dissolution: Perspective of Partners of Cancer Patients. Frontiers in Psychology 12: 624902
Pundole, X.; Suarez-Almazor, M.E. 2020: Cancer and Rheumatoid Arthritis. Rheumatic Diseases Clinics of North America 46(3): 445-462
Calvo, V.; Fernandez-Cruz, A.; Nuñez, B.; Blanco, M.; Morito, A.; Martínez, M.; Traseira, C.; Garitaonaindía, Y.; Aguado, R.; Ramos, A.; Royuela, A.; Franco, F.F.; Provencio, M. 2021: Cancer and SARS-CoV-2 Infection: a Third-Level Hospital Experience. Clinical Epidemiology 13: 317-324
Ashrafizadeh, M.; Taeb, S.; Hushmandi, K.; Orouei, S.; Shahinozzaman, M.; Zabolian, A.; Moghadam, E.R.; Raei, M.; Zarrabi, A.; Khan, H.; Najafi, M. 2020: Cancer and SOX proteins: new insight into their role in ovarian cancer progression/inhibition. Pharmacological Research 161: 105159
Ladouceur, A.; Tessier-Cloutier, B.; Clarke, A.E.; Ramsey-Goldman, R.; Gordon, C.; Hansen, J.E.; Bernatsky, S. 2020: Cancer and Systemic Lupus Erythematosus. Rheumatic Diseases Clinics of North America 46(3): 533-550
Lindman, B.R. 2020: Cancer and TAVR: Reassuring Data, but Individualized and Shared Decision-Making Still Required. JACC. Cardiooncology 2(5): 744-746
Haupt, S.; Haupt, Y. 2021: Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity. Frontiers in Genetics 12: 632719
Peto, R.; Roe, F.J.; Lee, P.N.; Levy, L.; Clack, J. 1975: Cancer and ageing in mice and men. British Journal of Cancer 32(4): 411-426
Balducci, L.; Ershler, W.B. 2005: Cancer and ageing: a nexus at several levels. Nature Reviews. Cancer 5(8): 655-662
Serrano, M.; Blasco, M.A. 2007: Cancer and ageing: convergent and divergent mechanisms. Nature Reviews. Molecular Cell Biology 8(9): 715-722
Campisi, J. 2003: Cancer and ageing: rival demons?. Nature Reviews. Cancer 3(5): 339-349
Santos, J.C.; Bever, S.R.; Sullivan, K.A.; Pyter, L.M. 2019: Cancer and cancer survival modulates brain and behavior in a time-of-day-dependent manner in mice. Scientific Reports 9(1): 6497
Alam, N.; Wright, A.K.; Ashcroft, D.M.; Renehan, A.G. 2020: Cancer and cardiovascular disease. Lancet 395(10241): 1903-1904
Knisely, J.P.S.; Henry, S.A.; Saba, S.G.; Puckett, L.L. 2020: Cancer and cardiovascular disease. Lancet 395(10241): 1904
Hiatt, R.A.; Beyeler, N. 2020: Cancer and climate change. LANCET. Oncology 21(11): E519-E527
Briggs, S.; Cavet, J.; Lamb, C.; Lightowlers, S. 2021: Cancer and climate change: the environmental impact of cancer care. LANCET. Oncology 22(2): E38
Powell, J.E.; Kelly, A.M.; Parkes, S.E.; Cole, T.R.; Mann, J.R. 1995: Cancer and congenital abnormalities in Asian children: a population-based study from the West Midlands. British Journal of Cancer 72(6): 1563-1569
Brustugun, O.T. 2021: Cancer and coronavirus risk. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 141(2)
Szelei, A.ón.; Döme, P.ét. 2020: Cancer and depression: a concise review. Orvosi Hetilap 161(22): 908-916
Olatunde, A.; Nigam, M.; Singh, R.K.; Panwar, A.S.; Lasisi, A.; Alhumaydhi, F.A.; Jyoti Kumar, V.; Mishra, A.P.; Sharifi-Rad, J. 2021: Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell International 21(1): 499
Martel, A. 1946: Cancer and endocrine glands. Laval Medical 11(7): 718-727
Jee, Y.-S. 2021: Cancer and exercise immunity: 6th series of scientific evidence. Journal of Exercise Rehabilitation 17(3): 151-152
Paternostro, R.; Sieghart, W.; Trauner, M.; Pinter, M. 2021: Cancer and hepatic steatosis. Esmo Open 6(4): 100185
Ceulemans, G. 1949: Cancer and hormone therapy; Some general ideas. Bruxelles Medical 29(13): 676
Kumar, H. 2021: Cancer and immunity: who is shaping whom?. International Reviews of Immunology 40(5): 317-318
Waterman, N. 1957: Cancer and immunology. IIi. Bulletin de l'Association Francaise Pour l'Etude du Cancer 44(1): 106-114
Waterman, N. 1957: Cancer and immunology. IV. the cancer antigen. Bulletin de l'Association Francaise Pour l'Etude du Cancer 44(1): 115-123
Waterman, N. 1955: Cancer and immunology: the Rose test in cancer. Bulletin de l'Association Francaise Pour l'Etude du Cancer 42(3): 371-381
Pham, F.; Moinard-Butot, F.; Coutzac, C.él.; Chaput, N. 2021: Cancer and immunotherapy: a role for microbiota composition. European Journal of Cancer 155: 145-154
Balkwill, F.; Mantovani, A. 2010: Cancer and inflammation: implications for pharmacology and therapeutics. Clinical Pharmacology and Therapeutics 87(4): 401-406
Oliaro, T. 1954: Cancer and its history. Minerva Farmaceutica 3(1-2): 10-12
Luan, F.-J.; Wan, Y.; Mak, K.-C.; Ma, C.-J.; Wang, H.-Q. 2020: Cancer and mortality risks of patients with scoliosis from radiation exposure: a systematic review and meta-analysis. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 29(12): 3123-3134
Arnal, A.; Roche, B.; Gouagna, L.-C.ém.; Dujon, A.; Ujvari, B.; Corbel, V.; Remoue, F.; Poinsignon, A.; Pompon, J.; Giraudeau, M.; Simard, F.éd.ér.; Missé, D.ée.; Lefèvre, T.; Thomas, F.éd.ér. 2020: Cancer and mosquitoes - An unsuspected close connection. Science of the Total Environment 743: 140631
Steel, J.; Lenfeld, J. 1948: Cancer and musk glands. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 142(1-2): 109-111
Sadeghi-Yarandi, M.; Karimi, A.; Ahmadi, V.; Sajedian, A.A.; Soltanzadeh, A.; Golbabaei, F. 2020: Cancer and non-cancer health risk assessment of occupational exposure to 1,3-butadiene in a petrochemical plant in Iran. Toxicology and Industrial Health 36(12): 960-970
McClure, E.S.; Vasudevan, P.; DeBono, N.; Robinson, W.R.; Marshall, S.W.; Richardson, D. 2020: Cancer and noncancer mortality among aluminum smelting workers in Badin, North Carolina. American journal of industrial medicine 63(9): 755-765
Cristiani, G. 1961: Cancer and old age. Revista de la Asociacion Medica Argentina 75: 540-546
Pistelli, A.; Sartori, S. 2020: Cancer and pregnancy: management of acute myeloid leukemia in a 23 wks pregnant woman. The experience of Florence Teratology Information Service. Reproductive Toxicology 97: 14
Pullamsetti, S.S.; Nayakanti, S.; Chelladurai, P.; Mamazhakypov, A.; Mansouri, S.; Savai, R.; Seeger, W. 2020: Cancer and pulmonary hypertension: Learning lessons and real-life interplay. Global Cardiology Science and Practice 1: E202010
Berard, J.; Ode; Moulin 1958: Cancer and pulmonary tuberculosis. Le Poumon et le Coeur 14(9): 891-893
Janus, N.; Launay-Vacher, V.; Byloos, E.; Machiels, J-P.; Duck, L.; Kerger, J.; Wynendaele, W.; Canon, J-L.; Lybaert, W.; Nortier, J.; Deray, G.; Wildiers, H. 2010: Cancer and renal insufficiency results of the BIRMA study. British Journal of Cancer 103(12): 1815-1821
Jomain, J. 1956: Cancer and renal thrombosis. Journal d'Urologie Medicale et Chirurgicale 62(1-2): 77-78
Hugenin, R. 1945: Cancer and returnees from Germany. La Lutte Contre le Cancer 23: 95-114
Morrisroe, K.; Nikpour, M. 2020: Cancer and scleroderma: recent insights. Current Opinion in Rheumatology 32(6): 479-487
Grassi, L.; Riba, M. 2020: Cancer and severe mental illness: Bi-directional problems and potential solutions. Psycho-Oncology 29(10): 1445-1451
Yin, W.; Wang, J.; Jiang, L.; James Kang, Y. 2021: Cancer and stem cells. Experimental Biology and Medicine 246(16): 1791-1801
Nelson, D.S.; Nelson, M.; Farram, E.; Inoue, Y. 1981: Cancer and subversion of host defences. Australian Journal of Experimental Biology and Medical Science 59(Pt 3): 229-262
McMillan, D.C. 2013: Cancer and systemic inflammation: stage the tumour and stage the host. British Journal of Cancer 109(3): 529
Roxburgh, C.S.D.; McMillan, D.C. 2014: Cancer and systemic inflammation: treat the tumour and treat the host. British Journal of Cancer 110(6): 1409-1412
Huebner, K.; Croce, C.M. 2003: Cancer and the FRA3B/FHIT fragile locus: it's a HIT. British Journal of Cancer 88(10): 1501-1506
Bloodgood, J.C. 1917: Cancer and the Oral Cavity. Dental Register 71(5): 224-228
Wagner, W. 2018: Cancer and the arts: a Pacifist's Guide to the War on Cancer. Esmo Open 3(6): E000430
Mathavarajah, S.; VanIderstine, C.; Dellaire, G.; Huber, R.J. 2021: Cancer and the breakdown of multicellularity: what Dictyostelium discoideum, a social amoeba, can teach us. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 43(4): E2000156
Balkwill, F. 2004: Cancer and the chemokine network. Nature Reviews. Cancer 4(7): 540-550
Garrafa, V. 1973: Cancer and the dentist. Arquivos do Centro de Estudos da Faculdade de Odontologia da U. F. M. G 10(1-2): 85-107
Rosh, R. 1946: Cancer and the dentist. Journal of Dental Medicine 2(2): 35-38
Goldstein, B.D. 1992: Cancer and the environment. Science 255(5047): 904
Price, P.B. 1948: Cancer and the general practitioner. Rocky Mountain Medical Journal 45(12): 1096-1101
Blair, G.E.; Cook, G.P. 2008: Cancer and the immune system: an overview. Oncogene 27(45): 5868
Małyszko, J.; Kozlowski, L.; Kozłowska, K.; Małyszko, M.; Małyszko, J. 2017: Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?. Oncotarget 8(39): 66601-66619
Friedman, G.A. 1957: Cancer and the law. Medical Times 85(3): 295-303
Gunjur, A. 2020: Cancer and the microbiome. LANCET. Oncology 21(7): 888
Cher, L.M. 2001: Cancer and the nervous system. Medical Journal of Australia 175(5): 277-282
Lindegren, C.C. 1959: Cancer and the respiratory grana. Nature 184: 397-400
Leiva, O.; Newcomb, R.; Connors, J.M.; Al-Samkari, H. 2020: Cancer and thrombosis: new insights to an old problem. Journal de Medecine Vasculaire 45(6s): 6s8
Pullen, L.C. 2021: Cancer and transplant: a delicate balance. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21(2): 443-444
Fisher, G. 1948: Cancer and trauma, possible civil liability. La Lutte Contre le Cancer 26(83): 14-18
Fischer, G. 1947: Cancer and trauma, possible civil liability. Concours Medical 69(47): 1945
Puigvert, A.; Oriol Anguera, A. 1947: Cancer and tuberculosis in the kidney. Archivos Espanoles de Urologia 4(3): 200-218
Grudeva-Popova, J. 2005: Cancer and venous thromboembolism. Journal of BUON: Official Journal of the Balkan Union of Oncology 10(4): 483-489
Rasmussen, M.S.; Münster, A.-M.B. 2010: Cancer and venous thromboembolism. Ugeskrift for Laeger 172(12): 958
Palacios-Acedo, A.-L.; Mege, D.; Crescence, L.; Panicot-Dubois, L.; Dubois, C. 2020: Cancer animal models in thrombosis research. Thrombosis Research 191(Suppl 1): S112-S116
Shulman, S. 1990: Cancer around nuclear plant. Nature 347(6294): 604
Ribatti, D. 2021: Cancer as a Genetic or Epigenetic Disease?. Critical Reviews in Eukaryotic Gene Expression 31(5): 1-5
Tanyi, Z.; Mirnics, Z.; Ferenczi, A.; Smohai, M.át.é; Mészáros, V.; Kovács, D.ór.; Jakubovits, E.; Kövi, Z. 2020: Cancer as a Source of Posttraumatic Growth: a Brief Review. Psychiatria Danubina 32(Suppl 4): 401-411
Stewart, A.M. 1973: Cancer as a cause of abortions and stillbirths: the effect of these early deaths on the recognition of radiogenic leukaemias. British Journal of Cancer 27(6): 465-472
Laconi, E.; Marongiu, F.; DeGregori, J. 2020: Cancer as a disease of old age: changing mutational and microenvironmental landscapes. British Journal of Cancer 122(7): 943-952
Timp, W.; Feinberg, A.P. 2013: Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nature Reviews. Cancer 13(7): 497-510
Saini, G.; Aneja, R. 2021: Cancer as a prospective sequela of long COVID-19. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 43(6): E2000331
Pulvermacher, E. 1947: Cancer as a result of war injury. MedizinischeKlinik 42(23-24): 857
Kitano, H. 2004: Cancer as a robust system: implications for anticancer therapy. Nature Reviews. Cancer 4(3): 227-235
Espinos Gisbert, D. 1945: Cancer as a social disease. Revista de Sanidad 19: 167-181
Merlo, L.M.F.; Pepper, J.W.; Reid, B.J.; Maley, C.C. 2006: Cancer as an evolutionary and ecological process. Nature Reviews. Cancer 6(12): 924-935
Seeger, P.G. 1951: Cancer as an infectious disease. Die Pharmazie 6(9): 462-466
Schäfer, M.; Werner, S. 2008: Cancer as an overhealing wound: an old hypothesis revisited. Nature Reviews. Molecular Cell Biology 9(8): 628-638
Demircioglu, F.; Wang, J.; Candido, J.; Costa, A.S.H.; Casado, P.; de Luxan Delgado, B.; Reynolds, L.E.; Gomez-Escudero, J.; Newport, E.; Rajeeve, V.; Baker, A-Marie.; Roy-Luzarraga, M.; Graham, T.A.; Foster, J.; Wang, Y.; Campbell, J.J.; Singh, R.; Zhang, P.; Schall, T.J.; Balkwill, F.R.; Sosabowski, J.; Cutillas, P.R.; Frezza, C.; Sancho, P.; Hodivala-Dilke, K. 2020: Cancer associated fibroblast FAK regulates malignant cell metabolism. Nature Communications 11(1): 1290
Jena, B.C.; Das, C.K.; Bharadwaj, D.; Mandal, M. 2020: Cancer associated fibroblast mediated chemoresistance: a paradigm shift in understanding the mechanism of tumor progression. Biochimica et Biophysica Acta. Reviews on Cancer 1874(2): 188416
Simon, T.; Salhia, B. 2022: Cancer-Associated Fibroblast Subpopulations with Diverse and Dynamic Roles in the Tumor Microenvironment. Molecular Cancer Research: Mcr 20(2): 183-192
Alexander, J.; Cukierman, E. 2020: Cancer associated fibroblast: Mediators of tumorigenesis. Matrix Biology: Journal of the International Society for Matrix Biology 91-92: 19-34
Gok Yavuz, B.; Gunaydin, G.; Gedik, M.Emre.; Kosemehmetoglu, K.; Karakoc, D.; Ozgur, F.; Guc, D. 2019: Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1 + TAMs. Scientific Reports 9(1): 3172
Gironda, D.J.; Adams, D.L.; He, J.; Xu, T.; Gao, H.; Qiao, Y.; Komaki, R.; Reuben, J.M.; Liao, Z.; Blum-Murphy, M.; Hofstetter, W.L.; Tang, C.-M.; Lin, S.H. 2020: Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy. Journal of Translational Medicine 18(1): 413
Bhattacharya, S.; Hanpude, P.; Maiti, T.Kanti. 2015: Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Scientific Reports 5: 18462
Witham, C.M.; Paxman, A.L.; Baklous, L.; Steuart, R.F.L.; Schulz, B.L.; Mousley, C.J. 2021: Cancer associated mutations in Sec61γ alter the permeability of the ER translocase. Plos Genetics 17(8): E1009780
Azizi, L.; Cowell, A.R.; Mykuliak, V.V.; Goult, B.T.; Turkki, P.; Hytönen, V.P. 2021: Cancer associated talin point mutations disorganise cell adhesion and migration. Scientific Reports 11(1): 347
Khorana, A.A.; Kuderer, N.M.; McCrae, K.; Milentijevic, D.; Germain, G.; Laliberté, F.ço.; MacKnight, S.D.; Lefebvre, P.; Lyman, G.H.; Streiff, M.B. 2020: Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels. Cancer Medicine 9(21): 8062-8073
Weitz, J.I.; Haas, S.; Ageno, W.; Goldhaber, S.Z.; Turpie, A.G.G.; Goto, S.; Angchaisuksiri, P.; Nielsen, J.ør.D.; Kayani, G.; Farjat, A.E.; Schellong, S.; Bounameaux, H.; Mantovani, L.G.; Prandoni, P.; Kakkar, A.K.; Loualidi, A.; Colak, A.; Bezuidenhout, A.; Abdool-Carrim, A.; Azeddine, A.; Beyers, A.; Dees, A.; Mohamed, A.; Aksoy, A.; Abiko, A.; Watanabe, A.; Krichell, A.; Fernandez, A.A.; Tosetto, A.; Khotuntsov, A.; Oropallo, A.; Slocombe, A.; Kelly, A.; Clark, A.; Gad, A.; Arouni, A.; Schmidt, A.; Berni, A.; Kleiban, A.J.; Machowski, A.; Kazakov, A.; Galvez, A.; Lockman, A.; Falanga, A.; Chauhan, A.; Riera-Mestre, A.; Mazzone, A.; D'Angelo, A.; Herdy, A.; Kato, A.; Salem, A.A.E.E.M.; Husin, A.; Erdelyi, B.; Jacobson, B.; Amann-Ve 2020: Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. Journal of Thrombosis and Thrombolysis 50(2): 267-277
Check, E. 2007: Cancer atlas maps out sample worries. Nature 447(7148): 1036-1037
Lu, Y.; Li, P.; Luo, G.; Liu, D.; Zou, H. 2020: Cancer attributable to human papillomavirus infection in China: Burden and trends. Cancer 126(16): 3719-3732
Sahu, D.P.; Subba, S.H.; Giri, P.P. 2020: Cancer awareness and attitude towards cancer screening in India: a narrative review. Journal of Family Medicine and Primary Care 9(5): 2214-2218
Bragazzi, N.L.; Sellami, M. 2021: Cancer bioenergetics as emerging holistic cancer theory: the role of metabolic fluxes and transport proteins involved in metabolic pathways in the pathogenesis of malignancies. State-of-the-art and future prospects. Advances in Protein Chemistry and Structural Biology 123: 27-47
Lai, A.Y.; Wade, P.A. 2011: Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nature Reviews. Cancer 11(8): 588-596
Iacobuzio-Donahue, C.A.; Michael, C.; Baez, P.; Kappagantula, R.; Hooper, J.E.; Hollman, T.J. 2019: Cancer biology as revealed by the research autopsy. Nature Reviews. Cancer 19(12): 686-697
Sundara Rajan, S.; Ludwig, K.R.; Hall, K.L.; Jones, T.L.; Caplen, N.J. 2020: Cancer biology functional genomics: from small RNAs to big dreams. Molecular Carcinogenesis 59(12): 1343-1361
Austin, R. 2017: Cancer biology still needs physicists. Nature 550(7677): 431
Patterson, M. 2001: Cancer biology. Manipulating the system. Nature Reviews. Genetics 2(2): 89
Zlotorynski, E. 2017: Cancer biology: A Neat target of p53. Nature Reviews. Molecular Cell Biology 18(9): 532
Deuker, M.M.; McMahon, M. 2014: Cancer biology: Enzyme meets a surprise target. Nature 510(7504): 225-226
Umbreit, N.T.; Pellman, D. 2017: Cancer biology: Genome jail-break triggers lockdown. Nature 550(7676): 340-341
Strzyz, P. 2016: Cancer biology: Hypoxia as an off switch for gene expression. Nature Reviews. Molecular Cell Biology 17(10): 610
Wrighton, K.H. 2011: Cancer biology: Role of nuclear PTEN revealed. Nature Reviews. Molecular Cell Biology 12(3): 134
Weiser, K.C.; Justice, M.J. 2005: Cancer biology: Sleeping Beauty awakens. Nature 436(7048): 184-186
Strzyz, P. 2016: Cancer biology: TGFβ and EMT as double agents. Nature Reviews. Molecular Cell Biology 17(4): 202-203
Zlotorynski, E. 2016: Cancer biology: The dark side of p21. Nature Reviews. Molecular Cell Biology 17(8): 461
Strzyz, P. 2017: Cancer biology: The skin's power of elimination. Nature Reviews. Molecular Cell Biology 18(10): 594
Burgess, D.J. 2017: Cancer biology: Therapy-induced transcription is cryptically widespread. Nature Reviews. Molecular Cell Biology 18(8): 469
Passegué, E. 2006: Cancer biology: a game of subversion. Nature 442(7104): 754-755
Berns, A. 2006: Cancer biology: can less be more for p53?. Nature 443(7108): 153-154
Steeg, P.S. 2005: Cancer biology: emissaries set up new sites. Nature 438(7069): 750-751
Sharpless, N.E.; DePinho, R.A. 2007: Cancer biology: gone but not forgotten. Nature 445(7128): 606-607
Dingli, D.; Nowak, M.A. 2006: Cancer biology: infectious tumour cells. Nature 443(7107): 35-36
Wallace, V.A. 2006: Cancer biology: second step to retinal tumours. Nature 444(7115): 45-46
Downward, J. 2006: Cancer biology: signatures guide drug choice. Nature 439(7074): 274-275
Huntly, B.J.P.; Gilliland, D.Gary. 2005: Cancer biology: summing up cancer stem cells. Nature 435(7046): 1169-1170
Merlino, G. 2005: Cancer biology: the weakest link?. Nature 436(7047): 33-35
Jeffrey, S.S. 2008: Cancer biomarker profiling with microRNAs. Nature Biotechnology 26(4): 400-401
Longo, G. 2014: Cancer biomarkers: Detected twice for good measure. Nature Nanotechnology 9(12): 959-960
Yong, E. 2014: Cancer biomarkers: Written in blood. Nature 511(7511): 524-526
Hartwell, L.; Mankoff, D.; Paulovich, A.; Ramsey, S.; Swisher, E. 2006: Cancer biomarkers: a systems approach. Nature Biotechnology 24(8): 905-908
Srivastava, S. 2005: Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer. Cancer Biomarkers: Section a of Disease Markers 1(1): 1-2
Kelloff, G.J.; Sigman, C.C. 2012: Cancer biomarkers: selecting the right drug for the right patient. Nature Reviews. Drug Discovery 11(3): 201-214
Resasco, A.; MacLellan, A.; Ayala, M.A.; Kitchenham, L.; Edwards, A.M.; Lam, S.; Dejardin, S.; Mason, G. 2021: Cancer blues? a promising judgment bias task indicates pessimism in nude mice with tumors. Physiology and Behavior 238: 113465
Wadman, M. 1999: Cancer body 'must do more for minorities'. Nature 397(6717): 283
Sun, D.; Cao, M.; Li, H.; He, S.; Chen, W. 2020: Cancer burden and trends in China: a review and comparison with Japan and South Korea. Chinese Journal of Cancer Research 32(2): 129-139
Pettersen, K.; Andersen, S.; Degen, S.; Tadini, V.; Grosjean, Jël.; Hatakeyama, S.; Tesfahun, A.N.; Moestue, S.; Kim, J.; Nonstad, U.; Romundstad, Pål.R.; Skorpen, F.; Sørhaug, S.; Amundsen, T.; Grønberg, Børn.H.; Strasser, F.; Stephens, N.; Hoem, D.; Molven, A.; Kaasa, S.; Fearon, K.; Jacobi, C.; Bjørkøy, G. 2017: Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Scientific Reports 7(1): 2046
Rounis, K.; Makrakis, D.; Tsigkas, A.-P.; Georgiou, A.; Galanakis, N.; Papadaki, C.; Monastirioti, A.; Vamvakas, L.; Kalbakis, K.; Vardakis, N.; Kontogianni, M.; Gioulbasanis, I.; Mavroudis, D.; Agelaki, S. 2021: Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study. Translational Lung Cancer Research 10(8): 3538-3549
Wiegert, E.V.M.; de Oliveira, L.C.; Calixto-Lima, L.; Mota E Silva Lopes, M.ár.S.d.; Peres, W.A.F. 2020: Cancer cachexia: Comparing diagnostic criteria in patients with incurable cancer. Nutrition: 79-80: 110945
Li, Y.; Jin, H.; Chen, Y.; Huang, T.; Mi, Y.; Zou, Z. 2021: Cancer cachexia: molecular mechanism and pharmacological management. Biochemical Journal 478(9): 1663-1688
Argilés, J.M.; Busquets, Sílvia.; Stemmler, B.; López-Soriano, F.J. 2014: Cancer cachexia: understanding the molecular basis. Nature Reviews. Cancer 14(11): 754-762
Vidaurreta, J. 1946: Cancer can be cured; what you should know about cancer. Cuadernos Medicos y de Divulgacion Cientifica 3(12): 3-10
Traynor, K. 2020: Cancer care adapts during pandemic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 77(18): 1458
Kochbati, L.; Vanderpuye, V.; Moujahed, R.; Rejeb, M.B.; Naimi, Z.; Olasinde, T. 2020: Cancer care and COVID-19: tailoring recommendations for the African radiation oncology context. Ecancermedicalscience 14: 1144
Lidington, E.K.; Smrke, A.; Ingley, K.M.; Strauss, S.J.; Husson, O.; Younger, E. 2020: Cancer care and well-being in adolescents and young adults during the coronavirus disease 2019 pandemic: a UK sarcoma perspective. Cancer 126(24): 5359-5360
Vela-Ruiz, J.é M.; Ramos, W.; Cruz-Vargas, J.A.D.L. 2020: Cancer care challenges during COVID -19 pandemic. Revista Peruana de Medicina Experimental y Salud Publica 37(3): 580-581
Wakefield, D. 2021: Cancer care disparities in the LGBT community. Current Opinion in Supportive and Palliative Care 15(3): 174-179
Edge, R.; Meyers, J.; Tiernan, G.; Li, Z.; Schiavuzzi, A.; Chan, P.; Vassallo, A.; Morrow, A.; Mazariego, C.; Wakefield, C.E.; Canfell, K.; Taylor, N. 2021: Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: a patient, carer and healthcare worker perspective. Plos one 16(9): E0257420
Neal, R.D.; Nekhlyudov, L.; Wheatstone, P.; Koczwara, B. 2020: Cancer care during and after the pandemic. Bmj 370: M2622
Alessy, S.A.; Davies, E.A.; Jazieh, A.-R. 2020: Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia. Ecancermedicalscience 14: 1076
Casolino, R.; Inno, A.; Cassandrini, P.; Cirillo, M.; Magarotto, R.; Modena, A.; Nicodemo, M.; Picece, V.; Turazza, M.; Marchetti, F.; Valerio, M.; Alongi, F.; Barbieri, E.; Bisoffi, Z.; Carbognin, G.; Ruffo, G.; Salgarello, M.; Zamboni, G.; Verzè, M.; Brunelli, D.; Gori, S. 2017: Cancer care for migrant patients: the value of a dedicated service. Annals of Oncology: Official Journal of the European Society for Medical Oncology 28 Suppl. 6: Vi87
Fraser, A.; McNeill, R.; Robinson, J. 2022: Cancer care in a time of COVID: lung cancer patient's experience of telehealth and connectedness. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 30(2): 1823-1830
Colomer, R.; Germà, J.R.; Rosell, R.; Borràs, J.M. 2004: Cancer care in rural areas. British Journal of Cancer 90(8): 1688; Author Reply 1689
Andall-Brereton, G.; Bromfield, B.; Smith, S.; Spence, D. 2020: Cancer care in the Commonwealth Caribbean in COVID times. LANCET. Oncology 21(8): 1007-1009
Khizanishvili, G.; Henshall, S.; Gabunia, T. 2021: Cancer care prioritised: Georgia expands access to cancer medicines. LANCET. Oncology 22(1): 15-17
Lubuzo, B.; Hlongwana, K.; Ginindza, T. 2022: Cancer care reform in South Africa: a case for cancer care coordination: a narrative review. Palliative and Supportive Care 20(1): 129-137
Bouche, G. 2017: Cancer care: Tap latent source of frugal cancer ideas. Nature 550(7675): 188
Emery, J.D. 2008: Cancer care: what role for the general practitioner?. Medical Journal of Australia 189(9): 535
Yang, W.F.Z.; Lee, R.Z.Y.; Kuparasundram, S.; Tan, T.; Chan, Y.H.; Griva, K.; Mahendran, R. 2021: Cancer caregivers unmet needs and emotional states across cancer treatment phases. Plos one 16(8): E0255901
Rezende, L.F.M.; Murata, E.; Giannichi, B.; Tomita, L.Y.; Wagner, G.A.; Sanchez, Z.M.; Celis-Morales, C.; Ferrari, G. 2020: Cancer cases and deaths attributable to lifestyle risk factors in Chile. Bmc Cancer 20(1): 693
Roy, I.; Boyle, K.A.; Vonderhaar, E.P.; Zimmerman, N.P.; Gorse, E.; Mackinnon, A.Craig.; Hwang, R.F.; Franco-Barraza, J.; Cukierman, E.; Tsai, S.; Evans, D.B.; Dwinell, M.B. 2017: Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 97(3): 302-317
Osato, S.; Mori, H. 1955: Cancer cell chromosomes observed under the electron microscope. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149(7-8): 847-850
Ohoka, N.; Nagai, K.; Hattori, T.; Okuhira, K.; Shibata, N.; Cho, N.; Naito, M. 2014: Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death and Disease 5: E1513
De Ridder, I.; Kerkhofs, M.; Veettil, S.P.; Dehaen, W.; Bultynck, G. 2021: Cancer cell death strategies by targeting Bcl-2's BH4 domain. Biochimica et Biophysica Acta. Molecular Cell Research 1868(5): 118983
Park, S.-H.; Jung, H.; Lee, H.; Kim, T.M.; Cho, J.W.; Jang, W.-D.; Hyun, J.Y.; Shin, I. 2020: Cancer cell death using metabolic glycan labelling techniques. Chemical Communications 56(73): 10650-10653
Mishra, G.P.; Kumar, D.; Chaudhary, V.S.; Murmu, G. 2020: Cancer cell detection by a heart-shaped dual-core photonic crystal fiber sensor. Applied Optics 59(33): 10321-10329
MacGregor, M.; Safizadeh Shirazi, H.; Chan, K.M.; Ostrikov, K.; McNicholas, K.; Jay, A.; Chong, M.; Staudacher, A.H.; Michl, T.D.; Zhalgasbaikyzy, A.; Brown, M.P.; Kashani, M.N.; Di Fiore, A.; Grochowski, A.; Robb, S.; Belcher, S.; Li, J.; Gleadle, J.M.; Vasilev, K. 2021: Cancer cell detection device for the diagnosis of bladder cancer from urine. Biosensors and Bioelectronics 171: 112699
Taya, S.A.; Colak, I.; Suthar, B.; Ramahi, O.M. 2021: Cancer cell detector based on a slab waveguide of anisotropic, lossy, and dispersive left-handed material. Applied Optics 60(27): 8360-8367
Zhang, R.; Niu, G.; Lu, Q.; Huang, X.; Chau, J.H.C.; Kwok, R.T.K.; Yu, X.; Li, M.-H.; Lam, J.W.Y.; Tang, B.Z. 2020: Cancer cell discrimination and dynamic viability monitoring through wash-free bioimaging using AIEgens. Chemical Science 11(29): 7676-7684
Shamloo, A.; Naghdloo, A.; Besanjideh, M. 2021: Cancer cell enrichment on a centrifugal microfluidic platform using hydrodynamic and magnetophoretic techniques. Scientific Reports 11(1): 1939
Li, C.; Xu, Y.; Liu, S.-Y.; Zhang, Y.; Yin, W.; Dai, Z.; Zou, X. 2021: Cancer cell identification by facile imaging of intracellular reductive substances with fluorescent nanosensor. Talanta 234: 122650
Gao, R.; He, B.; Huang, Q.; Wang, Z.; Yan, M.; Lam, E.W.-F.; Lin, S.; Wang, B.; Liu, Q. 2021: Cancer cell immune mimicry delineates onco-immunologic modulation. Iscience 24(10): 103133
Liotta, L.A. 1992: Cancer cell invasion and metastasis. Scientific American 266(2): 54-9 62-3
Routila, J.; Suvila, K.; Grénman, R.; Leivo, I.; Westermarck, J.; Ventelä, S. 2021: Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma. Bmc Cancer 21(1): 868
Guerreiro, E.M.; Øvstebø, R.; Thiede, B.; Costea, D.E.; Søland, T.M.; Kanli Galtung, H. 2020: Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics. Plos one 15(9): E0238591
McDermott, U. 2018: Cancer cell lines as patient avatars for drug response prediction. Nature Genetics 50(10): 1350-1351
Wass, A.V.; Butler, G.; Taylor, T.B.; Dash, P.R.; Johnson, L.J. 2020: Cancer cell lines show high heritability for motility but not generation time. Royal Society Open Science 7(4): 191645
Sun, Q.; Wu, J.; Jin, L.; Hong, L.; Wang, F.; Mao, Z.; Wu, M. 2020: Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer. Journal of Materials Chemistry. B 8(32): 7253-7263
Cai, D.; Liu, L.; Han, C.; Ma, X.; Qian, J.; Zhou, J.; Zhu, W. 2019: Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells. Scientific Reports 9(1): 14475
Oliveira, G.L.; Coelho, A.R.; Marques, R.; Oliveira, P.J. 2021: Cancer cell metabolism: Rewiring the mitochondrial hub. Biochimica et Biophysica Acta. Molecular Basis of Disease 1867(2): 166016
Jang, M.; Kim, S.Soo.; Lee, J. 2013: Cancer cell metabolism: implications for therapeutic targets. Experimental and Molecular Medicine 45: E45
Miyazaki, K.; Oyanagi, J.; Hoshino, D.; Togo, S.; Kumagai, H.; Miyagi, Y. 2019: Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix. Scientific Reports 9(1): 292
Corey, S.J.; Yu, J. 2011: Cancer cell migration: when red light switched to green. Asian Journal of Andrology 13(2): 177-178
Paul, C.D.; Mistriotis, P.; Konstantopoulos, K. 2017: Cancer cell motility: lessons from migration in confined spaces. Nature Reviews. Cancer 17(2): 131-140
Hamuro, J.; Kikuchi, T.; Takatsuki, F.; Suzuki, M. 1996: Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy. British Journal of Cancer 73(4): 465-471
Zimmerman, J.W.; Pennison, M.J.; Brezovich, I.; Yi, N.; Yang, C.T.; Ramaker, R.; Absher, D.; Myers, R.M.; Kuster, N.; Costa, F.P.; Barbault, A.; Pasche, B. 2012: Cancer cell proliferation is inhibited by specific modulation frequencies. British Journal of Cancer 106(2): 307-313
Yu, L-Gang. 2017: Cancer cell resistance to anoikis: MUC1 glycosylation comes to play. Cell Death and Disease 8(7): E2962
Yaglom, J.A.; Wang, Y.; Li, A.; Li, Z.; Monti, S.; Alexandrov, I.; Lu, X.; Sherman, M.Y. 2018: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations. Scientific Reports 8(1): 3010
Bonnotte, B.; Favre, N.; Reveneau, S.; Micheau, O.; Droin, N.; Garrido, C.; Fontana, A.; Chauffert, B.; Solary, E.; Martin, F. 1998: Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death and Differentiation 5(6): 480-487
Melnik, S.; Dvornikov, D.; Müller-Decker, K.; Depner, S.; Stannek, P.; Meister, M.; Warth, A.; Thomas, M.; Muley, T.; Risch, A.; Plass, C.; Klingmüller, U.; Niehrs, C.; Glinka, A. 2018: Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification. Cell Discovery 4: 37
Barkley, D.; Rao, A.; Pour, M.; França, G.S.; Yanai, I. 2021: Cancer cell states and emergent properties of the dynamic tumor system. Genome Research 31(10): 1719-1727
Buchheit, C.L.; Weigel, K.J.; Schafer, Z.T. 2014: Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nature Reviews. Cancer 14(9): 632-641
Yu, J.Xin.; Upadhaya, S.; Tatake, R.; Barkalow, F.; Hubbard-Lucey, V.M. 2020: Cancer cell therapies: the clinical trial landscape. Nature Reviews. Drug Discovery 19(9): 583-584
Yin, L.; Hu, P.; Shi, X.; Qian, W.; Zhau, H.E.; Pandol, S.J.; Lewis, M.S.; Chung, L.W.K.; Wang, R. 2020: Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Scientific Reports 10(1): 1216
Sistigu, A.; Yamazaki, T.; Vacchelli, E.; Chaba, K.; Enot, D.P.; Adam, J.; Vitale, I.; Goubar, A.; Baracco, E.E.; Remédios, C.; Fend, L.; Hannani, D.; Aymeric, L.; Ma, Y.; Niso-Santano, M.; Kepp, O.; Schultze, J.L.; Tüting, T.; Belardelli, F.; Bracci, L.; La Sorsa, V.; Ziccheddu, G.; Sestili, P.; Urbani, F.; Delorenzi, M.; Lacroix-Triki, M.; Quidville, V.; Conforti, R.; Spano, J-Philippe.; Pusztai, L.; Poirier-Colame, V.; Delaloge, S.; Penault-Llorca, F.; Ladoire, S.; Arnould, L.; Cyrta, J.; Dessoliers, M-Charlotte.; Eggermont, A.; B 2014: Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nature Medicine 20(11): 1301-1309
Nguyen, C.Huu.; Stadler, S.; Brenner, S.; Huttary, N.; Krieger, S.; Jäger, W.; Dolznig, H.; Krupitza, G. 2016: Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching. British Journal of Cancer 115(3): 364-370
Miao, S.; Shu, D.; Zhu, Y.; Lu, M.; Zhang, Q.; Pei, Y.; He, A-Di.; Ma, R.; Zhang, B.; Ming, Z-Yin. 2019: Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa. Cell Death and Disease 10(2): 87
Rathore, M.; Girard, C.; Ohanna, M.; Tichet, M.; Ben Jouira, R.; Garcia, E.; Larbret, F.; Gesson, M.; Audebert, S.; Lacour, J-P.; Montaudié, H.; Prod'Homme, V.; Tartare-Deckert, S.; Deckert, M. 2019: Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway. Oncogene 38(30): 5873-5889
Yang, A-Jun.; Wang, M.; Wang, Y.; Cai, W.; Li, Q.; Zhao, T-Ting.; Zhang, L-Han.; Houck, K.; Chen, X.; Jin, Y-Ling.; Mu, J-Ying.; Dong, J-Fei.; Li, M. 2018: Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma. Oncogenesis 7(1): 12
He, Y.; Bouwstra, R.; Wiersma, V.R.; de Jong, M.; Jan Lourens, H.; Fehrmann, R.; de Bruyn, M.; Ammatuna, E.; Huls, G.; van Meerten, T.; Bremer, E. 2019: Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis. Nature Communications 10(1): 533
Zhang, Y.; Zhai, Q.; Feng, X.; Chen, D.; Lu, Y.; Hu, J.; Xie, H.; Zhou, L.; Wu, J.; Zheng, S. 2021: Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23(7): 1314-1324
Li, C.I.; Zhang, Y.; Cieślik, M.; Wu, Y.-M.; Xiao, L.; Cobain, E.; Tang, M.-T.C.; Cao, X.; Porter, P.; Guenthoer, J.; Robinson, D.R.; Chinnaiyan, A.M. 2021: Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(11): 3079-3093
Kluz, P.N.; Kolb, R.; Xie, Q.; Borcherding, N.; Liu, Q.; Luo, Y.; Kim, M-Chul.; Wang, L.; Zhang, Y.; Li, W.; Stipp, C.; Gibson-Corley, K.N.; Zhao, C.; Qi, H.H.; Bellizzi, A.; Tao, A.W.; Sugg, S.; Weigel, R.J.; Zhou, D.; Shen, X.; Zhang, W. 2020: Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling. Oncogene 39(14): 2877-2889
Xu, W.Wen.; Li, B.; Guan, X.Yuan.; Chung, S.K.; Wang, Y.; Yip, Y.Ling.; Law, S.Y.K.; Chan, K.Tak.; Lee, N.P.Y.; Chan, K.Wah.; Xu, L.Yan.; Li, E.Min.; Tsao, S.Wah.; He, Q-Yu.; Cheung, A.L.M. 2017: Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nature Communications 8: 14399
Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L.T.; Choyke, P.L.; Kobayashi, H. 2011: Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nature Medicine 17(12): 1685-1691
Mertens, R.T.; Parkin, S.; Awuah, S.G. 2020: Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(iii) dithiocarbamates. Chemical Science 11(38): 10465-10482
Johnson, A.M.; Boland, J.M.; Wrobel, J.; Klezcko, E.K.; Weiser-Evans, M.; Hopp, K.; Heasley, L.; Clambey, E.T.; Jordan, K.; Nemenoff, R.A.; Schenk, E.L. 2021: Cancer Cell-Specific Major Histocompatibility Complex Ii Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 16(10): 1694-1704
Fu, Z.; Wu, Y.; Ren, C.; Song, W.; Zhang, X.; Yue, M.; Li, Y. 2020: Cancer cell-targeted nanoprobe for multilayer imaging of diverse biomarkers and precise photodynamic therapy. Chemical Communications 56(96): 15208-15211
Takaoka, A. 2018: Cancer cells deliver a suppressive cargo. Nature Immunology 19(3): 207-208
Chi, Y.; Remsik, J.; Kiseliovas, V.; Derderian, C.; Sener, U.; Alghader, M.; Saadeh, F.; Nikishina, K.; Bale, T.; Iacobuzio-Donahue, C.; Thomas, T.; Pe'er, D.; Mazutis, L.; Boire, A. 2020: Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science 369(6501): 276-282
Liu, Z.; Lee, S.Jong.; Park, S.; Konstantopoulos, K.; Glunde, K.; Chen, Y.; Barman, I. 2020: Cancer cells display increased migration and deformability in pace with metastatic progression. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 34(7): 9307-9315
Cirone, M. 2021: Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses. Critical Reviews in Biochemistry and Molecular Biology 2021: 1-10
Fish, L.; Zhang, S.; Yu, J.X.; Culbertson, B.; Zhou, A.Y.; Goga, A.; Goodarzi, H. 2018: Cancer cells exploit an orphan RNA to drive metastatic progression. Nature Medicine 24(11): 1743-1751
Ostler, K.R.; Davis, E.M.; Payne, S.L.; Gosalia, B.B.; Expósito-Céspedes, J.; Le Beau, M.M.; Godley, L.A. 2007: Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene 26(38): 5553-5563
Azimi, T.; Loizidou, M.; Dwek, M.V. 2020: Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin. Scientific Reports 10(1): 12020
Herbut, P.A. 1947: Cancer cells in bronchial secretions. American Journal of Pathology 23(5): 867
Floor, S.; van Staveren, W.C.G.; Larsimont, D.; Dumont, J.E.; Maenhaut, C. 2011: Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 30(46): 4609-4621
Fajers, C.M.; Jonsson, G. 1949: Cancer cells in prostate secretion. Nordisk Medicin 41(12): 561
Roberts, S.S.; Cole, W.H. 1959: Cancer cells in the circulating blood. Seminar Report. Merck Sharp and Dohme 4(2): 2-10
Roberts, S.S.; Cole, W.H. 1961: Cancer cells in the circulating blood. Seminar International 10: 2-10
Engell, H.C. 1955: Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chirurgica Scandinavica. Supplementum 201: 1-70
De Watteville 1949: Cancer cells in the vaginal secretions; Demonstration of the Pap smear test. Schweizerische Medizinische Wochenschrift 79(24): 553
Chen, Y.; Xu, S.; Huang, C.; Ling, Y.; Liang, C.; Miao, Y.; Sun, X.; Li, Y.; Zhou, Z. 2020: Cancer cells invasion to the gastric bare area adipose tissue: a poor prognostic predictor for gastric cancer. World Journal of Surgical Oncology 18(1): 300
Kashani, A.S.; Packirisamy, M. 2020: Cancer cells optimize elasticity for efficient migration. Royal Society Open Science 7(10): 200747
Kim, D-S.; Choi, Y-B.; Han, B-G.; Park, S-Y.; Jeon, Y.; Kim, D-H.; Ahn, E-R.; Shin, J-E.; Lee, B.I.; Lee, H.; Hong, K-M.; Kim, S-Y. 2011: Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking. Oncogene 30(48): 4780-4790
Usmani, S.M.; Mempel, T.R. 2021: Cancer cells relax and resist cytotoxic attack. Immunity 54(5): 853-855
Grüner, B.M.; Fendt, S-Maria. 2020: Cancer cells stock up in lymph vessels to survive. Nature 585(7823): 36-37
Bar, J.; Feniger-Barish, R.; Lukashchuk, N.; Shaham, H.; Moskovits, N.; Goldfinger, N.; Simansky, D.; Perlman, M.; Papa, M.; Yosepovich, A.; Rechavi, G.; Rotter, V.; Oren, M. 2009: Cancer cells suppress p53 in adjacent fibroblasts. Oncogene 28(6): 933-936
Harada, H.; Inoue, M.; Itasaka, S.; Hirota, K.; Morinibu, A.; Shinomiya, K.; Zeng, L.; Ou, G.; Zhu, Y.; Yoshimura, M.; McKenna, W.Gillies.; Muschel, R.J.; Hiraoka, M. 2012: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nature Communications 3: 783
Poojan, S.; Bae, S-Hyun.; Min, J-Woong.; Lee, E.Young.; Song, Y.; Kim, H.Yeon.; Sim, H.Won.; Kang, E-Kyung.; Kim, Y-Ho.; Lee, H-Ock.; Hong, Y.; Park, W-Yang.; Jang, H.; Hong, K-Man. 2020: Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment. Experimental and Molecular Medicine 52(7): 1102-1115
Kogure, A.; Naito, Y.; Yamamoto, Y.; Yashiro, M.; Kiyono, T.; Yanagihara, K.; Hirakawa, K.; Ochiya, T. 2020: Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts. Plos one 15(6): E0234613
Dornier, E.; Norman, J.C. 2018: Cancer cells with trapped nuclei cut their way through the extracellular matrix. Nature Communications 9(1): 3954
Villanueva, M.Teresa. 2020: Cancer cells' loss is T cells' gain. Nature Reviews. Drug Discovery 19(1): 21
Pinkel, D. 2000: Cancer cells, chemotherapy and gene clusters. Nature Genetics 24(3): 208-209
Weigelin, B.; Friedl, P. 2016: Cancer cells: Stemness shaped by curvature. Nature Materials 15(8): 827-828
Ballmaier 1999: Cancer center combines public and private groups. Nature Medicine 5(9): 973
Carando, Q. 1949: Cancer center; plessio-roentgenterapia and radiumterapia. Archivio di Radiologia 23: 32-39
Ault, A. 1999: Cancer centers set sights on tobacco settlement. Nature Medicine 5(1): 10
Sheridan, C. 2014: Cancer centers zero in on exceptional responders. Nature Biotechnology 32(8): 703-704
Hartwell, L. 2002: Cancer centre didn't shoot the messenger. Nature 416(6883): 785
MacDonald, N. 1992: Cancer centres--their role in palliative care. Journal of Palliative Care 8(1): 38-42
Istre, B. 1948: Cancer cervicis uteri in pregnancy. Nordisk Medicin 40(42): 1892
Sadoff, L. 1993: Cancer chemotherapeutic and biologic agents. Ca: a Cancer Journal for Clinicians 43(2): 127; Author Reply 127-8
Mitchell, J.S. 1949: Cancer chemotherapy (transl.). Jornada Medica 3(22): 141-150
Balducci, L.; Phillips, D.M.; Wallace, C.; Hardy, C. 1987: Cancer chemotherapy in the elderly. American Family Physician 35(3): 133-143
Conti, J.A.; Christman, K. 1995: Cancer chemotherapy in the elderly. Journal of Clinical Gastroenterology 21(1): 65-71
Gillison, T.L.; Chatta, G.S. 2010: Cancer chemotherapy in the elderly patient. Oncology 24(1): 76-85
Petsko, G.A. 1995: Cancer chemotherapy. Heavy metal revival. Nature 377(6550): 580-581
Greenwald, E.S. 1966: Cancer chemotherapy. i. New York State Journal of Medicine 66(19): 2532-2548
Cox, K.R. 1961: Cancer chemotherapy. i. Medical Journal of Australia 48(2): 630-635
Greenwald, E.S. 1966: Cancer chemotherapy. Ii. New York State Journal of Medicine 66(20): 2670-2681
Cox, K.R. 1961: Cancer chemotherapy. Ii. Medical Journal of Australia 48(2): 671
Mountain, C.F. 1962: Cancer chemotherapy. Ii. Medical Record and Annals 55: 174-175
Stark, G.R. 1986: Cancer chemotherapy. Progress in understanding multidrug resistance. Nature 324(6096): 407-408
Thomson, L. 1979: Cancer chemotherapy: a guide for nurses. Nursing Times 75(47 Suppl): 17-20
Fox, B.W.; Dexter, T.M. 1978: Cancer chemotherapy: in vitro test. Nature 274(5669): 315-316
Wadman, M. 2005: Cancer chief embraces top drugs job. Nature 437(7059): 606
Chang, S. 2013: Cancer chromosomes going to POT1. Nature Genetics 45(5): 473-475
DePinho, R.A.; Polyak, K. 2004: Cancer chromosomes in crisis. Nature Genetics 36(9): 932-934
Yang, H.; Wei, Q.; Li, D.; Wang, Z. 2020: Cancer classification based on chromatin accessibility profiles with deep adversarial learning model. Plos Computational Biology 16(11): E1008405
Nguyen, T.T.H.; Nguyen, P.V.; Tran, Q.V.; Vo, N.X.; Vo, T.Q. 2020: Cancer classification from microarray data for genomic disorder research using optimal discriminant independent component analysis and kernel extreme learning machine. International Journal for Numerical Methods in Biomedical Engineering 36(9): E3372
Waters, D.J.; Wildasin, K. 2006: Cancer clues from pet dogs. Scientific American 295(6): 94-101
Lim, H.; Lee, Y-Han.; Bae, S.; Koh, D-Hyun.; Yoon, M.; Lee, B-Eun.; Kim, J-Soo.; Kwon, H-Jang. 2021: Cancer cluster among small village residents near the fertilizer plant in Korea. Plos one 16(2): E0247661
Bruusgaard, C. 1956: Cancer coli and recti. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 76(10): 325-328 Passim
Fries, B. 1957: Cancer coli, symptomatology and diagnosis. Svenska Lakartidningen 54(43): 3205-3216
Bollag, W.; Majewski, S.; Jablonska, S. 1994: Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia 8(Suppl 3): S11-S15
Knight, J. 2001: Cancer comes under scrutiny in fresh genomics initiative. Nature 410(6831): 855
Schoormans, D.; Widdershoven, J.W.; Mommersteeg, P.M.C. 2020: Cancer comorbidity in patients with non-obstructive coronary artery disease: Depressive symptoms related to C-reactive protein. BrainBehaviorandImmunity-Health 5: 100088
Check Hayden, E. 2008: Cancer complexity slows quest for cure. Nature 455(7210): 148
Warner, E.L.; Wilson, A.; Ellington, L.; Sun, Y.; Cloyes, K.G.; Waters, A.R.; Nelson, T.; Kirchhoff, A.C. 2021: Cancer content and social media platform influence young adult cancer caregivers' social support on social media. Journal of Psychosocial Oncology 2021: 1-8
Mensah, K.B.; Mensah, A.B.B. 2020: Cancer control in Ghana: a narrative review in global context. Heliyon 6(8): E04564
Malan, G. 1951: Cancer control in the United States. Minerva Medica 42(33): Varia 505
Miller, B.S. 1952: Cancer control in the United States. El Dia Medico 24(18): 397-402
Cameron, C.S. 1948: Cancer control in the United States. Journal of the American Medical Women's Association 3(4): 166-168
Engstrom, P.F. 1986: Cancer control objectives for the year 2000. Progress in Clinical and Biological Research 216: 1-10
Kim, J.; Shin, N. 2021: Cancer coping, healthcare professionals' support and posttraumatic growth in brain-tumor patients. Psychology Health and Medicine 2021: 1-8
Simopoulos, D.N.; Sisk, A.E.; Priester, A.; Felker, E.R.; Kwan, L.; Delfin, M.K.; Reiter, R.E.; Marks, L.S. 2019: Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage. Bju International 124(2): 275-281
Palca, J. 1989: Cancer data are puzzling. Nature 338(6215): 449
Jiang, Z.; Zhang, Y.; Zhang, Y.; Jia, Z.; Zhang, Z.; Yang, J. 2021: Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression. Cell Communication and Signaling: Ccs 19(1): 93
Ibrahim, S.A.; Kulshrestha, A.; Katara, G.K.; Amin, M.A.; Beaman, K.D. 2016: Cancer derived peptide of vacuolar ATPase 'a2' isoform promotes neutrophil migration by autocrine secretion of IL-8. Scientific Reports 6: 36865
Harrington, M. 2014: Cancer detection by fruit fly olfaction. Lab Animal 43(3): 76
El-Shenawee, M.; Vohra, N.; Bowman, T.; Bailey, K. 2019: Cancer detection in excised breast tumors using terahertz imaging and spectroscopy. Biomedical Spectroscopy and Imaging 8(1-2): 1-9
Loeb, R.A. 1959: Cancer detection in general practice. Gp 19(4): 114-119
Green, T.; Atkin, K.; Macleod, U. 2015: Cancer detection in primary care: insights from general practitioners. British Journal of Cancer 112 Suppl. 1: S41-S49
Abdulla, U.G.; Bukshtynov, V.; Seif, S. 2021: Cancer detection through Electrical Impedance Tomography and optimal control theory: theoretical and computational analysis. Mathematical Biosciences and Engineering: Mbe 18(4): 4834-4859
Biller-Andorno, N. 2014: Cancer detection: Breast-screening trials are ethical. Nature 511(7508): 155
The Lancet Oncology 2020: Cancer detection: the quest for a single liquid biopsy for all. LANCET. Oncology 21(6): 733
Zhuang, L.; Fitzgerald, R.C. 2017: Cancer development: Origins in the oesophagus. Nature 550(7677): 463-464
Kristiansen, M.Fríðheim.; Petersen, M.Skaalum.; Strøm, M. 2021: Cancer diagnosed during the COVID-19 pandemic in the Faroe Islands. Acta Oncologica 2021: 1-3
Myerson, R.; Lu, T.; Yuan, Y.; Liu, G.Guo-En. 2019: Cancer diagnosis and care among rural-to-urban migrants in China. Bmj Global Health 4(6): E001923
Weller, D. 2020: Cancer diagnosis and treatment in the COVID-19 era. European Journal of Cancer Care 29(3): E13265
Gómez-Moreno, M.; Sánchez-Seco, V.G.án.; Moreno-García, S.; Cámara, P.S.; Sabin-Muñoz, J.; Ayuso-Peralta, L.; Oreja-Guevara, C.; Díaz-Díaz, J.; Sainz de la Maza, S.; Costa-Frossard, L.; Pilo de la Fuente, B.én.; Aladro-Benito, Y. 2021: Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment. Multiple Sclerosis and Related Disorders 49: 102747
Wilkinson, A.N. 2021: Cancer diagnosis in primary care: Six steps to reducing the diagnostic interval. Canadian Family Physician Medecin de Famille Canadien 67(4): 265-268
Buchner, M.; Gabsch, H.C. 1954: Cancer diagnosis in the laboratory. Zeitschrift für Arztliche Fortbildung 48(14): 486-491
Collins, J.H. 1949: Cancer diagnosis through cytological study. Ginecologia y Obstetricia de Mexico 4(2-3): 180-184
Xiao, Y.; Wu, J.; Lin, Z. 2021: Cancer diagnosis using generative adversarial networks based on deep learning from imbalanced data. Computers in Biology and Medicine 135: 104540
Zhang, C.; Zhao, Y.; Xu, X.; Xu, R.; Li, H.; Teng, X.; Du, Y.; Miao, Y.; Lin, H-Chu.; Han, D. 2020: Cancer diagnosis with DNA molecular computation. Nature Nanotechnology 15(8): 709-715
Condon, L.; Curejova, J.; Leeanne Morgan, D.; Fenlon, D. 2021: Cancer diagnosis, treatment and care: a qualitative study of the experiences and health service use of Roma, Gypsies and Travellers. European Journal of Cancer Care 30(5): E13439
Hamilton, W. 2020: Cancer diagnostic delay in the COVID-19 era: what happens next?. LANCET. Oncology 21(8): 1000-1002
Schraw, J.M.; Desrosiers, T.A.; Nembhard, W.N.; Langlois, P.H.; Meyer, R.E.; Canfield, M.A.; Rasmussen, S.A.; Chambers, T.M.; Spector, L.G.; Plon, S.E.; Lupo, P.J. 2020: Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer 126(15): 3483-3492
Medina-Lara, A.; Grigore, B.; Lewis, R.; Peters, J.; Price, S.; Landa, P.; Robinson, S.; Neal, R.; Hamilton, W.; Spencer, A.E. 2020: Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technology Assessment 24(66): 1-332
Uhr, J.W. 2007: Cancer diagnostics: one-stop shop. Nature 450(7173): 1168-1169
Dierge, E.; Larondelle, Y.; Feron, O. 2020: Cancer diets for cancer patients: Lessons from mouse studies and new insights from the study of fatty acid metabolism in tumors. Biochimie 178: 56-68
Astigueta-Pérez, J.; Abad-Licham, M.; Chávez-Chirinos, C.; Beraun-Milla, L.; Lachos-Dávila, A.; Diaz-Pérez, E.; Portugal-Valdivia, K.; Castañeda, P.P.; Alférez, I.ía.P.ér.; Mezones-Holguín, E. 2020: Cancer disease progression and death during the COVID-19 pandemic: a multidisciplinary analysis for the Peruvian setting. Ecancermedicalscience 14: 1098
Hoehn, R.S.; Zureikat, A.H. 2020: Cancer disparities in the COVID-19 era. Journal of Surgical Oncology 122(3): 371-372
Mired, D.; Johnson, S.; Tamamyan, G. 2020: Cancer disparities in war-torn and post-war regions. Nature Reviews. Cancer 20(7): 359-360
Lubek, J.E. 2020: Cancer does not care about coronavirus. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 130(3): 229-230
Uhr, J.W.; Scheuermann, R.H.; Street, N.E.; Vitetta, E.S. 1997: Cancer dormancy: opportunities for new therapeutic approaches. Nature Medicine 3(5): 505-509
Tang, J.; Li, Y.; Lyon, K.; Camps, J.; Dalton, S.; Ried, T.; Zhao, S. 2014: Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer. Oncogene 33(7): 814-822
Kong, X.; Kuilman, T.; Shahrabi, A.; Boshuizen, J.; Kemper, K.; Song, J-Ying.; Niessen, H.W.M.; Rozeman, E.A.; Geukes Foppen, M.H.; Blank, C.U.; Peeper, D.S. 2017: Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. Nature 550(7675): 270-274
Mullard, A. 2015: Cancer drug developers counteract kinase gatekeeper mutations. Nature Reviews. Drug Discovery 14(10): 667-668
Holohan, C.; Van Schaeybroeck, S.; Longley, D.B.; Johnston, P.G. 2013: Cancer drug resistance: an evolving paradigm. Nature Reviews. Cancer 13(10): 714-726
Schubert, C. 2011: Cancer drugs find a companion with new diagnostic tests. Nature Medicine 17(10): 1157
Hoag, H. 2011: Cancer drugs should add months, not weeks, say experts. Nature Medicine 17(1): 7
Wilkie, A.O.M. 2007: Cancer drugs to treat birth defects. Nature Genetics 39(9): 1057-1059
Swinbanks, D. 1989: Cancer drugs: restrictions recommended. Nature 342(6252): 843
Igiraneza, P.C.él.és.; Omondi, L.A.; Nikuze, B.; Uwayezu, M.G.; Fitch, M.; Niyonsenga, G. 2021: Cancer du sein chez les Rwandaises en âge de procréer du district sud de Kayonza : facteurs influençant les pratiques de dépistage. Canadian Oncology Nursing Journal 31(3): 258-265
Spallone, G.; Ventura, A.; Mazzeo, M.; DI Raimondo, C.; Lombardo, P.; Silvaggio, D.; Bianchi, L. 2021: Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab. Italian Journal of Dermatology and Venereology 156(1): 112-113
Patni, N.; Hota, A.; Patni, A.; Misra, P. 2021: Cancer during Corona Pandemic: Plight of cancer patients when two evils join hands. Current Problems in Cancer 45(3): 100671
Stafford, L.; Sinclair, M.; Gerber, K.; Collins, L.; Newman, L.; Saunders, C.; Ives, A.; Mason, K.D.; Peate, M.; Lippey, J.; Umstad, M.P.; Shanahan, K.; Little, R. 2021: Cancer during pregnancy: a qualitative study of healthcare experiences of Australian women. European Journal of Cancer Care 30(4): E13425
Barrois, M.; Anselem, O.; Pierga, J.Y.; Goldwasser, F.ço.; Bouscary, D.; Alessandrini, V.; Goffinet, F.ço.; Tsatsaris, V. 2021: Cancer during pregnancy: Factors associated with termination of pregnancy and perinatal outcomes. European Journal of Obstetrics Gynecology and Reproductive Biology 261: 110-115
Gomes, J.S.; Sand, I.C.P.V.d.; Girardon-Perlini, N.M.O. 2021: Cancer during pregnancy: from the diagnosis to the repercussions on the family experience of maternity. Revista da Escola de Enfermagem da U S P 55: E20200518
Amulree, B.L. 1951: Cancer education in Great Britain. Acta - Unio Internationalis Contra Cancrum 7(2 Spec. No.): 181-182
Tafur, A.J.; Wysokinski, W.E.; McBane, R.D.; Wolny, E.; Sutkowska, E.; Litin, S.C.; Daniels, P.R.; Slusser, J.P.; Hodge, D.O.; Heit, J.A. 2012: Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 23(8): 1998-2005
Menya, D.; Oduor, M.; Kigen, N.; Maina, S.K.; Some, F.; Kibosia, C.; Chumba, D.; Murgor, F.A.; Carel, R.S.; Middleton, D.R.S.; Abebi-Ardekani, B.; Schüz, J.; McCormack, V.A. 2018: Cancer epidemiology fieldwork in a resource-limited setting: Experience from the western Kenya ESCCAPE esophageal cancer case-control pilot study. Cancer Epidemiology 57: 45-52
Peto, J. 2001: Cancer epidemiology in the last century and the next decade. Nature 411(6835): 390-395
Dickman, S. 1991: Cancer epidemiology. Gold mine in east Germany. Nature 349(6312): 728
Jones, P.A.; Laird, P.W. 1999: Cancer epigenetics comes of age. Nature Genetics 21(2): 163-167
Rodríguez-Paredes, M.; Esteller, M. 2011: Cancer epigenetics reaches mainstream oncology. Nature Medicine 17(3): 330-339
Wilkinson, A.W.; Gozani, O. 2017: Cancer epigenetics: Reading the future of leukaemia. Nature 543(7644): 186-188
Burgess, D.J. 2017: Cancer epigenetics: Therapy-induced transcription is cryptically widespread. Nature Reviews. Genetics 18(8): 455
Tsai, H-Chen.; Baylin, S.B. 2011: Cancer epigenetics: linking basic biology to clinical medicine. Cell Research 21(3): 502-517
Esteller, M. 2007: Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Reviews. Genetics 8(4): 286-298
Zhu, X.; Li, S.; Xu, B.; Luo, H. 2021: Cancer evolution: a means by which tumors evade treatment. Biomedicine and PharmacoTherapy 133: 111016
Vendramin, R.; Litchfield, K.; Swanton, C. 2021: Cancer evolution: Darwin and beyond. EMBO Journal 40(18): E108389
Swanton, C. 2014: Cancer evolution: the final frontier of precision medicine?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 25(3): 549-551
Matsushita, H.; Vesely, M.D.; Koboldt, D.C.; Rickert, C.G.; Uppaluri, R.; Magrini, V.J.; Arthur, C.D.; White, J.Michael.; Chen, Y-Shiuan.; Shea, L.K.; Hundal, J.; Wendl, M.C.; Demeter, R.; Wylie, T.; Allison, J.P.; Smyth, M.J.; Old, L.J.; Mardis, E.R.; Schreiber, R.D. 2012: Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482(7385): 400-404
Jiang, M.; Zhang, W.; Zhang, R.; Liu, P.; Ye, Y.; Yu, W.; Guo, X.; Yu, J. 2020: Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer. Oncogene 39(24): 4681-4694
Madeo, M.; Colbert, P.L.; Vermeer, D.W.; Lucido, C.T.; Cain, J.T.; Vichaya, E.G.; Grossberg, A.J.; Muirhead, D.; Rickel, A.P.; Hong, Z.; Zhao, J.; Weimer, J.M.; Spanos, W.C.; Lee, J.H.; Dantzer, R.; Vermeer, P.D. 2018: Cancer exosomes induce tumor innervation. Nature Communications 9(1): 4284
Teare, M.D.; Wallace, S.A.; Harris, M.; Howell, A.; Birch, J.M. 1994: Cancer experience in the relatives of an unselected series of breast cancer patients. British Journal of Cancer 70(1): 102-111
Meidani, A. 2020: Cancer experiences, interactions of care and gender. Soins; la Revue de Reference Infirmiere 65(845): 33-35
Ledford, H. 2016: Cancer experts unveil wishlist for US government 'moonshot'. Nature 537(7620): 288-289
Lim, J.; Cho, H.; Bunds, K.S.; Lee, C-Won. 2020: Cancer family caregivers' quality of life and the meaning of leisure. Health Care for Women International 2020: 1-21
Schünemann, M.; Anker, S.D.; Rauchhaus, M. 2008: Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards onco-cardiology. Nature Clinical Practice. Oncology 5(11): 632-633
Vrinten, C.; Wardle, J.; Marlow, L.Av. 2016: Cancer fear and fatalism among ethnic minority women in the United Kingdom. British Journal of Cancer 114(5): 597-604
Check, E. 2003: Cancer fears cast doubts on future of gene therapy. Nature 421(6924): 678
Goldacre, M.J.; Wotton, C.J.; Seagroatt, V.; Yeates, D. 2005: Cancer following hip and knee arthroplasty: record linkage study. British Journal of Cancer 92(7): 1298-1301
Schultz, D.éb.B.; Nascimento, F.áb.A.; Camargo, C.H.F.; Ashizawa, T.; Teive, H.él.A.G. 2020: Cancer frequency in patients with spinocerebellar ataxia type 10. Parkinsonism and Related Disorders 76: 1-2
Ratajczak, M.Z.; Bujko, K.; Mack, A.; Kucia, M.; Ratajczak, J. 2018: Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms. Leukemia 32(12): 2519-2526
Borisov, N.; Sorokin, M.; Tkachev, V.; Garazha, A.; Buzdin, A. 2020: Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments. Bmc Medical Genomics 13(Suppl 8): 111
Mendiratta, G.; Ke, E.; Aziz, M.; Liarakos, D.; Tong, M.; Stites, E.C. 2021: Cancer gene mutation frequencies for the U.S. population. Nature Communications 12(1): 5961
Dai, W.; Wu, J.; Wang, D.; Wang, J. 2020: Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres. Gene Therapy 27(6): 266-280
Bougeret, C.; Virone-Oddos, A.; Adeline, E.; Lacroix, F.; Lefranc, C.; Ferrero, L.; Huet, T. 2000: Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2. Cancer Gene Therapy 7(5): 789-798
Qazilbash, M.H.; Xiao, X.; Seth, P.; Cowan, K.H.; Walsh, C.E. 1997: Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53. Gene Therapy 4(7): 675-682
Kim, C-Y.; Jeong, M.; Mushiake, H.; Kim, B-M.; Kim, W-B.; Ko, J.P.; Kim, M-H.; Kim, M.; Kim, T-H.; Robbins, P.D.; Billiar, T.R.; Seol, D-W. 2006: Cancer gene therapy using a novel secretable trimeric TRAIL. Gene Therapy 13(4): 330-338
Yamabe, K.; Shimizu, S.; Ito, T.; Yoshioka, Y.; Nomura, M.; Narita, M.; Saito, I.; Kanegae, Y.; Matsuda, H. 1999: Cancer gene therapy using a pro-apoptotic gene, caspase-3. Gene Therapy 6(12): 1952-1959
Ren, C.; Kumar, S.; Chanda, D.; Kallman, L.; Chen, J.; Mountz, J.D.; Ponnazhagan, S. 2008: Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Therapy 15(21): 1446-1453
Song, W.; Dong, Z.; Jin, T.; Mantellini, M.G.; Núñez, G.; Nör, J.E. 2008: Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. Cancer Gene Therapy 15(10): 667-675
Gottesman, M.M. 2003: Cancer gene therapy: an awkward adolescence. Cancer Gene Therapy 10(7): 501-508
McCormick, F. 2001: Cancer gene therapy: fringe or cutting edge?. Nature Reviews. Cancer 1(2): 130-141
Rak, J. 2021: Cancer genes and blood clots. Blood 137(15): 1996-1997
Vogelstein, B.; Kinzler, K.W. 2004: Cancer genes and the pathways they control. Nature Medicine 10(8): 789-799
Harris, A.L. 1991: Cancer genes. Telling changes of base. Nature 350(6317): 377-378
Ledford, H. 2019: Cancer geneticists tackle troubling ethnic bias in studies. Nature 568(7751): 154-155
Griffith, G.L.; Edwards, R.T.; Gray, J. 2004: Cancer genetics services: a systematic review of the economic evidence and issues. British Journal of Cancer 90(9): 1697-1703